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STEREOSELECTIVE RADICAL CYCLOPROPANATION REACTIONS OF 
ALKENES VIA COBALT(II)-BASED METALLORADICAL CATALYSIS
1.1 INTRODUCTION
Carbon-centered radicals, specifically alkyl radicals, have been extensively 
explored as versatile intermediates for chemical synthesis because of their potent reactivity 
and diverse pathways.1 Among their important synthetic applications, alkyl radicals are 
well demonstrated to undergo radical additions, atom abstraction reactions, and varied 
fragmentation reactions, for construction of diversified organic molecules. Despite the rich 
reaction profiles of alkyl radicals, their reactivity and selectivity in the context of free 
radical reactions are, in general, difficult to control largely due to their free nature. 
To harness the vast potential of homolytic radical reactions for stereoselective 
organic synthesis,2 metalloradical catalysis (MRC) has recently been introduced as a 
conceptually new approach for addressing some enduring challenges in the field.3,4 With 
cobalt(II) complexes of D2-symmetric amidoporphyrins [Co(Por)], known to adopt a low-
spin ground state with (dxy)2(dxz,yz)4(dz2)1 electron configuration, as well-defined 
metalloradical catalysts, they are highly capable of activating various diazo compounds to 
generate [Co(Por)]-supported carbon-centered radicals (α-Co(III)-alkyl radicals) and 
release nitrogen gas as the only byproduct (Scheme 1.1).5 The bonding interaction is thus 
dominated by the formation of a covalent Co–C bond between Co-dz2 orbital and the 
carbon’s sp2 orbital. Additional bond interaction between Co-dxz/yz and carbon’s p 
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orbitals, a common feature in classic metallocarbene complexes, is only fractional in part 
due to the fully-filled dxz/yz and singly-filled p orbitals. These metal-supported alkyl 
radicals have been shown to subsequently undergo a variety of typical radical reactions, 
especially radical addition reactions to alkenes for asymmetric cyclopropanation reactions 
with effective control of reactivity and stereoselectivity.
Scheme 1.2|| Molecular Orbital Diagram, the Bonding Interactions of Metalloradical 
Catalysts and Their Related Metalloalkyl Radicals
 
 Optically active cyclopropanes are widely used as versatile synthetic building 
blocks in organic chemistry. They are also commonly found as basic structural elements in 
a wide range of naturally occurring compounds and pharmaceuticals. As a robust strategy, 
transition metal-catalyzed asymmetric cyclopropanation of olefins with diazo compounds 
has emerged as one of the most extensively studied reactions to construct optically active 
three-membered carbocycles.6 The catalytic pathways are generally recognized through an 
electrophilic addition of the Fischer-type metallocarbene intermediates to olefin 
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compounds, termed as an electrophilic [1+2] addition. In the past years, various diazo 
compounds have been continuously applied for stereoselective cyclopropanation of 
alkenes through the development of a variety of metal complexes as the catalysts. For 
example, Rh2(II)- and Cu(I)-based complexes have been shown to be effective for a wide 
range of asymmetric cyclopropanation reactions, producing chiral cyclopropane 
derivatives with high level of optical purity.6 While many systems have been elegantly 
developed, there are still several remaining major challenges associated with 
metallocarbene cyclopropanation. On one hand, existing catalytic systems generally work 
well with styrene derivatives as well as some electron-rich olefins. Nevertheless, 
asymmetric cyclopropanation of electron-deficient olefins have been troublesome 
presumably due to the electrophilic nature of the formed metal-carbene intermediates in 
the catalytic cycles. On the other hand, the applications of utilizing acceptor/acceptor-
substituted diazo compounds and donor-substituted diazo compounds for asymmetric 
olefin cyclopropanation are rarely reported. For instance, with diazo compounds containing 
two adjacent electron-withdrawing groups, they have inherently low reactivity with Lewis 
acidic metal catalysts for the formation of corresponding metallocarbene intermediates. 
Even if generated under forcing conditions, their subsequent reactions towards olefins are 
often difficult to control in terms of enantioselectivity due to the high electrophilicity of 
the acceptor/acceptor-substituted metallocarbenes.6-7 It is noteworthy to mention that the 
dimerization of diazo compounds is a common side reaction in cyclopropanation systems, 
which usually require the use of excess olefins and slow addition of the diazo compounds 
to minimize this side reaction although they are not ideally practical.8
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Fundamentally different from the previous electrophilic catalytic systems, 
asymmetric radical cyclopropanation reactions via Co(II)-based metalloradical catalysis 
have been shown to be highly capable of constructing a wide array of enantioenriched 
cyclopropane derivatives. The successful development of these radical cyclopropanation 
systems provides a complementary synthetic strategy to solve the aforementioned major 
challenges that associate with the previous 2e systems in the area of olefin 
cyclopropanation. In this review, we will provide an overview the recent progress in 
[Co(Por)]-catalyzed stereoselective radical cyclopropanation reactions with various diazo 
compounds as radical precursors, including acceptor/H-, acceptor/acceptor-, donor/H-
substituted diazo compounds as shown in Scheme 1.2. 
Scheme 1.2|| Asymmetric Radical Olefin Cyclopropanation with Different Diazo 
Compounds via Co(II)-Based Metalloradical Catalysis (MRC)
1.2 SYNTHESIS OF COBALT(II) COMPLEXES OF D2-SYMMETRIC 
CHIRAL PORPHYRINS
As stable 15e metalloradicals, Co(II) complexes of porphyrins embrace excellent 
thermal stability and metal coordination stability due to the macrocyclic chelation effect 
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via the well-defined tetra-coordination. Based on the planar porphyrin backbone, the
physical and chemical properties of the corresponding [Co(Por)] catalysts, in principle, can 
be systematically decorated through the installation of different substituents onto the 
aromatic ring structure of porphyrin ligands. Despite these unique features, one major issue 
that might impede the potential applicability of Co(II)-porphyrins for asymmetric catalysis 
is searching for facile and robust synthetic methods to access a range of chiral porphyrins
with varied electronic, steric, and chiral environments. In this regard, our group have 
developed a general and durable synthetic protocol for the rapid construction of D2-
symmetric chiral porphyrins via palladium-catalyzed quadruple cross-coupling reactions 
by using 5,15-bis(2’,6’-dibromophenyl)porphyrins as synthons.9 As depicted in Scheme 
1.3, the tetrabromoporphyrin synthon could be constructed from 2,2'-((2,6-
dibromophenyl)methylene)bis(1H-pyrrole) and commercially available aldehydes via
MacDonald [2+2] porphyrin synthesis by using Lindsey’s condition.10 The resulting core 
structures feature two meso-R groups at the 10- and 20-positions to modulate the electronic 
and steric properties.
Scheme 1.3|| General Synthetic Route for Synthesis of 5,15-Bis(2’,6’-
dibromophenyl)porphyrins Synthons
 
Chapter 1. Review on Asymmetric Radical Cyclopropanation via Co(II)-MRC  
Upon the formation of tetrabromoporphyrin synthons, the combination of 
Pd(OAc)2 and XantPhos could effectively catalyze the quadruple amidation reactions of 
the tetrabromoporphyrin synthons with optically pure amides to afford a series of chiral 
porphyrin ligands in up to 90% yield (Scheme 1.4).11 With the subsequent cobalt metalation 
step, D2-symmetric Co(II) complexes of chiral porphyrins could usually be synthesized as 
stable purple solids in high yields.
Scheme 1.4|| General Synthetic Route for Cobalt(II) Complexes of D2-Symmetric 
Chiral Porphyrins [Co(D2-Por*)]
 
The representative structures of the Co(II)-based amidoporphyrin catalysts are 
displayed in Scheme 1.5. These D2-symmetric catalysts commonly embrace the following 
features: First, to minimize the steric repulsion, four substituted phenyl groups usually 
adopt a conformation that is almost perpendicular to the porphyrin plane. This unique 
geometry also enables the chiral amido groups as well as the nonchiral substituents on 10-
and 20-position of the porphyrin to frame a cavity-like environment for asymmetric 
catalytic reactions. Second, with the partial double bond character of the four amido C−N 
bonds, the chiral units would have a good sense of rigidity for asymmetric induction, while
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maintain a certain degree of flexibility to accommodate different substrates during catalytic 
reactions. Finally, the nonchiral substituents are also essential for the catalyst environment,
because they would allow the facile modulation of cavity size, as well as the orientation of 
four chiral units. 
Scheme 1.5|| Selected Examples of Cobalt(II) Complexes of D2-Symmetric Chiral 
Porphyrins [Co(D2-Por*)] 
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1.3 COBALT(II) PORPHYRIN-CATALYZED ASYMMETRIC RADICAL 
CYCLOPROPANATION WITH ACCEPTOR/H-SUBSTITUTED DIAZO
1.3.1 Asymmetric Radical Cyclopropanation with Alkyl Diazoacetates
As the benchmark reaction, alkyl diazoacetates were first employed successfully as 
radical precursors for asymmetric cyclopropanation of styrene by using the first generation 
catalyst: cobalt(II) complex of a D2-symmetric chiral porphyrin 3,5-DitBu-ChenPhyrin, 
[Co(P1)] (Scheme 1.6).11 The desired cyclopropanes were obtained in up to 88% yield with 
>99:1 dr and 98% ee. It is noteworthy to mention that the [Co(P1)]-based metalloradical
cyclopropanation system could be effectively operated in an one-time fashion with alkenes 
as limiting reagents. In addition, the dimerization of diazo compounds, a common side 
reaction in metal-carbene transfer processes, is significantly minimized, obviating the
Scheme 1.6|| [Co(P1)]-Catalyzed Asymmetric Radical Cyclopropanation of Styrene 
with Diazoacetate
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slow addition of diazo compounds. No significant formation of dimerization side products
also suggests that Co-supported alkyl radical species distinctively favor addition to olefins 
rather than dimerization with another molecule of diazo compound. These complementary 
attributes are found to be quite general and suitable for all the radical cyclopropanation 
systems we developed later on. 
Scheme 1.7|| Postulated Mechanism for [Co(P1)]-Catalyzed Asymmetric Radical 
Cyclopropanation of Styrene with Diazoacetates
 
The plausible reaction mechanism of this radical cyclopropanation system was 
proposed in Scheme 1.7. In addition to the rigidity and the cavity-like conformation of the 
catalyst, we rationalized that the key to achieve the well-controlled reactivity and 
selectivity of this radical process might be also due to the hydrogen bonding interaction 
between the chiral amide N–H unit on the ligand and the carbonyl unit of the carbene 
moiety, which plays an important role to further rigidify the radical intermediates A (α-
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Co(III)-alkyl radicals) for enantioselective radical olefin addition to generate intermediates 
B (γ-Co(III)-alkyl radicals), and also presumably accelerate the reaction rate by lowering 
their energy in the transition state (Scheme 1.7). During the investigation, we found that 
the use of DMAP as the additive could significantly enhance the overall diastereo- and 
enantioselectivity of the radical cyclopropanation process albeit with slightly decreased 
yield.11,12
Further investigation showed that styrene and its derivatives bearing varied 
electronic and steric properties can be cyclopropanated with tert-butyl diazoacetate in high 
yields with excellent control of trans-selectivity and enantioselectivity (Scheme 1.8).11,13
Notably, this asymmetric radical system remains its high trans-selectivity when other 
diazoacetates, such as less sterically hindered ethyl diazoacetate were used.
Scheme 1.8|| Asymmetric Radical Cyclopropanation of Different Styrene Derivatives 
with Diazoacetates Catalyzed by [Co(P1)]
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After the initial results, we have further expanded the potential of this radical 
cyclopropanation system to tackle some of the long-standing challenges in metal-mediated 
carbene cyclopropanation (Scheme 1.9). As discussed, Fischer-type carbene species 
generally favor reactions with electron-rich olefins. The metal-carbene radical 
intermediates may be less sensitive to the electronic property of the alkenes used, enabling 
a broader spectrum of olefin scope, especially the electron-deficient ones. Such a 
hypothesis has led us to the discovery of stereoselective radical cyclopropanation of 
electron-deficient olefins by Co(II)-based MRC. By using [Co(P1)] as the catalyst, we 
reported the first transition metal-catalyzed asymmetric cyclopropanation of electron-
deficient olefins, including unsaturated esters, amides, ketones, and nitriles (Scheme 1.9).14 
Scheme 1.9|| [Co(P1)]-Catalyzed Asymmetric Radical Cyclopropanation of Electron-
Deficient Olefins with tert-Butyl Diazoacetate
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With the absence of dimerization of diazo compounds, the catalytic reactions were 
performed under mild conditions in a one-pot protocol using olefins as the limiting 
reagents, forming the desired electrophilic cyclopropane derivatives in high yields. In most 
cases, both excellent diastereo- and enantioselectivities were achieved. 
The exceptional reactivity of Co(II)-based MRC towards electron-deficient olefins 
implies some nucleophilic character of the formed α-Co(III)-alkyl radical (vide supra, 
Scheme 1.7), which further differentiate [Co(Por)]-based radical cyclopropanation systems 
from typical electrophilic (Fischer-type) transition-metal carbene-mediated 
cyclopropanation systems. In collaboration with Prof. de Bruin, we carried out a 
comprehensive study on the mechanism of [Co(Por)]-catalyzed cyclopropanation of 
olefins with diazoacetates.5a EPR and HRMS experiments in combination with DFT 
calculations supported an unprecedented stepwise radical reaction mechanism of the 
Co(II)-catalyzed cyclopropanation (vide supra, Scheme 1.7). DFT calculations suggested 
the Co(II)-based metalloradical is able to decompose diazo compounds to generate an 
unusual α-Co(III)-alkyl radical (A) as the key intermediate of the catalytic cycle. The net 
process may be considered as a radical transfer in which the radical character is transferred 
from the cobalt-center to the α-carbon atom of the diazo moiety. The α-Co(III)-alkyl radical 
(A), which was detected experimentally using EPR and HRMS techniques, is capable of 
undergoing common radical reactions such as radical addition and substitution.5 
Consequently, radical addition of the radical intermediate A to the C=C bond of olefin 
substrates results in further radical transfer to form the -Co(III)-alkyl radical (B), which 
subsequently undergoes ring-closure reaction via intramolecular radical substitution by 
breaking the relatively weak Co–C bond and regenerates the metalloradical catalyst. Both 
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the α-Co(III)-alkyl radical and -Co(III)-alkyl radical are essentially carbon-based radicals, 
however, they are not “free” any more as their reactivity and selectivity are well regulated 
by the electronic, steric, and chiral environments of the covalently-attached [Co(Por)] 
moiety. Further computational study suggests that the carbon radical center in the 
intermediate A bears certain nucleophilicity, which makes its exceptional reactivity toward 
electron-deficient olefin understandable.5b Moreover, it is suggested that the charge of the 
alkyl radical could be deliberately tuned through the introduction of different α-carbon 
substituents of the original diazo compounds. Accordingly, the substituents of diazo 
compounds may be used as tools for tuning the electronic properties of the metal-supported 
alkyl radicals in order to match varied substrates in different carbene transformations.
Encouragingly, experimental observations also allowed us to shed more light on the 
possible existence of the cobalt(III)-alkyl radicals.15 The stoichiometric reaction of 
[Co(TPP)] with ethyl styryldiazoacetate was found to produce a symmetric dinuclear 
cobalt(III) porphyrin complex in 90% yield (Scheme 1.10, left side). The dimeric complex 
was believed to form from radical dimerization of γ-Co(III)-allylic radical resonated from 
the initially generated α-cobalt(III)-allylic radical. In addition to the radical C–C coupling-
based homo-dimerization, the γ-Co(III)-allylic radical intermediate was also effectively 
trapped by the radical scavenger TEMPO, resulting in the hetero-dimerization product via 
a radical C–O coupling reaction in 74% yield (Scheme 1.10, right side). Consistent with 
the computational studies, these experimental results further confirmed the existence of the 
cobalt(III)-alkyl radicals that were proposed as key intermediates in the radical-type 
mechanism of [Co(Por)]-catalyzed cyclopropanation (vide supra, Scheme 1.7).
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Scheme 1.10|| Experimental Evidence for α-Cobalt(III)-Alkyl Radicals: Homo- and 
Hetero-Dimerizations
  
1.3.2 Asymmetric Radical Cyclopropanation with Succinimidyl Diazoacetates
In addition to alkyl diazoacetates, succinimidyl diazoacetates were also 
successfully applied to Co(II)-catalyzed asymmetric radical cyclopropanation of alkenes 
as shown in Scheme 1.11. For example, cyclopropane succinimidyl ester could be prepared 
in 86% yield with >99% de and 92% ee through [Co(P1)]-catalyzed asymmetric 
cyclopropanation of styrene with succinimidyl diazoacetate (N2CHCO2Su).16
To demonstrate the synthetic utility, the resulting cyclopropyl chiral synthons 
permitted the enantioselective synthesis of cyclopropyl carboxamides upon reacting with 
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various amines (Scheme 1.11). The hydroxylsuccinimide ester functionality in the 
enantioenriched chiral synthon was ready to react with a broad range of different amines 
such as the unprotected tripeptide (S)-H2N-Gly-Ala-COOH and D-glucosamine under mild 
conditions to deliver the corresponding cyclopropyl tripeptide and cyclopropyl 
carboxamido sugar, respectively. 
Scheme 1.11|| Co(II)-Catalyzed Asymmetric Radical Cyclopropanation with 
Succinimidyl Diazoacetates and its Synthetic Applications
 
1.3.3 Asymmetric Radical Cyclopropanation with Diazosulfones
So far, most catalytic cyclopropanation systems typically employ diazocarbonyl 
compounds as carbene sources, the utilization of other acceptor/H-substituted diazo 
compounds in the context of metal-catalyzed asymmetric cyclopropanation has been less 
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developed. To showcase the effectiveness of [Co(Por)]-based catalytic systems, we have 
employed diazosulfones as diazo source, for the first time, for asymmetric radical 
cyclopropanation, leading to the streamlined synthesis of corresponding cyclopropyl 
sulfones in high yields with excellent stereocontrol (Scheme 1.12).17 During the course of 
study, we designed and synthesized a new D2-symmetric chiral porphyrin 2,6-DiMeO-
ZhuPhyrin (P2) as supporting ligand, which features higher rigidity and polarity of the 
chiral environment due to intramolecular hydrogen bonding interactions and the use of the 
cyclic structure of (S)-2-tetrahydofurnancarboxamide as demonstrated by single crystal 
structures. The Co(II) complex of this chiral ligand [Co(P2)] was shown to effectively 
catalyze asymmetric olefin cyclopropanation with diazosulfones. The catalytic system can 
be generally applied to various aromatic olefins as well as electron-deficient olefins, 
leading to the high-yielding formation of the corresponding cyclopropyl sulfones with up 
to 99% de and 97% ee.
The model of hydrogen bonding interactions (Scheme 1.12, in the middle) also well 
explains the high reactivity and selectivity for this Co(II)-based MRC system. In addition 
to the ligand–diazo interaction, the hydrogen bonding in [Co(P2)] itself tends to prevent 
the chiral units from free rotation through a rigid bicyclic-like conformation. In this way,
the chiral units of the catalyst is not only further rigidified, but also forced closer to the 
metal center to better transfer the chiral information.17-18
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Scheme 1.12|| [Co(P2)]-Catalyzed Diastereo- and Enantioselective Cyclopropanation 
of Different Alkenes with Diazosulfones
 
1.4 COBALT(II) PORPHYRIN-CATALYZED ASYMMETRIC RADICAL 
CYCLOPROPANATION WITH ACCEPTOR/ACCEPTOR DIAZO 
Diazo compounds bearing two electron-withdrawing groups, namely 
acceptor/acceptor-substituted diazo compounds, typically suffer low reactivity and poor 
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enantioselectivity in transition metal-catalyzed carbene transfer cyclopropanation 
reactions, presumably due to the electrophilic nature of formed Fischer-type 
metallocarbene intermediates.6,7 In contrast to the 2e catalytic systems, Co(II)-based 1e 
cyclopropanation mode has emerged as a possible solution to this challenge partially 
because radical pathways are in general less influenced by electronic properties. 
1.4.1 Asymmetric Radical Cyclopropanation with Alkyl α-Nitrodiazoacetates
Initial efforts were focused on the evaluation of α-nitrodiazoacetate (NDAs) as 
potential radical precursors for the cyclopropanation of styrene by different [Co(Por)] 
catalysts (Scheme 1.13).19 By using ethyl α-nitrodiazoacetate (ENDA) as radical precursor, 
it was found that Co(TPP) displayed very low reactivity and diastereoselectivity. 
Considering the two electron-withdrawing α-substituents of ENDA are usually suitable 
hydrogen bonding acceptors, it is anticipated that the D2-symmetric chiral 
amidoporphyrins might possibly facilitate the catalytic reactivity and selectivity by 
enabling double hydrogen bonding interactions between two of the chiral amide N–H 
moieties on the ligand and both electron-withdrawing groups of the carbene moiety. 
Indeed, with [Co(P1)] as the metalloradical catalyst, the experimental results confirmed 
our hypothesis by affording a dramatically accelerated cyclopropanation process.19 In 
addition to the evidently promoted reactivity towards these less reactive diazo compounds, 
the potential double hydrogen bonding interactions also rigidify the α-cobalt(III)-alkyl 
radical intermediate towards its subsequent radical addition to the olefin substrates, which 
lead to a high level of stereocontrol. 
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Scheme 1.13|| Enantioselective Z-Cyclopropanation of Styrene with Ethyl α-Nitro 
Diazoacetate: [Co(TPP)] Versus [Co(P1)]
 
The unique reactivity of [Co(P1)]-based catalytic radical system toward this 
challenging diazo compounds is general and suitable for a wide spectrum of alkenes, like 
electron-sufficient, electron-neutral, and electron-deficient ones, forming the 
corresponding optically active cyclopropyl nitroester compounds in up to 98% yield 
(Scheme 1.14). In addition to high diastereo- and enantioselectivity, the catalytic process 
exhibits the atypical Z-selectivity. The system also represents the first highly effective and 
selective catalytic system for asymmetric cyclopropanation with acceptor/acceptor-
substituted diazo compounds as the radical source.20
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Scheme 1.14|| [Co(P1)]-Catalyzed Asymmetric Z-Cyclopropanation Reactions of 
Different Alkenes with Alkyl α-NitroDiazoacetates
  
1.4.2 Asymmetric Radical Cyclopropanation with α-Cyanodiazoacetates
By adopting the aforementioned double H-bonding hypothesis, another type of 
acceptor/acceptor-substituted diazo compounds, α-cyanodiazoacetates (CDAs), were also 
attempted, where cyano group is normally considered as a stronger hydrogen bond acceptor 
than a nitro group. The results showed that [Co(P1)] is also an effective catalyst for olefin 
cyclopropanation with tert-butyl α-cyanodiazoacetate (t-BCDA) with even higher 
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stereoselectivity (Scheme 1.15).21 Substrate evaluation revealed that the Co(II)-based
catalytic system is suitable for both aromatic and aliphatic olefins with varied electronic 
properties, affording densely functionalized cyclopropane products with high optical 
purity.
Scheme 1.15|| [Co(P1)]-Catalyzed Asymmetric Radical Cyclopropanation of Alkenes 
with α-Cyanodiazoacetate
  
The resulting enantiomerically enriched 1,1-cyclopropanenitrile esters (Scheme 
1.15), together with previous 1,1-cyclopropanenitro esters (Scheme 1.14), serve as 
versatile building blocks for a number of densely functionalized chiral cyclopropane 
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molecules. For instance, the facile reduction of the cyano, nitro, and ester groups would 
directly lead to the production of enantioenriched cyclopropyl amino acid derivatives and 
amino alcohols, which are of great interest for synthetic and biological applications.
1.4.3 Asymmetric Radical Cyclopropanation with α-Ketodiazoacetates
The dicarbonyl diazo compounds such as α-ketodiazoacetates (KDAs) represent 
one class of important acceptor/acceptor-substituted diazo compounds (Scheme 1.16).22 
The development of asymmetric cyclopropanation reactions with KDAs would be highly 
attractive since the resulting chiral 1,1-cyclopropyl ketoesters serve as versatile synthons, 
which can not only be converted into chiral cyclopropane derivatives with different 
geminal functionalities, but also facilely be transformed into other valuable chiral 
molecules through various ring-opening and ring-expanding reactions in the presence of 
two electron-withdrawing groups at the geminal position. 
Nevertheless, the high enantiocontrol of such a process is mechanistically 
challenging. As illustrated in Scheme 1.16, the postulated α-Co(III)-alkyl radical 
intermediate has to enable effective differentiation between two similar carbonyl groups 
from a common KDA in order to allow the selective radical olefin addition, which is 
rationalized as the enantiodetermining step. Moreover, the 3-exo-tet cyclization of γ-
Co(III)-alkyl radical intermediate is similarly challenging for obtaining high 
diastereoselectivity due to the same issue caused by the two analogous carbonyl-based 
substituents. 
By evaluating different metalloradical catalysts and optimizing reaction conditions, 
we found that [Co(P1)] is a suitable catalyst to effectively activate KDAs and remarkably 
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Scheme 1.16|| [Co(P1)]-Catalyzed Asymmetric Radical Cyclopropanation of Alkenes 
with α-Ketodiazoacetates
   
differentiate the two different acceptor-substituents for the high degree of 
enantioinduction.22 Metalloradical catalyst [Co(P1)] has again been demonstrated to be the 
catalyst of choice for highly asymmetric olefin cyclopropanation with α-ketodiazoacetates 
(KDA) (Scheme 1.16).22 With simple α-acetodiazoacetate, radical cyclopropanation 
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reactions of different kinds of olefins appeared to be highly yielding and selective, leading 
to effective synthesis of 1,1-cyclopropaneketoesters as E diastereoisomers with up to 99%
ee.
1.4.4 Asymmetric Radical Cyclopropanation with Alkyl α-Formyldiazoacetates
To further challenge the capability of Co(II)-based MRC, we have explored the 
feasibility of accessing α-formyldiazoacetates (FDA) as radical precursors for asymmetric 
cyclopropanation reactions.23 From the results shown in Scheme 1.17, upon diazo 
activation by [Co(P1)], the cobalt-supported alkyl radical smoothly underwent a highly 
Scheme 1.17|| [Co(P1)]-Catalyzed Asymmetric Radical Cyclopropanation of Alkenes 
with α-Formyldiazoacetates.
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asymmetric olefin cyclopropanation, without affecting the otherwise reactive aldehyde 
functionality. This asymmetric radical process is generally applicable for a broad scope of 
alkenes, offering a direct method for the high-yielding synthesis of 1,1-
cyclopropaneformylesters with excellent control of diastereo- and enantioselectivity. The 
great tolerance of functional groups that are otherwise reactive toward ionic reactions is 
believed to have close relevance to the radical pathway of Co(II)-based metalloradical 
catalysis. Notably, the resulting products were readily transformed into other chiral 1,1-
bifunctionalized cyclopropanes and chiral dihydrofurans.
1.5 COBALT(II) PORPHYRIN-CATALYZED ASYMMETRIC RADICAL 
CYCLOPROPANATION WITH DONOR/H DIAZO
While tremendous progress has been made with the use of various diazo 
compounds, including aforementioned acceptor/H, acceptor/donor, acceptor/acceptor 
diazo compounds,6 metal-catalyzed asymmetric carbene transfer cyclopropanation with 
donor-substituted diazo compounds has been rarely reported.24 Along with their instability 
and short half-life of the diazo compounds, the underlying challenge might be also ascribed 
to the diminished electrophilicity of the corresponding donor-substituted metallocarbene 
intermediates, which would decrease the reactivity toward olefins for productive 
cyclopropanation. To this end, we developed a fundamentally new approach based on the 
concept of metalloradical catalysis (MRC) to address this long-standing challenge in the 
field via stereoselective radical chemistry (Scheme 1.18).25
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With cobalt(II) complex of D2-symmetric chiral porphyrin 3,5-DitBu-Xu(2′-
Naph)Phyrin, [Co(P3)], as the identified optimal catalyst, it can effectively catalyze 
asymmetric cyclopropanation of alkenes with donor-substituted diazo compounds, 
generated in situ from N-arylsulfonyl hydrazones in the presence of base.25 The Co(II)-
catalyzed radical cyclopropanation can be operated under mild conditions and is applicable 
to a broad spectrum of alkenes, affording the 1,2-bisaryl and related cyclopropane 
compounds in high yields with effective control of both diastereoselectivity and 
enantioselectivity. Among other additional attributes, the Co(II)-based cyclopropanation is 
Scheme 1.18|| [Co(P3)]-Catalyzed Radical Cyclopropanation of Alkenes with In Situ-
Generated Aryl Diazomethanes
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highlighted by its high degree of functional group tolerance, a feature that is closely related 
to its underlying radical mechanism. This system also signifies the compatibility of the 
Co(II)-based metalloradical system with the use of both bases and polar solvents.
Notably, by simply modulating the sulfonyl source from 4-methyl phenylsulfonyl 
(Ts) to 2,4,6-triisopropylphenylsulfonyl (Tris) as shown in Scheme 1.18, it allows the facile 
generation of donor-substituted diazo compounds from sulfonylhydrazones even at 0 oC
for highly enantioselective radical cyclopropanation reactions.
Recently, Chattopadhyay and coworkers also demonstrated the possibility of using 
in situ-generated heteroaryl-substituted diazomethanes as radical precursors for olefin 
cyclopropanation reactions (Scheme 1.19).26 In the presence of Co(TPP), the desired 
compounds could be obtained in good yields.
Scheme 1.19|| [Co(TPP)]-Catalyzed Radical Cyclopropanation of Alkenes with In
Situ-Generated Heteroaryl Diazomethanes
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1.6 COBALT(II) PORPHYRIN-CATALYZED ASYMMETRIC 
INTRAMOLECULAR RADICAL CYCLOPROPANATION WITH
ACCEPTOR/ACCEPTOR DIAZO
In addition to the intermolecular version, asymmetric intramolecular 
cyclopropanation reactions via MRC has also been shown to be highly durable processes. 
At the beginning, these intramolecular cyclopropanation reactions catalyzed by [Co(P1)] 
was not optimal as shown in Scheme 1.20. The desired 3-oxabicyclo[3.1.0]hexan-2-one 
derivative was obtained in 99% yield and 99% de, yet with moderate 55% ee.27
Scheme 1.20|| [Co(P4)]-Catalyzed Asymmetric Intramolecular Radical 
Cyclopropanation with α-Cyanodiazoacetate: [Co(P1)] Vs [Co(P4)]
   
During the course of catalyst development, the design of new Co(II) complex of 
3,5-DitBu-QingPhyrin ([Co(P4)]) via an iterative approach led to a perfect solution, and 
the enantioselectivity of the catalytic reaction was significantly improved to 96% ee. The 
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key for the catalyst innovation is to prepare the cyclopropanecarboxamide with two 
contiguous stereogenic centers (P4), which was synthesized iteratively via [Co(P1)]-
catalyzed asymmetric intermolecular cyclopropanation of α-methylstyrene with 
diazoacetates (vide infra, Scheme 1.8).11 This iterative approach has a great impact on the 
development of a new generation of [Co(D2-Por*)] catalysts, which allows the chiral 
catalysts bearing two consecutive stereogenic centers on each chiral arm with more diverse 
asymmetric environments. 
Scheme 1.21|| Iterative Approach for the Development of New Generation of 
Cobalt(II)-Based D2-Symmetric Chiral Porphyrin [Co(P4)]
 
Systematically experimental studies disclosed that [Co(P4)] is capable of providing 
excellent asymmetric induction for intramolecular cyclopropanation of various allylic α-
cyanodiazoacetates (Scheme 1.22, left side).27 The formation of corresponding 3-
oxabicyclo[3.1.0]hexan-2-one derivatives from the radical cyclopropanation were 
exclusively diastereoselective and highly enantioselective. The remarkable 
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diastereocontrol suggests that the final ring-closure step (intramolecular radical 
substitution) in the stepwise radical addition-substitution pathway for this intramolecular 
radical cyclopropanation is a low-barrier or barrierless process, which is the same as shown 
in the intermolecular cyclopropanation (vide supra, Scheme 1.7).5a
Scheme 1.22|| [Co(P4)]-Catalyzed Asymmetric Intramolecular Radical 
Cyclopropanation with Various Acceptor/Acceptor Diazo Compounds
   
The [Co(P4)]-catalyzed asymmetric intramolecular radical cyclopropanation was 
then successfully extended to a wide spectrum of other acceptor/acceptor-substituted diazo 
compounds, such as α-nitrodiazoacetates, α-ketodiazoacetates, and α-esterdiazoacetates 
(Scheme 1.22, right side).27 Moreover, non-acceptor α-substituents, including hydrogen, 
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and electron-donating methyl group, were also shown to be suitable to afford the 
corresponding 3-oxabicyclo[3.1.0]hexan-2-one derivatives in high yields with excellent 
diastereoselectivities and enantioselectivities. The effectiveness of [Co(P4)] is believed to 
largely result from the multiple stereogenic centers of the new porphyrin ligands, which 
offer sufficient asymmetric induction, together with either double hydrogen-bonding 
interactions or mono hydrogen-bonding interaction in cases of acceptor/acceptor-
substituted and monoacceptor-substituted diazo compounds, respectively. 
1.7 SUMMARY AND OUTLOOK
Guided by the concept of metalloradical catalysis (MRC), the development of 
cobalt(II) complexes of D2-symmetric chiral amidoporphyrin [Co(Por)] as stable
metalloradical catalysts enables a fundamentally new approach for controlling 
stereoselectivity in asymmetric radical cyclopropanation reactions of alkenes. The Co(II)-
based metalloradical catalysts have been shown to effectively activate a broad spectrum of 
diazo compounds, including acceptor/H, acceptor/acceptor and donor/H ones, to generate 
various α-Co(III)-alkyl radicals in a controlled and catalytic manner. The formed metal-
supported alkyl radicals have further been demonstrated to be capable of undergoing
radical additions to alkenes for asymmetric cyclopropanation reactions with effective 
control of reactivity and stereoselectivity by the modular porphyrin ligands. Attributed to 
the radical reaction profile, the radical olefin cyclopropanation reactions via Co(II)-based 
MRC are usually least affected by the electronic properties of substrates and reagents. 
Moreover, the mild reaction condition and high degree of functional group tolerance are 
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also important features that are likely related to the proposed radical mechanism. The 
establishment of Co(II)-catalyzed radical cyclopropanation reactions provides a solution
for several major challenges in the corresponding 2e- ionic cyclopropanation systems, 
including the successful employment of electron-deficient olefins, acceptor/acceptor-
substituted and donor/H-substituted diazo compounds. The demonstrated general substrate 
scope and functional group tolerance encourage further applications of the Co(II)-based
radical processes for new cyclopropane products with diverse substituents, especially 
active functionalities without the need of protection and deprotection.
Beyond radical addition reactions to double bond systems, α-Co(III)-alkyl radicals 
have also been demonstrated to undergo other radical reactions in a controlled manner, 
such as addition to alkynes28 and C–H abstraction reactions.29 The catalytic cycles based 
on these radical reactions allow for development of varied new asymmetric 
transformations. As one of the most attractive features of radical processes, radical 
cascades initiated by α-Co(III)-alkyl radical species would provide more opportunities for 
the construction of complicated organic molecules in a rapid fashion and with possible 
stereocontrol.30
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CHAPTER 2
ASYMMETRIC RADICAL CYCLOPROPANATION OF ALKENES WITH IN 
SITU-GENERATED DONOR-SUBSTITUTED DIAZO REAGENTS VIA 
COBALT(II)-BASED METALLORADICAL CATALYSIS
2.1 INTRODUCTION
There has been lasting interest in devising strategies to control stereoselectivities, 
especially enantioselectivities, of radical reactions for applications in organic synthesis.1
Among recent advances,1,2 metalloradical catalysis (MRC), which aims at the development 
of metalloradical-based systems for both catalytic initiation and selective control of radical 
processes, has led to the discovery of new catalytic pathways for stereoselective radical 
reactions.3,4 As stable metalloradicals with well-defined open-shell d7 electronic structures, 
cobalt(II) complexes of D2-symmetric chiral porphyrins [Co(D2-Por*)] have emerged as a 
new class of effective catalysts for asymmetric radical transformations through catalytic 
generation of metal-stabilized organic radicals, such as the fundamentally new α-
metalloalkyl radicals and α-metalloaminyl radicals, as the key intermediates.5 To date, 
Co(II)-based metalloradical catalysis (Co(II)-MRC) has exhibited capability of activating 
both acceptor- and acceptor/acceptor-substituted diazo reagents to generate corresponding 
α-Co(III)-alkyl radicals (also known as Co(III)-carbene radicals) as key intermediates for 
various C-centered radical processes, including radical cyclopropanation of alkenes.6,7
Studies suggest that potential hydrogen-bonding interactions between carbonyl groups of 
these types of diazo reagents and the amide units of the porphyrin ligands in the resulting 
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α-Co(III)-alkyl radicals play an important role in enhancing reactivity and controlling 
stereoselectivity. 
It was unclear if Co(II)-MRC could also be applicable to other types of diazo
reagents that lack a carbonyl group, such as donor-substituted diazo reagents. Specifically, 
we wondered whether [Co(D2-Por*)] metalloradical catalysts were able to activate 
aryldiazomethanes to generate the corresponding α-Co(III)-benzyl radical intermediate I
(Scheme 2.1). 
Scheme 2.1|| Proposed Catalytic Pathway for Asymmetric Radical Cyclopropanation 
with In Situ-Generated Donor-Substituted Diazo Reagents
   
In the absence of carbonyl functionalities, what element of interaction could be 
explored for the effective control of enantioselectivity in the subsequent radical addition of 
the α-Co(III)-benzyl radical I to the olefin substrate? Furthermore, would the final step, 3-
exo-tet radical cyclization of the resulting γ-Co(III)-alkyl radicals II, be diastereoselective? 
Additional questions arose from the intrinsic instability of donor-substituted 
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diazomethanes, which are typically generated in situ from stable sulfonyl hydrazone 
precursors.8 Would Co(II)-MRC system be compatible with the basic conditions required 
for the in-situ generation protocol? If these questions could be answered positively, it 
would further expand the application of Co(II)-based radical cyclopropanation for the 
catalytic synthesis of enantioenriched 1,2-bisaryl and related cyclopropane compounds 3.
Asymmetric olefin cyclopropanation with diazo reagents represents one of the most general 
methods for the construction of optically active three-membered carbocycles.9 While 
tremendous progress has been made with the use of several types of diazo reagents, 
asymmetric cyclopropanation with donor-substituted diazo reagents has been much less 
developed.10 The underlying challenge may be ascribed to the diminished electrophilicity 
of the corresponding donor-substituted metallocarbene intermediates associated with most 
catalytic systems, which would decrease the reactivity toward olefins for cyclopropanation. 
As a novel alternative involving the further transfer of the initially formed 
electrophilic Rh2-carbenes into nucleophilic chiral sulfur ylides (Scheme 2.2), Aggarwal 
and coworkers developed an indirect approach for asymmetric cyclopropanation with 
sulfonyl hydrazones as diazo precursors using the combination of dirhodium carboxylates 
and chiral sulfides as the catalyst that works specifically for electron-deficient olefins.8c,10c
Nevertheless, it would be desirable to develop new catalytic systems that are capable of 
direct asymmetric cyclopropanation of diverse alkenes with donor-substituted diazo 
reagents.11  
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Scheme 2.2|| Asymmetric Radical Cyclopropanation with In Situ-Generated Donor-
Substituted Diazo with Dirhodium Carboxylates and Chiral Sulfides as Catalysts
 
In view of the radical pathway of MRC (Scheme 2.1), we hypothesized that the 
radical cyclopropanation approach could potentially address the aforementioned issues 
with donor-substituted diazo reagents because a neutral radical process is generally less 
sensitive to electronic effects. In this project, we have developed the first asymmetric 
catalytic system that is highly effective for direct cyclopropanation of alkenes with α-aryl 
diazomethanes. Under mild conditions, the Co(II)-based metalloradical system is suitable 
for various alkenes, allowing for the efficient construction of the corresponding 
cyclopropane rings with excellent control of both diastereoselectivity and 
enantioselectivity. The Co(II)-catalyzed cyclopropanation is further highlighted by its
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functional group tolerance, a feature that is in accordance with the underlying radical 
mechanism.
2.2 RESULTS AND DISCUSSION
2.2.1 Condition Optimization for Asymmetric Cyclopropanation of Styrene with 
Tosylhydrazone 1a
Our study began with the investigation of catalytic cyclopropanation of styrene (2a)
with benzaldehyde tosylhydrazone (1a), which is known to generate α-
phenyldiazomethane under basic conditions (Table 2.1). To our delight, even simple 
metalloradical catalyst [Co(TPP)] (TPP = 5,10,15,20-tetraphenylporphyrin) could catalyze 
the reaction in the presence of Cs2CO3 in methanol, forming the desired 1,2-diphenyl 
cyclopropane 3aa in 46% yield (entry 1). This result signifies the compatibility of Co(II)-
based metalloradical system with both bases and polar solvents that are required for in-situ 
generation of donor-substituted diazomethanes from the corresponding hydrazone 
precursors.
We then evaluated the possibility of stereoselective control of the catalytic reaction 
through the use of Co(II) complexes of D2-symmetric chiral amidoporphyrins [Co(D2-
Por*)]. When the first-generation catalyst [Co(P1)] (P1 = 3,5-DitBu-ChenPhyrin) was 
used,6i cyclopropane 3aa could form in higher yield with significant level of both 
enantioselectivity and diastereoselectivity (entry 2). To further improve the 
stereoselectivity of the catalytic reaction, we then turned our attention to the second-
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Table 2.1|| Asymmetric Cyclopropanation of Styrene with Tosylhydrazones by 
Metalloradical Catalysts [Co(D2-Por*)]a
a Reactions were carried out with 1x (0.1 mmol) and 2a (1.5 equiv.) in the presence of 
Cs2CO3 (2 equiv.) by [Co(D2-Por*)] (2 mol %) in methanol (0.6 mL) at 40 oC for 24 h. b
Isolated yields. c The diastereomeric ratio (dr) was determined by 1H NMR. d Enantiomeric 
excess of the major trans diastereomer was determined by chiral HPLC.  
generation Co(II)-based metalloradical catalysts.6b While the phenyl-substituted [Co(P2)]
(P2 = 3,5-DitBu-QingPhyrin) was found to be less selective, the naphthyl-substituted 
[Co(P3)] (P3 = 3,5-DitBu-Xu(2’-Naph)Phyrin)) could effectively catalyze the formation 
of cyclopropane 3aa with excellent diastereoselectivity but lower enantioselectivity (entry 
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4). It should be noted that comparable reactivity was observed with the use of preformed 
α-phenyldiazomethane (Table 2.2).
Table 2.2|| Asymmetric Cyclopropanation of Styrene Directly with 
Phenyldiazomethane a
 
a Carried out with 1a’’ (0.1 mmol) and 2a (1.5 equiv.) in solvent (0.6 mL). b NMR yields. 
c In the parenthesis, isolated yield. d Determined by 1H NMR. e Determined by chiral HPLC 
for the major trans diastereomer.
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The ineffective asymmetric induction is likely attributed to the low-barrier rotation 
of the α-benzyl radical unit around the Co(III)–C σ bond in intermediate I (vide supra, 
Scheme 2.1) that diminishes its approaching preference to the prochiral styrene substrate 
between the re and si faces. To restrict the rotation within the chiral pocket of the porphyrin 
ligand, we decided to use benzaldehyde tosylhydrazone derivative that contains an ortho-
methoxy group (1b) as the radical precursor for the catalytic process (vide supra, Table 
2.1, entry 5). Considering methoxy groups are known to serve as good hydrogen bond 
acceptors,12 we postulated that the potential formation of N–H O hydrogen bond between 
the amido group of the chiral ligand and the methoxy group of tosylhydrazone 1b (Figure 
2.1) might rigidify the resulting α-Co(III)-alkyl radical intermediate I, leading to an 
improved stereoselective outcome. We were excited that the corresponding cyclopropane 
3ba was indeed obtained in good yield (78%) with high diastereoselectivity (95:5 dr) as 
well as excellent enantioselectivity (99% ee) (Table 2.1, entry 5).
                
Figure 2.1|| Spartan Modeling of Proposed α-Co(III)-Alkyl Radical Intermediate I
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Accordingly, asymmetric induction of the cyclopropanation process was 
significantly reduced when the methoxy group in 1b was replaced by a sterically 
comparable ethyl group despite the high reactivity (entry 6, Table 2.1). Moreover, low 
enantioselectivity was observed when the methoxy group in the tosylhydrazone 1b was 
moved from ortho- to either meta- or para- positions of the phenyl ring although with 
similarly high diastereoselectivity (entries 7 and 8, Table 2.1). These results are in 
agreement with the hypothesized hydrogen-bonding interaction.
Further investigation of solvent effect on the developed radical cyclopropanation 
revealed that both polar and non-polar solvents were suitable albeit with varied yields and 
selectivities, and the solvent of choice was still methanol (Table 2.3).
Table 2.3|| Solvent Effect on Asymmetric Cyclopropanation of Styrene 2a with 
Tosylhydrazones 1b by [Co(P3)]a
 
a Carried out with 1b (0.1 mmol) and 2a (1.5 equiv.) in the presence of Cs2CO3 (2 equiv.) 
in solvent (0.6 mL). b Isolated yields. c Determined by 1H NMR. d Determined by chiral 
HPLC for the major trans diastereomer.
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2.2.2 Asymmetric Radical Cyclopropanation of Different Alkenes
Under the optimized conditions, the scope of [Co(P3)]/1b-based catalytic system 
was then evaluated by employing different alkenes with varied steric and electronic 
properties as substrates for asymmetric radical cyclopropanation (Table 2.4). Like styrene, 
its derivatives bearing substituents with different electronic properties, including electron-
donating MeO and electron-withdrawing CF3 groups, could be radically cyclopropanated 
with 1b, generating the corresponding 1,2-bisaryl cyclopropanes in high yields with 
excellent control of both diastereoselectivity and enantioselectivity (entries 1–3). 
Halogenated styrenes such as those with a Br atom at various positions were also shown to 
be suitable substrates for the catalytic process, providing the desired cyclopropanes in 
similarly high yields and stereoselectivities (entries 4–6). The relative and absolute 
configurations of cyclopropane 3bd (entry 4) were established as trans and (1S,2S), 
respectively, by anomalous-dispersion effects in X-ray diffraction of its single crystal. 
As demonstrated for 2-bromostyrene (2f) together with 2,4,6-trimethylstyrene (2g), 
sterically hindered styrene derivatives could also undergo productive cyclopropanation 
reactions with 1b by [Co(P3)] (entries 6 and 7). Furthermore, this metalloradical system 
was also applicable for 1,1-disubstituted olefins as demonstrated with the reactions of -
substituted styrene derivatives 2h, 2i and 2j, affording the desired cyclopropanes with 
enantioselective control of the newly-formed quaternary stereogenic centers (entries 8–10). 
Distinctly, the Co(II)-based radical process could tolerate functional groups as exemplified 
by the highly enantioselective cyclopropanation of 3-aminostyrene (entry 11). In addition 
to the expanded aromatic olefins such as 2-vinylnaphthalene (entry 12), conjugated dienes, 
including both aromatic diene 2m and aliphatic diene 2n, could also be employed as 
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Table 2.4|| Asymmetric Cyclopropanation of Different Olefins with Tosylhydrazone 
1b Catalyzed by [Co(P3)]a
a Reactions were carried out with 1b (0.1 mmol) and 2x (1.5 equiv.) in the presence of 
Cs2CO3 (2 equiv.) by [Co(P3)] (2 mol %) in methanol (0.6 mL) at 40 oC for 24 h; Isolated 
yields; The diastereomeric ratio (dr) was determined by 1H NMR; Enantiomeric excess of 
the major trans diastereomer was determined by chiral HPLC. b The reaction was 
performed on 1.0 mmol scale. c (1S,2S) Absolute configuration was determined in X-ray 
diffraction measurements on crystal. d 5 mol % [Co(P3)] was used. e 5.0 equiv. 2q. 
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substrates for the Co(II)-based cyclopropanation but with relatively lower 
stereoselectivities (entries 13 and 14). It was notable that both electron-rich and -deficient 
non-aromatic olefins, such as vinyl ether 2o, acrylamide 2p and vinyl ketone 2q could be 
enantioselectively cyclopropanated as well (entries 15–17) with moderate control of 
stereoselectivities. The observed substrate scope and reactivity profile of [Co(P3)]-
catalyzed cyclopropanation is in agreement with the underlying radical mechanism via 
Co(II)-based metalloradical catalysis (vide supra, Scheme 2.1). It was also noteworthy to 
mention that the one-pot protocol of the Co(II)-catalyzed radical cyclopropanation could 
be scaled up ten-fold as demonstrated with the high-yielding synthesis of cyclopropane 
3ba on 1.0 mmol scale without affecting the excellent stereoselectivity (entry 1). 
2.2.3 Asymmetric Cyclopropanation of Styrene with Various Benzaldehyde 
Sulfonylhydrazone Derivatives
Guided by the postulated importance of hydrogen-bonding interaction in the key α-
Co(III)-benzyl radical intermediates I, we then sought to identify other benzaldehyde 
sulfonylhydrazone derivatives as effective radical precursors for asymmetric 
cyclopropanation (Table 2.5). Like arylhydrazone 1b (entry 1), 2,5-
dimethoxybenzaldehyde-derived tosylhydrazone (1f) could be also effectively activated by 
the metalloradical catalyst [Co(P3)] for radical cyclopropanation of styrene, affording the 
corresponding cyclopropane 3fa in 91% yield with 90% de and 94% ee (entry 2). 
Considering that fluorine atoms in organic fluorides have been demonstrated as a potential 
hydrogen bond acceptor in application for asymmetric catalysis,13 we explored the use of 
fluorine-containing arylhydrazones as diazo precursors for asymmetric radical styrene 
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Table 2.5|| Asymmetric Cyclopropanation of Styrene with Various Sulfonyl 
Hydrazones Catalyzed by [Co(P3)]a
 
a Reactions were carried out with 1x (0.1 mmol) and 2a (1.5 equiv.) in the presence of 
Cs2CO3 (2 equiv.) by [Co(P3)] (2 mol %) in methanol (0.6 mL) for 24 h. b Ts = 4-
toluenesulfonyl; Tris = (2,4,6-triisopropyl)phenyl sulfonyl. c  Isolated yields. d The 
diastereomeric ratio (dr) was determined by 1H NMR. e Enantiomeric excess of the major 
trans diastereomer was determined by chiral HPLC. 
cyclopropanation. Remarkably, fluoroarene-based tosylhydrazones such as 1g–1j were 
found to be even more active than 1b as radical precursors for Co(II)-based 
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cyclopropanation, enabling the operation of the catalytic process even at room temperature 
(entries 3, 6, 8 and 10). The desired fluorine-containing bisaryl cyclopropane products 3ga–
3ja were obtained in up to 90% yield with 88–92% de and 68–88% ee. Attempts to further 
improve enantioselectivity of the cyclopropanation of styrene with 2,6-
difluorobenzaldehyde-derived tosylhydrazone 1g at lower temperature were unsuccessful 
due to ineffective generation of 2,6-difluorophenyl diazomethane at 0 oC (entry 4). Since 
the decomposition of the sterically bulky (2,4,6-triisopropylphenyl)sulfonyl hydrazone salt 
was shown to be considerably faster than tosylhydrazone salt,14 the low temperature 
asymmetric cyclopropanation was reexamined with the use of 2,6-difluorobenzaldehyde-
derived (2,4,6-triisopropylphenyl)sulfonyl hydrazone 1g’. As expected, the catalytic 
cyclopropanation reaction could proceed effectively at 0 oC, affording the desired 
cyclopropane 3ga in 83% yield with considerably enhanced stereoselectivities (entry 5). 
Likewise, the radical cyclopropanation reactions with related (2,4,6-
triisopropylphenyl)sulfonyl hydrazones 1h’–1j’ could also be productively conducted at 0 
oC, affording the cyclopropane derivatives 3ha–3ja with significantly improved 
diastereoselectivity and enantioselectivity (entries 7, 9 and 11). Considering unique 
bioactivities of organofluorine compounds,15 these enantioenriched fluorine-containing 
bisaryl cyclopropanes should find useful synthetic applications for chiral organic fluorides.
Under the same conditions, o-chlorobenzaldehyde-derived sulfonylhydrazone also 
gave a similar result compared to the result from o-fluorobenzaldehyde-derived 
sulfonylhydrazone (Scheme 2.3). Nevertheless, o-bromo- and o-iodobenzaldehyde-derived 
sulfonylhydrazones proved to be less effective radical precursors for the catalytic process.
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Scheme 2.3|| Asymmetric Cyclopropanation of Styrene with Various o-Halogenated 
Benzaldehyde Sulfonyl Hydrazones 1x Catalyzed by [Co(P3)]a
 
a Carried out with 1x (0.1 mmol) and 2a (1.5 equiv.) in the presence of Cs2CO3 (2 equiv.) 
in methanol (0.6 mL); Tris = (2,4,6-triisopropyl)phenyl sulfonyl. b Isolated yields. c
Determined by 1H NMR. d Determined by chiral HPLC for the major trans diastereomer. e
1,2-bis(2-iodophenyl)ethene and 2-iodobenzaldehyde were formed as major side products.
2.2.4 Mechanistic Insights by Using (E)- and (Z)-β-Deuterostyrenes as Radical 
Probe for Cyclopropanation
To probe the underlying stepwise radical mechanism of the Co(II)-catalyzed 
cyclopropanation process, both (E)- and (Z)-β-deuterostyrenes were employed as 
substrates for evaluation of product distribution. While a concerted mechanism is usually 
stereospecific, a stepwise radical mechanism (Scheme 2.1) would result in the formation 
of four possible diastereomers from either (E)- or (Z)-β-deuterostyrene: two trans-
isotopomers A & B and two cis-isotopomers C & D due to the rotation of β-C–C bond in 
the γ-Co(III)-alkyl radical intermediate II before facile ring closure (Scheme 2.4).  
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Scheme 2.4|| The Rationale of both Isotopomers A and B Formation in the Major 
trans-Cyclopropanes 3ga from Cyclopropanation of (E)-β-Deuterostyrene 
Using [Co(P3)] as the catalyst, cyclopropanation of (E)-β-deuterostyrene with 
tosylhydrazone 1g led to the formation of trans-3ga as the dominant product with a 93:7 
ratio of isotopomers A and B (Scheme 2.4). Under the same conditions, the reaction of (Z)-
β-deuterostyrene resulted in the identical 93:7 ratio of isotopomeric distribution but in 
favoring B over A. The observation of trans-isotopomer B from (E)-β-deuterostyrene as 
well as trans-isotopomer A from (Z)-β-deuterostyrene is evidently a result of the rotation 
of β-C–C bond in intermediate II. When sterically less-hindered [Co(P4)] (P4 = 3,5-DitBu-
IbuPhyrin) was used as the catalyst,16 a significantly different isotopomeric ratio of trans-
isotopomers A & B (from 93:7 to 80:20) was observed, suggesting easier rotation of the β-
C–C bond in a less-crowded ligand environment (Schemes 2.4). Together, these 
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observations convincingly support the proposed stepwise radical mechanism of the Co(II)-
catalyzed cyclopropanation with N-arylsulfonyl hydrazones.
Scheme 2.4|| Cyclopropanation of (E)- and (Z)-β-Deuterostyrenes to Probe Radical 
Reaction Mechanism.
 
Furthermore, experiments were carried out for direct detection of the α-Co(III)-
benzyl radical species I (Scheme 2.1) by high-resolution mass spectrometry (HRMS).17
The exposure of [Co(P4)] to 10 equiv. of 1g with base in methanol resulted in a mixture 
that was filtered and analyzed by HRMS in the absence of any additives such as formic 
acid that commonly acts as electron carriers for ESI ionization. As shown in Figure 2.2,
the obtained spectrum clearly revealed a signal corresponding to [Co(P4)(2,6-
F2C6H3CH)]+ (m/z = 1361.6515), which resulted from the neutral α-Co(III)-benzyl radical 
I by the loss of one electron. The success in direct detection of the [Co(P4)(2,6-
F2C6H3CH)]+ by HRMS indicates possible stabilization of the α-Co(III)-benzyl radical by 
hydrogen-bonding interaction. 
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Figure 2.2|| The Signal of Neutral α-Co(III)-Benzyl Radicals I from Electrospray 
Ionization Mass Spectrometry (ESI-MS)
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2.3 CONCLUSIONS
In summary, Co(II)-based metalloradical catalysis (MRC) has, for the first time, 
been successfully applied to donor-substituted diazo reagents, generated from N-
arylsulfonyl hydrazones in the presence of base, for cyclopropanation of alkenes. Chiral 
metalloradical complex [Co(P3)] has been shown to be an effective catalyst for asymmetric 
radical cyclopropanation with α-aryldiazomethane precursors. The Co(II)-based 
cyclopropanation system is applicable to a broad combination of N-arylsulfonyl 
hydrazones and alkenes, affording the corresponding cyclopropane derivatives in high 
yields with excellent control of both diastereoselectivity and enantioselectivity. In view of 
the underdevelopment of donor-substituted diazo reagents in asymmetric 
cyclopropanation, the successful development of this new catalytic radical process will 
encourage further research efforts in applying sulfonyl hydrazones as stable precursors for 
various asymmetric catalytic processes.
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2.4 EXPERIMENTAL SECTION
2.4.1 General Considerations
All cyclopropanation reactions were carried out under a nitrogen atmosphere in an 
oven-dried glassware following standard Schlenk techniques. Anhydrous methanol and 
other reagents were directly used as purchased. Thin layer chromatography was performed 
on Merck TLC plates (silica gel 60 F254). Flash column chromatography was performed 
with ICN silica gel (60 Å, 230-400 mesh, 32-63 μm). 
Proton and carbon nuclear magnetic resonance spectra (1H NMR and 13C NMR) 
were recorded on Varian Inova 400 MHz, Bruke 500 MHz and Varian 600 MHz 
instruments with chemical shifts reported relative to residual solvent. 19F NMR spectra 
were recorded on a Varian Inova 400 spectrometer (376 MHz), using CFCl3 (δ = 0) as 
internal standard. Infrared spectra were measured with a Nicolet Avatar 320 spectrometer 
with a Smart Miracle accessory. Optical rotations were measured on a Rudolph Research 
Analytical AUTOPOL® IV digital polarimeter. HPLC measurements were carried out on 
a Shimadzu HPLC system with Chiralcel OD-H, OJ-H, AD-H and IC columns. HRMS 
data was obtained on an Agilent 6200 LC/MS ESI/TOF mass spectrometer with 
electrospray ionization and Agilent 7890 GC-7200 EI/QTOF MS. The X-ray diffraction 
data were collected using Bruker-AXS SMART-APEXII CCD diffractometer (CuKα, λ = 
1.54178 Å). Spartan modelling was performed using Spartan14V118 software. 
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2.4.2 Typical Procedure for the Preparation of Tosylhydrazones18
To a stirred solution of pure sulfonyl hydrizide (5.0 mmol) in methanol (12.0 mL), 
aldehyde (5.0 mmol) was added dropwise (or portionwise if solid) at room temperature. 
After approximately 3 h, the reaction mixture was cooled to 0 oC and the product was 
removed by filtration, washed with a small quantity of cold methanol. The crude solid was 
further purified by recrystallization in hot methanol. 
benzaldehyde tosylhydrazone 1a,18 93% yield. 1H NMR (400 MHz, 
CDCl3) δ 8.29 (b, 1H), 7.89 (d, J = 8.4 Hz, 2H), 7.78 (s, 1H), 7.63 – 7.50 
(m, 2H), 7.40 – 7.33 (m, 3H), 7.30 (d, J = 8.4 Hz, 2H), 2.40 (s, 3H). 13C
NMR (100 MHz, CDCl3) δ 147.86, 144.25, 135.24, 133.15, 130.39, 129.68, 128.60, 
127.92, 127.34, 21.57. 
benzaldehyde 2,4,6-triisopropylbenzenesulfonyl hydrazone 1a’,19
96% yield. 1H NMR (600 MHz, CDCl3) δ 7.99 (s, 1H), 7.76 (s, 1H), 
7.56 – 7.54 (m, 2H), 7.35 – 7.31 (m, 3H), 7.18 (s, 2H), 4.28 (hept, J
= 6.8 Hz, 2H), 2.90 (hept, J = 6.9 Hz, 1H), 1.32 (d, J = 6.8 Hz, 12H), 
1.25 (d, J = 6.9 Hz, 6H). 13C NMR (150 MHz, CDCl3) δ 156.14, 154.03, 148.96, 135.98, 
133.89, 132.89, 131.23, 129.93, 126.54, 36.84, 32.73, 27.52, 26.17.
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Phenyl Diazomethane 1a’’, Synthesized from benzaldehyde 2,4,6-
triisopropylbenzenesulfonyl hydrazone 1a’ according to the known 
literature.2 red liquid, 93% yield. 1H NMR (400 MHz, CDCl3) δ 7.28 (t, J = 7.5 Hz, 2H), 
7.03 (t, J = 7.5 Hz, 1H), 6.90 (d, J = 7.5 Hz, 2H), 4.92 (s, 1H). 13C NMR (150 MHz, CDCl3)
δ 132.41, 131.72, 126.52, 123.96 (As known in literature, diazo carbon is missing). IR 
(neat, cm-1): 2962.03, 2062.25 (C=N2), 1596.89, 1412.18, 1262.56, 1101.59, 1031.40, 
819.76, 736.79, 690.89.
2-methoxybenzaldehyde tosylhydrazone 1b, 95% yield. 1H NMR 
(400 MHz, CDCl3) δ 8.16 (s, 1H), 7.87 (d, J = 8.3 Hz, 2H), 7.83 (dd, 
J = 7.6, 1.7 Hz, 1H), 7.70 (s, 1H), 7.36 – 7.32 (m, 1H), 7.30 (d, J = 8.3 
Hz, 2H), 6.94 (t, J = 7.6 Hz, 1H), 6.85 (d, J = 8.4 Hz, 1H), 3.81 (s, 3H), 2.40 (s, 3H). 13C
NMR (100 MHz, CDCl3) δ 157.83, 144.10, 143.83, 135.39, 131.72, 129.61, 127.95, 
126.57, 121.61, 120.79, 110.90, 55.48, 21.57. IR (neat, cm-1): 3186.49, 1596.14, 1487.96, 
1434.28, 1329.63, 1160.67, 1046.43, 811.98, 666.65. HRMS (ESI) ([M+H]+) Calcd. For 
C15H17N2O3S+: 305.0954, found 305.0942.
2-ethylbenzaldehyde tosylhydrazone 1c, 93% yield. 1H NMR (400
MHz, CDCl3) δ 8.06 (s, 1H), 7.89 (d, J = 8.3 Hz, 2H), 7.69 (dd, J = 7.8 
Hz, 1.3 Hz, 1H), 7.31 (d, J = 8.3 Hz, 2H), 7.28 (d, J = 7.5 Hz, 1H), 7.22 
– 7.11 (m, 2H), 2.71 (q, J = 7.6 Hz, 2H), 2.41 (s, 3H), 1.13 (t, J = 7.6 Hz, 3H). 13C NMR 
(100 MHz, CDCl3) δ 146.78, 144.24, 143.31, 135.29, 130.48, 130.34, 129.66, 129.27, 
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127.98, 127.38, 126.13, 26.00, 21.58, 15.85. IR (neat, cm-1): 3143.63, 1597.23, 1442.73, 
1324.67, 1161.54, 1042.62, 945.01, 811.89, 700.38. HRMS (ESI) ([M+H]+) Calcd. For 
C16H19N2O2S+: 303.1162, found 303.1169. 
4-methoxybenzaldehyde tosylhydrazone 1d, 92% yield. 1H NMR (400 
MHz, CDCl3) δ 7.87 (d, J = 8.4 Hz, 2H), 7.73 (s, 1H), 7.51 (d, J = 8.8 Hz, 
2H), 7.30 (d, J = 8.4 Hz, 2H), 6.86 (d, J = 8.8 Hz, 2H), 3.81 (s, 3H), 2.40 (s,
3H). 13C NMR (100 MHz, CDCl3) δ 161.47, 148.25, 144.15, 135.31, 129.63, 128.98, 
127.93, 125.88, 114.08, 55.34, 21.57. IR (neat, cm-1): 3220.26, 1608.73, 1424.64, 1299.55, 
1158.69, 951.07, 826.22, 702.14. HRMS (ESI) ([M+H]+) Calcd. For C15H17N2O3S+:
305.0954, found 305.0977.
3-methoxybenzaldehyde tosylhydrazone 1e, 90% yield. 1H NMR 
(400 MHz, CDCl3) δ 7.89 (d, J = 8.1 Hz, 2H), 7.74 (s, 1H), 7.31 (d, J
= 8.1 Hz, 2H), 7.26 (t, J = 8.1 Hz, 2H), 7.15 (s, 1H), 7.11 (d, J = 7.5 
Hz, 1H), 6.92 (d, J = 8.3 Hz, 1H), 3.82 (s, 3H), 2.41 (s, 3H). 13C NMR (100 MHz, CDCl3)
δ 159.74, 147.73, 144.30, 135.21, 134.49, 129.68, 129.62, 127.92, 120.48, 116.72, 111.48, 
55.33, 21.58. IR (neat, cm-1): 3154.89, 1596.61, 1493.57, 1167.37, 1033.35, 893.12, 
793.05, 688.55. HRMS (ESI) ([M+H]+) Calcd. For C15H17N2O3S+: 305.0954, found 
305.0961.
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2,5-methoxybenzaldehyde tosylhydrazone 1f, 92% yield. 1H NMR 
(400 MHz, CDCl3) δ 8.11 (s, 1H), 7.85 (d, J = 8.4 Hz, 2H), 7.33 (d, J
= 3.2 Hz, 1H), 7.28 (d, J = 8.4 Hz, 2H), 6.88 (dd, J = 9.0, 3.2 Hz, 1H), 
6.77 (d, J = 9.0 Hz, 1H), 3.77 (s, 3H), 3.74 (s, 3H), 2.38 (s, 3H). 13C NMR (100 MHz, 
CDCl3) δ 153.60, 152.47, 144.12, 143.65, 135.37, 129.60, 127.94, 122.15, 118.15, 112.45, 
110.28, 56.12, 55.82, 21.57. IR (neat, cm-1): 3169.09, 1577.57, 1494.71, 1452.99, 1329.08, 
1159.86, 1050.23, 908.61, 799.06, 716.49. HRMS (ESI) ([M+H]+) Calcd. For 
C16H19N2O4S+: 335.1060, found 335.1083.
2,6-difluorobenzaldehyde tosylhydrazone 1g, 92% yield.1H NMR (400 
MHz, CDCl3) δ 7.92 (s, 1H), 7.90 (d, J = 8.1 Hz, 2H), 7.89 (s, 1H), 7.33 
(d, J = 8.1 Hz, 2H), 7.29 (ddd, J = 8.5, 6.2, 2.3 Hz, 1H), 6.90 (t, J = 8.5 
Hz, 2H), 2.42 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 160.99 (dd, J = 257.6, 6.2 Hz), 
144.34 (s), 137.59 (s), 135.02 (s), 131.31 (t, J = 10.5 Hz), 129.65 (s), 128.10 (s), 111.86 
(d, J = 24.4 Hz), 111.03 (t, J = 13.6 Hz), 21.61 (s). 19F NMR (376 MHz, CFCl3, CDCl3) δ
-112.60 (m, 2F). IR (neat, cm-1): 3141.82, 1624.52, 1465.42, 1324.20, 1159.43, 1059.69, 
1002.66, 949.96, 806.85, 712.76. HRMS (ESI) ([M+H]+) Calcd. For C14H13F2N2O2S+:
311.0660, found 311.0676.
2-fluorobenzaldehyde tosylhydrazone 1h, 87% yield. 1H NMR (400 
MHz, CDCl3) δ 8.13 (s, 1H), 8.01 (s, 1H), 7.88 (d, J = 8.5 Hz, 2H), 7.87 
– 7.81 (m, 1H), 7.37 – 7.33 (m, 1H), 7.32 (d, J = 8.5 Hz, 2H), 7.16 – 7.09 
(m, 1H), 7.02 (ddd, J = 10.4, 8.4, 1.0 Hz, 1H), 2.41 (s, 3H). 13C NMR (100 MHz, CDCl3)
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δ 161.18 (d, J = 252.5 Hz), 144.36 (s), 140.57 (d, J = 5.1 Hz), 135.19 (s), 131.92 (d, J =
8.5 Hz), 129.71 (s), 127.94 (s), 126.87 (d, J = 2.5 Hz), 124.37 (d, J = 3.5 Hz), 121.01 (d, J
= 9.9 Hz), 115.69 (d, J = 20.9 Hz), 21.59 (s). 19F NMR (376 MHz, CFCl3, CDCl3) δ -121.40
(m, 1F). IR (neat, cm-1): 3189.09, 1595.87, 1487.95, 1457.44, 1329.97, 1166.68, 1059.66, 
957.74, 757.20. HRMS (ESI) ([M+H]+) Calcd. For C14H14FN2O2S+: 293.0755, found 
293.0749.
2,4,6-trifluorobenzaldehyde tosylhydrazone 1i, 89% yield. 1H NMR 
(400 MHz, CDCl3) δ 7.99 (s, 1H), 7.89 (d, J = 8.1 Hz, 2H), 7.82 (s, 1H), 
7.33 (d, J = 8.1 Hz, 2H), 6.68 (t, J = 8.5 Hz, 2H), 2.43 (s, 3H). 13C NMR 
(100 MHz, CDCl3) δ 163.21 (dm, J = 254.3 Hz), 161.49 (dm, J = 259.3 Hz), 144.46 (s), 
136.65 (s), 134.95 (s), 129.62 (s), 128.10 (s), 107.84(m), 100.99 (td, J = 26.0, 2.7 Hz), 
21.63 (s). 19F NMR (376 MHz, CFCl3, CDCl3) δ -104.23 (p, J = 8.4 Hz, 1F), -108.55 (t, J
= 8.2 Hz, 2F). IR (neat, cm-1): 3158.70, 1618.23, 1459.17, 1151.30, 931.13, 826.01, 720.28. 
HRMS (ESI) ([M+H]+) Calcd. For C14H12F3N2O2S+: 329.0572, found 329.0570.
pentafluorobenzaldehyde tosylhydrazone 1j, 82% yield. 1H NMR (400 
MHz, CDCl3) δ 8.56 (s, 1H), 7.87 (d, J = 8.4 Hz, 2H), 7.80 (s, 1H), 7.34 
(d, J = 8.4 Hz, 2H), 2.43 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 145.05
(dm, J = 253.4 Hz), 144.78 (s), 141.73 (dm, J = 258.4 Hz), 137.70 (dm, J = 254.3 Hz), 
134.58 (s), 129.73 (s), 128.04 (s), 108.77 (td, J = 12.0, 3.8 Hz), 21.62 (d, J = 335.3 Hz). 
19F NMR (376 MHz, CFCl3, CDCl3) δ -141.45 (d, J = 14.8 Hz, 2F), -151.57 (t, J = 20.8 
Hz, 1F), -161.97 – -162.09 (m, 2F). IR (neat, cm-1): 3176.38, 1652.07, 1595.97, 1493.99, 
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1324.16, 1160.50, 970.95, 906.78, 792.94. HRMS (ESI) ([M+H]+) Calcd. For 
C14H10F5N2O2S+: 365.0383, found 365.0380.
2.4.3 Typical Procedure for the Preparation of 2,4,6-Triisopropyl Phenylsulfonyl 
Hydrazones18
To a stirred solution of pure 2,4,6-triisopropylbenzenesulfonyl hydrazide (5.0 
mmol) in THF (12.0 mL) at 0 oC, aldehyde (5.0 mmol) was added dropwise (or portionwise 
if solid). After approximately 3 h, the solvent was removed directly under reduced pressure, 
and the crude solid was further purified by recrystallization in hot methanol.
2,6-difluorobenzaldehyde 2,4,6-triisopropylbenzenesulfonyl 
hydrazone 1g’, 83% yield. 1H NMR (400 MHz, CDCl3) δ 8.31 (s, 
1H), 7.92 (s, 1H), 7.30 – 7.20 (m, 1H), 7.19 (s, 2H), 6.86 (t, J = 8.5 
Hz, 2H), 4.24 (hept, J = 6.7 Hz, 2H), 2.90 (hept, J = 6.9 Hz, 1H), 
1.30 (d, J = 6.7 Hz, 12H), 1.25 (d, J = 6.9 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 160.93 
(dd, J = 257.9, 6.1 Hz), 153.50 (s), 151.54 (s), 136.09 (s), 131.06 (d, J = 7.6 Hz), 130.92 
(s), 123.83 (s), 111.78 (d, J = 24.4 Hz), 111.14 (t, J = 13.4 Hz), 34.17 (s), 30.08 (s), 24.81 
(s), 23.50 (s). 19F NMR (376 MHz, CFCl3, CDCl3) -111.75 (dd, J = 8.2, 6.3 Hz, 2F). IR 
(neat, cm-1):  3158.70, 1618.23, 1459.17, 1151.30, 931.13, 826.01, 789.01, 720.28. HRMS 
(ESI) ([M+H]+) Calcd. For C22H29F2N2O2S+: 423.1918, found 423.1939.
Chapter 2. Asymmetric Cyclopropanation with In Situ-Generated Aryldiazomethanes 
2-fluorobenzaldehyde 2,4,6-triisopropylbenzenesulfonyl 
hydrazone 1h’, 81% yield. 1H NMR (400 MHz, CDCl3) δ 8.05 (s, 
1H), 8.01 (s, 1H), 7.80 (td, J = 7.6, 1.5 Hz, 1H), 7.36 – 7.28 (m, 1H), 
7.19 (s, 2H), 7.09 (t, J = 7.6 Hz, 1H), 7.06 – 6.98 (m, 1H), 4.27 (hept, 
J = 6.8 Hz, 2H), 2.90 (hept, J = 6.9 Hz, 1H), 1.31 (d, J = 6.8 Hz, 12H), 1.25 (d, J = 6.9 Hz, 
6H). 13C NMR (100 MHz, CDCl3) δ 161.15 (d, J = 252.0 Hz), 153.57 (s), 151.39 (s), 139.17 
(d, J = 5.0 Hz), 131.73 (d, J = 8.4 Hz), 131.16 (s), 126.76 (s), 124.27 (s), 123.91 (s), 121.18 
(d, J = 9.8 Hz), 115.68 (d, J = 21.0 Hz), 34.18 (s), 30.08 (s), 24.86 (s), 23.51 (s). 19F NMR 
(376 MHz, CFCl3, CDCl3) δ -121.68 (m, 1F). IR (neat, cm-1): 3179.06, 1601.47, 1441.29, 
1167.20, 949.74, 839.60, 755.30. HRMS (ESI) ([M+H]+) Calcd. For C22H30FN2O2S+:
405.2012, found 405.1995.
2,4,6-trifluorobenzaldehyde 2,4,6-triisopropylbenzenesulfonyl 
hydrazone 1i’, 75% yield. 1H NMR (400 MHz, CDCl3) δ 8.05 (s, 
1H), 7.82 (s, 1H), 7.19 (s, 2H), 6.66 (t, J = 8.5 Hz, 2H), 4.20 (hept, 
J = 6.8 Hz, 2H), 2.89 (hept, J = 6.9 Hz, 1H), 1.29 (d, J = 6.7 Hz, 
12H), 1.25 (d, J = 6.9 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ
163.03 (dm, J = 254.1 Hz), 161.29 (dm, J = 259.0 Hz), 153.58 (s), 151.55 (s), 135.21 (s), 
131.00 (s), 123.86 (s), 108.01(m), 100.87 (td, J = 26.1, 2.4 Hz), 34.19 (s), 30.08 (s), 24.81 
(s), 23.51 (s). 19F NMR (376 MHz, CFCl3, CDCl3) δ -104.70 (p, J = 8.0 Hz, 1F), -108.30
(t, J = 8.4 Hz, 2F). IR (neat, cm-1): 3185.54, 1615.83, 1435.14, 1166.49, 1027.07, 930.77, 
837.06, 652.16. HRMS (ESI) ([M+H]+) Calcd. For C22H28F3N2O2S+: 441.1824, found 
441.1814.
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pentafluorobenzaldehyde 2,4,6-triisopropylbenzenesulfonyl 
hydrazone 1j’, 73% yield. 1H NMR (400 MHz, CDCl3) δ 8.51 (s, 
1H), 7.80 (s, 1H), 7.20 (s, 2H), 4.19 (hept, J = 6.7 Hz, 2H), 2.92 (hept, 
J = 6.9 Hz, 1H), 1.29 (d, J = 6.7 Hz, 12H), 1.25 (d, J = 6.9 Hz, 6H).
13C NMR (100 MHz, CDCl3) δ 153.90 (s), 151.61 (s), 144.97 (dm, J = 258.1 Hz), 141.59 
(dm, J = 246.1, 13.3 Hz), 137.71 (dm, J = 249.4 Hz), 132.89 (s), 130.64 (s), 123.95 (s), 
108.70(m), 34.21 (s), 30.11 (s), 24.78 (s), 23.49 (s). 19F NMR (376 MHz, CFCl3, CDCl3)
δ -141.37 (m, 2F), -152.04 (m, 1F), -162.33 (m, 2F). IR (neat, cm-1): 3197.45, 1601.27, 
1494.88, 1163.62, 968.82, 901.81, 794.34, 680.74. HRMS (ESI) ([M+H]+) Calcd. For 
C22H26F5N2O2S+: 477.1635, found 477.1634.
2-Chlorobenzaldehyde 2,4,6-triisopropylbenzenesulfonyl 
hydrazone 1k’, 57% yield. 1H NMR (600 MHz, CDCl3) δ 8.16 (s, 
1H), 7.91 (s, 1H), 7.85 (dd, J = 7.9, 1.5 Hz, 1H), 7.32 (d, J = 8.0 Hz, 
1H), 7.28 – 7.26 (m, 1H), 7.21 (t, J = 7.6 Hz, 1H), 7.18 (s, 2H), 4.25 
(hept, J = 6.9 Hz, 2H), 2.90 (hept, J = 6.4 Hz, 1H), 1.30 (d, J = 6.8 Hz, 12H), 1.25 (d, J =
6.9 Hz, 6H). 13C NMR (150 MHz, CDCl3) δ 156.24, 154.07, 145.13, 136.64, 133.86, 
133.67, 133.55, 132.36, 130.01, 129.48, 126.57, 36.85, 32.77, 27.53, 26.17. IR (neat, cm-
1):3192.25, 1599.04, 1426.73, 1192.76, 945.51, 933.50, 845.51, 658.20. HRMS (ESI) 
([M+H]+) Calcd. For C22H30ClN2O2S +: 421.1711, found 421.1717.
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2-bromobenzaldehyde 2,4,6-triisopropylbenzenesulfonyl 
hydrazone 1l’, 58% yield. 1H NMR (600 MHz, CDCl3) δ 8.30 (s, 
1H), 8.15 (s, 1H), 7.83 (dd, J = 7.9, 1.7 Hz, 1H), 7.50 (d, J = 8.0 Hz, 
1H), 7.26 – 7.16 (m, 4H), 4.28 (hept, J = 6.7 Hz, 2H), 2.92 – 2.88 (m, 
1H), 1.31 (d, J = 6.8 Hz, 12H), 1.25 (d, J = 6.9 Hz, 6H). 13C NMR (150 MHz, CDCl3) δ
156.24, 154.05, 147.47, 135.62, 134.97, 133.95, 133.85, 130.42, 130.08, 126.57, 36.85, 
32.76, 27.53, 26.17. IR (neat, cm-1):3183.84, 1598.65, 1427.03, 1192.47, 1060.66, 932.10, 
845.40, 653.77. HRMS (ESI) ([M+H]+) Calcd. For C22H30BrN2O2S+: 465.1206, found 
465.1211.
2-iodobenzaldehyde 2,4,6-triisopropylbenzenesulfonyl 
hydrazone 1m’, 88% yield. 1H NMR (600 MHz, CDCl3) δ 7.99 (s, 
1H), 7.98 (s, 1H), 7.79 (ddd, J = 7.9, 3.2, 1.3 Hz, 2H), 7.28 (t, J = 7.7 
Hz, 1H), 7.18 (s, 2H), 7.03 (td, J = 7.7, 1.7 Hz, 1H), 4.25 (hept, J =
6.7 Hz, 2H), 2.90 (hept, J = 6.9 Hz, 1H), 1.30 (d, J = 6.8 Hz, 12H), 1.25 (d, J = 6.9 Hz, 
6H). 13C NMR (150 MHz, CDCl3) δ 156.23, 154.03, 151.87, 142.23, 137.65, 134.15, 
133.85, 130.89, 130.41, 126.57, 101.70, 36.84, 32.76, 27.54, 26.18. IR (neat, cm-
1):3215.97, 1597.80, 1131.96, 1191.82, 1058.66, 940.40, 844.68, 754.49, 672.63. HRMS 
(ESI) ([M+H]+) Calcd. For C22H30IN2O2S+: 513.1067, found 513.1073.
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2.4.4 General Procedure for [Co(Por)]-Catalyzed Cyclopropanation
An oven-dried Schlenk tube was charged with 1.0 equivalent of sulfonyl hydrazone 
(0.1 mmol), [Co(Por)] (2 mol %) and 2.0 equivalent of Cs2CO3 (0.2 mmol). The Schlenk 
tube was then evacuated and back filled with nitrogen for 3 times. The Teflon screw cap 
was replaced with a rubber septum, and olefin (0.15 mmol, 1.5 eq) and methanol (0.6 mL) 
were added. The Schlenk tube was then purged with nitrogen for 30 s and the rubber septum 
was replaced with a Teflon screw cap. The mixture was then stirred at 40 oC. After 24 h, 
the reaction mixture was concentrated and purified by flash chromatography. The fractions 
containing product were collected and concentrated by rotary evaporation to afford the 
compound as a mixture of trans/cis diastereomers. (In most cases, the cyclopropanated 
product was visualized on TLC using the cerium ammonium molybdate (CAM) stain)
1,2-diphenylcyclopropane (3aa)20. Yield: 64%. Rf = 0.50 (ethyl
acetate / hexanes = 1:50), isolated as a mixture of trans/cis
diastereomers trans/cis: 89/11. 1H NMR (400 MHz, CDCl3) δ 7.39 – 7.25 (m, 5H), 7.24 –
7.13 (m, 5H), 2.18 (d, J = 7.2 Hz, 2H), 1.46 (dd, J = 7.2, 6.6 Hz, 2H). 13C NMR (100 MHz, 
CDCl3) δ 142.50, 128.36, 125.75, 125.72, 28.00, 18.18. HPLC analysis: ee (trans)-isomer 
= -42%. ADH (100% hexanes, 0.8 mL/min) (trans)-isomer: tmajor = 10.12 min, tminor = 8.37 
min.
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1-methoxy-2-(2-phenylcyclopropyl)benzene (3ba). Yield: 78%. Rf
= 0.43 (ethyl acetate / hexanes = 1:20), isolated as a mixture of 
trans/cis diastereomers trans/cis: 95/5. [α]20 D = +198.0 (c = 0.5, 
CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.42 – 7.29 (m, 2H), 7.29 – 7.18 (m, 4H), 7.03 (d, 
J = 7.5 Hz, 1H), 6.97 (t, J = 7.5 Hz, 1H), 6.91 (d, J = 8.1 Hz, 1H), 3.88 (s, 3H), 2.59 – 2.46
(m, 1H), 2.27 – 2.12 (m, 1H), 1.51 – 1.38 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 158.13, 
142.97, 130.81, 128.25, 126.60, 126.10, 125.55, 125.05, 120.47, 110.26, 55.48, 26.52, 
21.62, 17.03. IR (neat, cm-1): 3061.93, 2965.26, 1602.47, 1489.30, 910.57, 835.92, 750.46. 
HPLC analysis: ee (trans)-isomer = 99%. ADH (100% hexanes, 0.8 mL/min) (trans)-
isomer: tmajor = 14.52 min, tminor =13.78 min. HRMS (EI) ([M]+) Calcd. for C16H16O+:
224.1195, Found 224.1196. 
1-ethyl-2-(2-phenylcyclopropyl)benzene (3ca). Yield: 87%. Rf =
0.50 (ethyl acetate / hexanes = 1:50), isolated as a mixture of trans/cis
diastereomers trans/cis: 85/15. 1H NMR (500 MHz, CDCl3) δ 7.31
(t, J = 7.6 Hz, 2H), 7.23 – 7.16 (m, 5H), 7.12 – 7.08 (m, 1H), 7.03 – 6.99 (m, 1H), 2.74 (q, 
J = 7.6 Hz, 2H), 2.27 – 2.25 (m, 1H), 2.09 – 2.06 (m, 1H), 1.51 – 1.48 (m, 1H), 1.43 – 1.36
(m, 1H), 1.19 (t, J = 7.6 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 143.57, 142.81, 139.45, 
128.38, 127.96, 127.38, 126.19, 125.84, 125.62, 125.34, 26.31, 25.98, 25.42, 16.60, 14.80. 
IR (neat, cm-1): 3061.86, 2964.52, 1602.23, 1489.47, 929.09, 750.23, 695.26. HPLC 
analysis: ee (trans)-isomer = 33%. ODH (99.9% hexanes : 0.1% isopropanol, 0.8 mL/min) 
(trans)-isomer: tmajor = 12.43 min, tminor = 17.09 min. HRMS (EI) Calcd. for C17H18+:
222.1403, Found 222.1402. 
Chapter 2. Asymmetric Cyclopropanation with In Situ-Generated Aryldiazomethanes 
1-methoxy-4-(2-phenylcyclopropyl)benzene (3da)21. Yield: 
23%. Rf = 0.43 (ethyl acetate / hexanes = 1:20), isolated as a 
mixture of diastereomers trans/cis: 93/7. 1H NMR (400 MHz, 
CDCl3) δ 7.32 – 7.26 (m, 2H), 7.19 (d, J = 6.8 Hz, 1H), 7.14 (d, J = 7.9 Hz, 2H), 7.09 (d, 
J = 7.9 Hz, 2H), 6.85 (d, J = 7.7 Hz, 2H), 3.80 (s, 3H), 2.16 – 2.07 (m, 2H), 1.41 – 1.38 
(m, 2H). 13C NMR (100 MHz, CDCl3) δ 157.84, 142.72, 134.51, 128.35, 126.90, 125.69,
125.61, 113.85, 55.33, 27.49, 27.31, 17.79. HPLC analysis: ee (trans)-isomer = 23%. ADH 
(100% hexanes, 0.8 mL/min) (trans)-isomer: tmajor = 24.46 min, tminor = 29.20 min.
1-methoxy-3-(2-phenylcyclopropyl)benzene (3ea). Yield: 
69%. Rf = 0.43 (ethyl acetate / hexanes = 1:20), isolated as a 
mixture of diastereomers trans/cis: 95/5. 1H NMR (500 MHz, CDCl3) δ 7.33 – 7.17 (m, 
6H), 6.86 – 6.73 (m, 3H), 3.84 (s, 3H), 2.22 – 2.18 (m, 2H), 1.50 – 1.47 (m, 2H). 13C NMR 
(125 MHz, CDCl3) δ 159.71, 144.25, 142.42, 129.34, 128.37, 127.68, 125.74, 118.13, 
111.64, 110.99, 55.17, 28.08, 28.03, 18.20. IR (neat, cm-1): 3026.87, 2833.70, 1601.77, 
1582.13, 1042.45, 993.87, 717.74, 692.66. HPLC analysis: ee (trans)-isomer = 23%. ADH 
(100% hexanes, 0.8 mL/min) (trans)-isomer: tmajor = 28.00 min, tminor = 32.64 min. HRMS 
(EI) (M+) Calcd. for C16H16O+: 224.1196, Found 224.1191. 
1-methoxy-2-(2-(4-methoxyphenyl)cyclopropyl)benzene
(3bb). Yield: 88%. Rf = 0.29 (ethyl acetate / hexanes = 1:20),
isolated as a mixture of diastereomers trans/cis: 95/5. [α]20 D = +254.7 (c = 0.5, CHCl3). 1H
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NMR (500 MHz, CDCl3) δ 7.26 – 7.14 (m, 3H), 6.97 (dd, J = 7.6, 1.7 Hz, 1H), 6.94 – 6.89 
(m, 1H), 6.89 – 6.82 (m, 3H), 3.84 (s, 3H), 3.80 (s, 3H), 2.40 (dt, J = 8.5, 5.4 Hz, 1H), 2.09 
(dt, J = 8.7, 5.4 Hz, 1H), 1.37 – 1.30 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 158.13,
157.71, 134.99, 131.00, 127.29, 126.50, 125.02, 120.46, 113.72, 110.24, 55.50, 55.30, 
25.80, 21.07, 16.49. IR (neat, cm-1): 2995.01, 1598.05, 1494.37, 1242.45, 1029.50, 903.31, 
804.44, 697.03. HPLC analysis: ee (trans)-isomer = 94%. ODH (99.5% hexanes:0.5% 
isopropanol, 0.8 mL/min) (trans)-isomer: tmajor = 12.52 min, tminor = 19.06 min. HRMS (EI) 
(M+) Calcd. for C17H18O2+: 254.1301, Found 254.1303. 
1-methoxy-2-(2-(4-(trifluoromethyl)phenyl)
cyclopropyl)benzene (3bc). Yield: 81%. Rf = 0.46 (ethyl 
acetate / hexanes = 1:20), isolated as a mixture of diastereomers 
trans/cis: 96/4. [α]20 D = +203.8 (c = 0.5, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.54 (d, J 
= 8.4 Hz, 2H), 7.31 – 7.26 (m, 2H), 7.23 – 7.17 (m, 1H), 6.99 (dd, J = 7.6, 1.7 Hz, 1H), 
6.96 – 6.91 (m, 1H), 6.88 (d, J = 8.2 Hz, 1H), 3.84 (s, 3H), 2.50 (ddd, J = 9.0, 6.2, 5.0 Hz, 
1H), 2.15 (dt, J = 8.8, 5.3 Hz, 1H), 1.52 – 1.48 (m, 1H), 1.43 (dt, J = 9.0, 5.4 Hz, 1H). 13C
NMR (125 MHz, CDCl3) δ 158.17, 147.33, 130.02, 127.74 (q, J = 32.2 Hz), 126.99, 126.18, 
125.25 – 125.09 (m), 124.41 (q, J = 271.7 Hz), 120.49, 110.26, 55.45, 26.33, 22.55, 17.15. 
19F NMR (376 MHz, CDCl3) δ -62.72 (s, 3F). IR (neat, cm-1): 3002.00, 1614.91, 1496.23, 
1323.24, 1117.08, 929.99, 818.51, 751.26. HPLC analysis: ee (trans)-isomer = 95%. ADH 
(100% hexanes, 0.8 mL/min) (trans)-isomer: tmajor = 19.12 min, tminor = 16.06 min. HRMS 
(EI) (M+) Calcd. for C17H15F3O+: 292.1070, Found 292.1075. 
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1-(2-(4-bromophenyl)cyclopropyl)-2-methoxybenzene (3bd).
Yield:85%. Rf = 0.42 (ethyl acetate / hexanes = 1:20), isolated as 
a mixture of diastereomers trans/cis: 94/6. [α]20 D = +135.2 (c = 0.5, CHCl3). 1H NMR (500 
MHz, CDCl3) δ 7.40 (d, J = 8.4 Hz, 2H), 7.21 – 7.16 (m, 1H), 7.07 (d, J = 8.4 Hz, 2H), 
6.96 (dd, J = 7.5, 1.7 Hz, 1H), 6.92 (td, J = 7.5, 0.8 Hz, 1H), 6.87 (d, J = 8.1 Hz, 1H), 3.83 
(s, 3H), 2.43 – 2.40 (m, 1H), 2.07 – 2.05 (m, 1H), 1.46 – 1.39 (m, 1H), 1.36 – 1.32 (m, 1H). 
13C NMR (125 MHz, CDCl3) δ 158.14, 142.09, 131.24, 130.32, 127.87, 126.82, 125.12, 
120.47, 119.09, 110.25, 55.47, 25.99, 21.92, 16.73. IR (neat, cm-1): 3000.63, 1599.82, 
1488.71, 1244.12, 1028.76, 899.24, 814.98, 747.52. HPLC analysis: ee (trans)-isomer = 
94%. ADH (100% hexanes, 0.8 mL/min) (trans)-isomer: tmajor = 30.20 min, tminor = 24.69 
min. HRMS (EI) (M+) Calcd. for C16H15BrO+: 302.0301, Found 302.0308. 
The X-ray diffraction data were measured on a Bruker D8 Venture PHOTON 100 
CMOS diffractometer equipped with a Cu Kα INCOATEC Imus micro-focus source (λ = 
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1.54178 Å). Indexing was performed using APEX2 (Difference Vectors method). Data 
integration and reduction were performed using SaintPlus 6.01. Absorption correction was 
performed by multi-scan method implemented in SADABS. Space groups were 
determined using XPREP implemented in APEX2. The structure was solved using 
SHELXS-97 (direct methods) and refined using SHELXL-2013 (full-matrix least-squares
on F2) contained in APEX2, WinGX v1.70.01 and OLEX2. All non-hydrogen atoms were 
refined anisotropically. All hydrogen atoms were placed in geometrically calculated 
positions and included in the refinement process using riding model with isotropic thermal 
parameters with Uiso(H) = 1.2Ueq(-CH,-CH2), Uiso(H) = 1.5Ueq(-CH3). Crystal data and 
refinement conditions are shown in the following Table. 


















Crystal size/mm3 0.09 × 0.06 × 0.03
Radiation CuKα (λ = 1.54178)
2Θ range for data collection/° 8.036 to 137.574
Index ranges -6 ≤ h ≤ 6, -16 ≤ k ≤ 16, -22 ≤ l ≤ 22
Reflections collected 17008
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Independent reflections 2481 [Rint = 0.0490, Rsigma = 0.0262]
Data/restraints/parameters 2481/0/164
Goodness-of-fit on F2 1.106
Final R indexes [I>=2σ (I)] R1 = 0.0228, wR2 = 0.0597
Final R indexes [all data] R1 = 0.0229, wR2 = 0.0598
Largest diff. peak/hole / e Å-3 0.73/-0.34
Flack parameter -0.022(7)
1-(2-(3-bromophenyl)cyclopropyl)-2-methoxybenzene (3be).
Yield: 85%. Rf = 0.46 (ethyl acetate / hexanes = 1:20), isolated as 
a mixture of diastereomers trans/cis: 94/6. [α]20 D = +400.2 (c = 0.5, CHCl3). 1H NMR (500 
MHz, CDCl3) δ 7.33– 7.32 (m, 1H), 7.31 – 7.26 (m, 1H), 7.20 – 7.09 (m, 3H), 6.97 – 6.82 
(m, 3H), 3.82 (s, 3H), 2.42 – 2.40 (m, 1H), 2.08 – 2.04 (m, 1H), 1.43 – 1.32 (m, 2H). 13C
NMR (125 MHz, CDCl3) δ 158.16, 145.51, 130.19, 129.75, 129.21, 128.62, 126.88, 
125.21, 124.90, 122.43, 120.46, 110.23, 55.46, 26.03, 22.05, 16.76. IR (neat, cm-1):
3001.29, 1595.81, 1461.71, 1244.64, 926.25, 776.21, 687.69. HPLC analysis: ee (trans)-
isomer = 94%. OJH (100% hexanes, 0.8 mL/min) (trans)-isomer: tmajor = 40.36 min, tminor
= 34.22 min. HRMS (EI) (M+) Calcd. for C16H15BrO+: 302.0301, Found 302.0306. 
1-bromo-2-(2-(2-methoxyphenyl)cyclopropyl)benzene (3bf).
Yield: 89%. Rf = 0.40 (ethyl acetate / hexanes = 1:20), isolated as a 
mixture of diastereomers trans/cis: 95/5. [α]20 D = +116.1 (c = 0.5, CHCl3). 1H NMR (500 
MHz, CDCl3) δ 7.57 (d, J = 7.9 Hz, 1H), 7.30 – 7.25 (m, 1H), 7.24 – 7.16 (m, 2H), 7.13 –
7.03 (m, 2H), 6.95 (t, J = 7.5 Hz, 1H), 6.89 (d, J = 8.2 Hz, 1H), 3.87 (s, 3H), 2.54 – 2.38
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(m, 2H), 1.45 – 1.39 (m, 1H), 1.38 – 1.32 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 158.22, 
141.77, 132.36, 130.33, 127.28, 127.16, 127.00, 126.76, 125.94, 125.39, 120.48, 110.21, 
55.51, 26.22, 20.79, 16.53. IR (neat, cm-1): 3001.06, 1600.19, 1475.28, 1244.35, 1023.19, 
905.39, 800.98, 659.99. HPLC analysis: ee (trans)-isomer = 96%. OJH (99.5% hexanes: 
0.5% isopropanol, 0.8 mL/min) (trans)-isomer: tmajor = 14.42 min, tminor = 12.80 min. 
HRMS (EI) (M+) Calcd. for C16H15BrO+: 302.0301, Found 302.0307. 
2-(2-(2-methoxyphenyl)cyclopropyl)-1,3,5-trimethylbenzene 
(3bg). Yield: 61%. Rf = 0.65 (ethyl acetate / hexanes = 1:20),
isolated as a mixture of diastereomers trans/cis:90/10. [α]20 D = +152.4 (c = 0.5, CHCl3).
1H NMR (500 MHz, CDCl3) δ 7.21 – 7.16 (m, 1H), 6.95 (d, J = 4.3 Hz, 2H), 6.91 (d, J =
8.2 Hz, 1H), 6.85 (s, 2H), 3.87 (s, 3H), 2.45 (dt, J = 9.1, 5.6 Hz, 1H), 2.37 (s, 6H), 2.28 (s, 
3H), 2.10 – 2.06 (m, 1H), 1.36 – 1.33 (m, 1H), 1.28 – 1.24 (m, 1H). 13C NMR (125 MHz, 
CDCl3) δ 157.79, 138.74, 135.62, 135.50, 131.66, 128.63, 126.13, 123.89, 120.62, 110.36, 
55.51, 23.11, 20.81, 20.56, 19.55, 19.07. IR (neat, cm-1): 2998.48, 1600.07, 1496.07, 
1243.08, 1028.70, 921.04, 849.68, 747.06. HPLC analysis: ee (trans)-isomer = 96%. ADH 
(100% hexanes, 0.8 mL/min) (trans)-isomer: tmajor = 8.87 min, tminor = 10.71 min. HRMS 
(EI) (M+) Calcd. for C19H22O+: 266.1665, Found 266.1671. 
1-(2-(4-chlorophenyl)-2-methylcyclopropyl)-2-
methoxybenzene (3bh) Yield: 90%. Rf = 0.65 (ethyl acetate / 
hexanes = 1:20), isolated as a mixture of diastereomers trans/cis:
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83/17. [α]20 D = +121.3 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.47 (d, J = 8.5 
Hz, 2H), 7.30 (d, J = 8.5 Hz, 2H), 7.24 (d, J = 8.1 Hz, 1H), 7.12 (d, J = 7.4 Hz, 1H), 6.96 
– 6.87 (m, 2H), 3.91 (s, 3H), 2.31 (dd, J = 8.1, 7.1 Hz, 1H), 1.31 (dd, J = 8.7, 5.0 Hz, 1H), 
1.17 – 1.13 (m, 1H), 0.99 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 159.53, 147.03, 130.33, 
129.39, 129.34, 128.26, 127.70, 127.37, 120.15, 109.75, 55.26, 28.63, 26.36, 21.25, 17.38.
IR (neat, cm-1): 3064.36, 2998.26, 1599.36, 1492.02, 1240.29, 1027.87, 829.62, 732.31. 
HPLC analysis: ee (trans)-isomer = 93%. ADH (100% hexanes, 0.8 mL/min) (trans)-
isomer: tmajor = 10.09 min, tminor = 11.99 min. HRMS (EI) (M+) Calcd. for C17H17ClO+:
272.0962, Found 272.0968. 
1-methoxy-2-(2-methyl-2-(o-tolyl)cyclopropyl)benzene (3bi).
Yield: 42%. Rf = 0.60 (ethyl acetate / hexanes = 1:20), isolated as a 
mixture of diastereomers trans/cis:83/17. [α]20 D = +88.5 (c = 0.5,
CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 7.3 Hz, 1H), 7.30 – 7.11 (m, 5H), 6.99 
– 6.93 (m, 2H), 3.97 (s, 3H), 2.55 – 2.52 (m, 1H), 2.49 (s, 3H), 1.25 (dd, J = 6.2, 4.8 Hz, 
1H), 1.18 (dd, J = 8.7, 4.8 Hz, 1H), 0.98 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 159.48, 
146.30, 137.48, 130.07, 129.91, 129.27, 128.13, 127.12, 126.16, 125.86, 120.06, 109.77, 
55.15, 26.69, 25.07, 20.26, 19.13, 18.13. IR (neat, cm-1): 2996.17, 1600.36, 1493.39, 
1240.27, 1028.20, 927.08, 748.58, 696.80. HPLC analysis: ee (trans)-isomer = 92%. ODH 
(100% hexanes, 0.8 mL/min) (trans)-isomer: tmajor = 13.30 min, tminor =17.60 min. HRMS 
(EI) (M+) Calcd. for C18H20O+: 252.1509, Found 252.1501. 
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1-(2-bromo-2-phenylcyclopropyl)-2-methoxybenzene (3bj).
Yield: 71%. Rf = 0.49 (ethyl acetate / hexanes = 1:20), isolated as a 
mixture of diastereomers trans/cis:75/25. [α]20 D = +11.9 (c = 0.5,
CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.74 (dd, J = 8.2, 1.3 Hz, 2H), 7.37 (dd, J = 10.6, 
4.5 Hz, 2H), 7.35 – 7.24 (m, 2H), 7.18 – 7.14 (m, 1H), 6.98 (d, J = 7.7 Hz, 2H), 4.00 (s, 
3H), 2.54 (t, J = 8.8 Hz, 1H), 1.83 (dd, J = 8.7, 1.2 Hz, 2H). 13C NMR (125 MHz, CDCl3)
δ 159.19, 144.75, 129.62, 129.28, 128.99, 128.47, 128.33, 127.94, 120.11, 110.04, 55.47, 
41.23, 26.65, 20.26. IR (neat, cm-1): 3001.36, 1600.62, 1494.35, 1245.70, 1027.47, 893.04, 
748.56, 695.89. HPLC analysis: ee (trans)-isomer = 95%. ADH (100% hexanes, 0.8
mL/min) (trans)-isomer: tmajor = 13.62 min, tminor = 17.70 min. HRMS (EI) (M+) Calcd. for 
C16H15BrO+: 302.0301, Found 302.0306.
3-(2-(2-methoxyphenyl)cyclopropyl)aniline (3bk). Yield: 
69%. Rf = 0.40 (ethyl acetate / hexanes = 1:3), isolated as a 
mixture of diastereomers trans/cis: 92/8. [α]20 D = +267.9 (c = 0.5, CHCl3). 1H NMR (500 
MHz, CDCl3) δ 7.26 – 7.14 (m, 1H), 7.09 (dd, J = 12.0, 4.7 Hz, 1H), 6.99 – 6.90 (m, 2H), 
6.87 (d, J = 8.2 Hz, 1H), 6.64 (d, J = 7.7 Hz, 1H), 6.53 (d, J = 6.4 Hz, 2H), 3.84 (s, 3H), 
3.45 (br, 2H), 2.49 – 2.46 (m, 1H), 2.09 – 2.06 (m, 1H), 1.36 (td, J = 7.5, 1.1 Hz, 2H). 13C
NMR (125 MHz, CDCl3) δ 158.12, 146.17, 144.33, 130.93, 129.20, 126.56, 124.98, 
120.50, 116.74, 112.91, 112.72, 110.31, 55.54, 26.61, 21.42, 17.14. IR (neat, cm-1):
3370.24, 3005.29, 1602.52, 1494.08, 1243,93, 1028.03, 865.37, 693.25. HPLC analysis: 
ee (trans)-isomer = 97%. ADH (97% hexanes : 3% isopropanol, 0.8 mL/min) (trans)-
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isomer: tmajor = 33.44 min, tminor =41.82 min. HRMS (ESI) ([M+H]+) Calcd. For 
C16H18NO+: 240.1383, Found 240.1375. 
2-(2-(2-methoxyphenyl)cyclopropyl)naphthalene (3bl). Yield: 
68%. Rf = 0.34 (ethyl acetate / hexanes = 1:20), isolated as a 
mixture of diastereomers trans/cis: 93/7. [α]20 D = +112.1 (c = 0.5,
CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.80 (dd, J = 11.6, 8.4 Hz, 3H), 7.65 (s, 1H), 7.43 
(dt, J = 14.8, 6.9 Hz, 2H), 7.35 (d, J = 8.4 Hz, 1H), 7.20 (dd, J = 8.0, 7.5 Hz, 1H), 7.04 (d, 
J = 7.5 Hz, 1H), 6.95 (t, J = 7.5 Hz, 1H), 6.88 (d, J = 8.2 Hz, 1H), 3.84 (s, 3H), 2.60 – 2.56
(m, 1H), 2.32 – 2.28 (m, 1H), 1.55 – 1.47 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 158.19, 
140.52, 133.54, 131.97, 130.74, 127.80, 127.57, 127.33, 126.68, 125.94, 125.16, 125.10, 
124.93, 124.01, 120.50, 110.29, 55.49, 26.80, 21.93, 16.87. IR (neat, cm-1): 3050.85, 
2934.61, 1630.05, 1598.67, 1494.91, 1025.18, 911.19, 742.18. HPLC analysis: ee (trans)-
isomer = 99%. ADH (100% hexanes, 0.8 mL/min) (trans)-isomer: tmajor = 31.76 min, tminor
= 30.74 min. HRMS (EI) (M+) Calcd. for C20H18O+: 274.1353, Found 274.1350. 
1-methoxy-2-(2-((trans)-styryl)cyclopropyl)benzene (3bm).
Yield: 77%. Rf = 0.46 (ethyl acetate / hexanes = 1:20), isolated 
as a mixture of diastereomers trans/cis: 81/19. [α]20 D = +193.1
(c = 0.5, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.34 (d, J = 7.3 Hz, 2H), 7.29 (t, J = 7.6 
Hz, 2H), 7.21 – 7.12 (m, 2H), 6.95 – 6.81 (m, 3H), 6.50 (d, J = 15.8 Hz, 1H), 5.98 (dd, J =
15.8, 8.7 Hz, 1H), 3.85 (s, 3H), 2.39 – 2.35 (m, 1H), 1.81 – 1.80 (m, 1H), 1.31 – 1.27 (m, 
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1H), 1.20 – 1.15 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 158.03, 137.69, 133.49, 130.38, 
128.46, 127.89, 126.62, 126.52, 125.66, 124.76, 120.52, 110.33, 55.58, 26.03, 19.65, 
16.05. IR (neat, cm-1): 3023.96, 2931.60, 1645.79, 1494.54, 1242.80, 1027.44, 956.56, 
692.08. HPLC analysis: ee (trans)-isomer = 81%. ODH (98% hexanes : 2% isopropanol, 
0.8 mL/min) (trans)-isomer: tmajor = 8.21 min, tminor = 8.83 min. HRMS (EI) (M+) Calcd. 
for C18H18O+: 250.1352, Found 250.1336. 
1-methoxy-2-(2-methyl-2-(prop-1-en-2-yl)cyclopropyl)benzene
(3bn). Yield: 50%. Rf = 0.54 (ethyl acetate / hexanes = 1:50), isolated 
as a mixture of diastereomers trans/cis:78/22. [α]20 D = -37.7 (c = 0.5,
CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.22 – 7.18 (m, 1H), 7.06 (d, J = 7.4 Hz, 1H), 6.90 
(td, J = 7.5, 0.8 Hz, 1H), 6.86 (d, J = 8.1 Hz, 1H), 4.93 (s, 1H), 4.78 (s, 1H), 3.84 (s, 3H), 
2.12 (dd, J = 8.4, 6.7 Hz, 1H), 1.88 (s, 3H), 1.18 (dd, J = 8.6, 4.8 Hz, 1H), 0.89 (dd, J =
6.3, 4.9 Hz, 1H), 0.82 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 159.48, 151.01, 129.15, 
126.96, 119.93, 111.79, 109.70, 109.04, 55.13, 28.09, 25.39, 20.31, 18.04, 16.23. IR (neat, 
cm-1): 3073.35, 2953.85, 1644.08, 1494.53, 1240.35, 1023.19, 890.13, 748.15. HPLC 
analysis: ee (trans)-isomer = 89%. ODH (100% hexanes, 0.8 mL/min) (trans)-isomer: tmajor
= 8.38 min, tminor = 9.42 min. HRMS (EI) (M+) Calcd. for C14H18O+: 202.1352, Found 
202.1347.
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1-methoxy-2-(2-propoxycyclopropyl)benzene (3bo). Yield: 49%. Rf
= 0.48 (ethyl acetate / hexanes = 1:10), isolated as a mixture of 
diastereomers trans/cis: 83/17. [α]20 D = +89.7 (c = 0.5, CHCl3). 1H
NMR (500 MHz, CDCl3) δ 7.15 (t, J = 7.8, 1.7 Hz, 1H), 6.85 (dd, J = 7.8, 1.8 Hz, 2H), 
6.77 (dd, J = 7.4, 1.5 Hz, 1H), 3.86 (s, 3H), 3.63 – 3.57 (m, 1H), 3.57 – 3.50 (m, 1H), 3.30 
– 3.27 (m, 1H), 2.34 – 2.30 (m, 1H), 1.64 – 1.60 (m, 2H), 1.24 – 1.19 (m, 1H), 1.03 (dd, J
= 12.7, 6.5 Hz, 1H), 0.94 (t, J = 7.4 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 158.06, 129.39,
126.58, 125.53, 120.30, 110.07, 72.42, 61.12, 55.35, 22.80, 18.20, 14.26, 10.64. IR (neat, 
cm-1): 2960.57, 1600.77, 1496.03, 1242.96, 1027.65, 938.07, 794.54, 747.61. HPLC 
analysis: ee (trans)-isomer = 91%. ODH (99% hexanes : 1% isopropanol, 0.8 mL/min) 
(trans)-isomer: tmajor = 24.16 min, tminor = 12.72 min. HRMS (EI) (M+) Calcd. for 
C13H18O2+: 206.1301, Found 206.1298. 
2-(2-methoxyphenyl)cyclopropane-1-carboxamide (3bp). Yield: 
41%. Rf = 0.40 (ethyl acetate / hexanes = 3:1), isolated as a mixture 
of diastereomers trans/cis: 71/29. [α]20 D = +33.2 (c = 0.5, CHCl3).
1H NMR (500 MHz, CDCl3) δ  7.20 – 7.17 (m, 1H), 6.92 – 6.84 (m, 3H), 5.63 (s, 1H), 5.51 
(s, 1H), 3.84 (s, 3H), 2.72 – 2.68 (m, 1H), 1.60 – 1.55 (m, 1H), 1.32 – 1.27 (m, 2H). 13C
NMR (125 MHz, CDCl3) δ 174.91, 158.33, 128.66, 127.41, 125.96, 120.34, 110.32, 55.43, 
24.30, 20.69, 14.53. IR (neat, cm-1): 3399.91, 3199.69, 3007.49, 1638.45, 1434.96, 
1243.99, 1020.30, 951.64, 799.30, 743.55. HPLC analysis: ee (trans)-isomer = 77%. OJH 
(90% hexanes : 10% isopropanol, 0.8 mL/min) (trans)-isomer: tmajor = 18.18 min, tminor =
25.97 min. HRMS (ESI) ([M+Na]+) Calcd. For C11H13NNaO2+: 214.0838, found 214.0842.
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2-(2-methoxyphenyl)cyclopropyl)ethan-1-one (3bq). Yield: 42%. Rf
= 0.35 (ethyl acetate / hexanes = 1:6). [α]20 D = +50.8 (c = 0.5, CHCl3).
1H NMR (600 MHz, CDCl3) δ 7.21 – 7.19 (m, 1H), 6.94 – 6.84 (m, 3H), 
3.84 (s, 3H), 2.68 (ddd, J = 9.1, 6.9, 4.2 Hz, 1H), 2.30 (s, 3H), 2.12 – 2.09 (m, 1H)), 1.64 
(ddd, J = 9.2, 5.1, 4.3 Hz, 1H), 1.40 – 1.36 (m, 1H). 13C NMR (150 MHz, CDCl3) δ 210.09,
160.98, 131.18, 130.23, 128.62, 122.99, 112.91, 58.03, 34.12, 33.17, 26.89, 19.59. IR (neat, 
cm-1): 2919.91, 1695.98, 1463.35, 1354.29, 1246.84, 1048.27, 965.23, 753.26. HPLC 
analysis: ee (trans)-isomer = 82%. IC (99.5% hexanes : 0.5% isopropanol, 1.0 mL/min) 
(trans)-isomer: tmajor = 34.73 min, tminor = 51.20 min. HRMS (ESI) ([M+H]+) Calcd. For 
C12H15O2+: 191.1067, found 191.1072.
1,4-dimethoxy-2-(2-phenylcyclopropyl)benzene (3fa). Yield: 91%. 
Rf = 0.29 (ethyl acetate / hexanes = 1:20), isolated as a mixture of 
diastereomers trans/cis: 95/5. [α]20 D  = +366.8 (c = 0.5, CHCl3). 1H
NMR (500 MHz, CDCl3) δ 7.32 – 7.29 (m, 2H), 7.23 – 7.16 (m, 3H), 6.80 (d, J = 8.8 Hz, 
1H), 6.70 (dd, J = 8.8, 3.0 Hz, 1H), 6.56 (d, J = 3.0 Hz, 1H), 3.80 (s, 3H), 3.79 (s, 3H), 
2.51 – 2.47 (m, 1H), 2.19 – 2.12 (m, 1H), 1.43 – 1.38 (m, 2H).13C NMR (125 MHz, CDCl3)
δ 153.80, 152.48, 142.76, 132.36, 128.26, 126.07, 125.62, 111.79, 111.51, 110.18, 56.32, 
55.70, 26.84, 21.67, 17.34. IR (neat, cm-1): 3024.22, 2998.62, 1603.03, 1496.39, 1157.29, 
1048.03, 931.01, 797.21, 696.10. HPLC analysis: ee (trans)-isomer = 94%. ODH (99% 
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hexanes : 1% isopropanol, 0.8 mL/min) (trans)-isomer: tmajor = 9.43 min, tminor = 11.10 min. 
HRMS (EI) (M+) Calcd. for C17H18O2+: 254.1301, Found 254.1303. 
1,3-difluoro-2-(2-phenylcyclopropyl)benzene (3g’a). Yield: 83%. Rf
= 0.54 (ethyl acetate / hexanes = 1:50). [α]20 D = +131.4 (c = 0.5,
CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.18 (m, 5H), 7.11 (td, J = 7.9, 3.9 Hz, 1H), 
6.84 (t, J = 7.9 Hz, 2H), 2.51 (dt, J = 8.8, 5.5 Hz, 1H), 2.12 (dt, J = 9.2, 5.6 Hz, 1H), 1.67 
(dt, J = 8.7, 5.6 Hz, 1H), 1.49 – 1.40 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 162.12 (dd, 
J = 247.5, 8.3 Hz), 142.12 (s), 128.38 (s), 127.03 (t, J = 10.5 Hz), 126.17 (s), 125.94 (s), 
117.69 (t, J = 16.6 Hz), 111.27 (dd, J = 19.2, 7.4 Hz), 24.07 (s), 17.17 (s), 15.58 (s). 19F
NMR (376 MHz , CFCl3, CDCl3) δ -115.47 (t, J = 6.9 Hz, 2F). IR (neat, cm-1): 3029.23, 
2926.13, 1604.44, 1482.60, 1267.08,  965.77, 714.05, 695.62. HPLC analysis: ee (trans)-
isomer = 93%. ADH (100% hexanes, 0.8 mL/min) (trans)-isomer: tmajor = 7.74 min, tminor
= 9.61 min. HRMS (EI) (M+) Calcd. for C15H12F2+: 230.0902, Found 230.0894. 
1-fluoro-2-(2-phenylcyclopropyl)benzene (3h’a). Yield: 75%. Rf =
0.49 (ethyl acetate / hexanes = 1:50). [α]20 D = +131.4 (c = 0.5, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.32 – 7.19 (m, 2H), 7.24 – 7.18 (m, 3H), 7.18 – 7.13 (m, 
1H), 7.12 – 6.99 (m, 3H), 2.41 – 2.36 (m, 1H), 2.24 – 2.20 (m, 1H), 1.50 – 1.43 (m, 2H). 
13C NMR (125 MHz, CDCl3) δ 161.68 (d, J = 245.4 Hz), 142.10 (s), 129.39 (d, J = 14.7 
Hz), 128.47 (s), 127.60 (s), 127.08 (t, J = 16.8 Hz), 126.08 (dd, J = 21.5, 9.5 Hz), 123.97 
(d, J = 3.1 Hz), 115.10 (d, J = 22.0 Hz), 26.53 (s), 20.73 (d, J = 4.5 Hz), 16.83 (s). 19F
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NMR (376 MHz, CFCl3, CDCl3) δ -119.99 – -120.20 (m, 1F). IR (neat, cm-1): 3029.40, 
2926.12, 1603.76, 1454.12, 1238.82, 907.78, 819.87, 749.91, 695.13. HPLC analysis: ee
(trans)-isomer = 76%. ODH (100% hexanes, 0.8 mL/min) (trans)-isomer: tmajor = 16.36 
min, tminor = 18.53 min. HRMS (EI) (M+) Calcd. for C15H13F+: 211.0996, Found 211.0991. 
1,3,5-trifluoro-2-(2-phenylcyclopropyl)benzene (3i’a). Yield: 
85%. Rf = 0.60 (ethyl acetate / hexanes = 1:50). [α]20 D = +173.2 (c
= 0.5, CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.34 – 7.20 (m, 5H), 6.65 – 6.61 (m, 2H), 
2.41 (dt, J = 8.8, 5.5 Hz, 1H), 2.01 (dt, J = 9.2, 5.6 Hz, 1H), 1.57 (dt, J = 8.8, 5.6 Hz, 1H), 
1.44 (dt, J = 9.1, 5.6 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 162.15 (d, J = 246.5 Hz), 
160.73 (d, J = 247.9 Hz), 141.85 (s), 128.41 (s), 126.18 (s), 126.03 (s), 113.85 (m), 99.84 
(m), 23.90 (s), 16.41 (s), 15.29 (s). 19F NMR (376 MHz, CFCl3, CDCl3) δ -111.91 (m, 3F). 
IR (neat, cm-1): 3029.60, 2925.93, 1634.92, 1496.27, 1116.25,  999.09, 768.84, 695.10. 
HPLC analysis: ee (trans)-isomer = 93%. ADH (100% hexanes, 0.8 mL/min) (trans)-
isomer: tmajor = 7.27 min, tminor =9.66 min. HRMS (EI) (M+) Calcd. for C15H11F3+: 248.0808, 
Found 248.0802. 
1,2,3,4,5-pentafluoro-6-(2-phenylcyclopropyl)benzene (3j’a).
Yield: 81%. Rf = 0.63 (ethyl acetate / hexanes = 1:50). [α]20 D =
+156.8 (c = 0.5, CHCl3).1H NMR (400 MHz, CDCl3) δ 7.35 – 7.31 
(m, 2H), 7.26 – 7.19 (m, 3H), 2.51 – 2.46 (m, 1H), 2.07 – 2.05 (m, 1H), 1.65 – 1.60 (m, 
1H), 1.56 – 1.51 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 147.89 – 144.13 (m), 140.85, 
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139.17 – 135.26 (m), 128.53, 126.41, 126.22, 115.72 – 114.99 (m), 24.18, 16.41, 15.23. 
19F NMR (376 MHz , CFCl3, CDCl3) δ -144.31 (dd, J = 21.9, 7.6 Hz, 2F), -158.40 (t, J =
21.0 Hz, 1F), -163.67 – -163.80 (m, 2F). IR (neat, cm-1): 3030.43, 1605.60, 1492.93, 
1463.70, 949.51, 843.57, 696.05. HPLC analysis: ee (trans)-isomer = 89%. ADH (100% 
hexanes, 0.8 mL/min) (trans)-isomer: tmajor =9.08 min, tminor =17.80 min. HRMS (EI) (M+)
Calcd. for C15H9F5+: 284.0619, Found 284.0619.
1-chloro-2-(2-phenylcyclopropyl)benzene (3k’a). Yield: 77%. Rf =
0.52 (ethyl acetate / hexanes = 1:50). [α]20 D = +111.6 (c = 0.5, CHCl3).
1H NMR (600 MHz, CDCl3) δ 7.38 (d, J = 7.9 Hz, 1H), 7.32 (t, J = 7.6 
Hz, 2H), 7.24 – 7.21 (m, 4H), 7.16 – 7.13 (m, 1H), 7.09 (d, J = 7.7 Hz, 1H), 2.52 – 2.49 
(m, 1H), 2.16 – 2.13 (m, 1H), 1.47 – 1.44 (m, 2H). 13C NMR (150 MHz, CDCl3) δ 144.81, 
142.39, 138.03, 131.89, 131.02, 129.70, 129.39, 129.16, 128.76, 128.54, 29.38, 27.78, 
19.46. IR (neat, cm-1): 2956.97, 1604.00, 1498.45, 1479.85, 1259.88, 1072.94, 800.72, 
696.31. HPLC analysis: ee (trans)-isomer = 75%. ADH (100% hexanes, 0.8 mL/min) 
(trans)-isomer: tmajor = 8.95 min, tminor = 8.33 min. HRMS (ESI) ([M+H]+) Calcd. for 
C15H14Cl+: 229.0779, Found 229.0784.
1-bromo-2-(2-phenylcyclopropyl)benzene (3l’a). Yield: 50%. Rf =
0.57 (ethyl acetate / hexanes = 1:50). [α]20 D = +82.1 (c = 0.5, CHCl3).
1H NMR (600 MHz, CDCl3) δ 7.57 (d, J = 7.8 Hz, 1H), 7.32 (t, J = 7.6 Hz, 2H), 7.28 –
7.20 (m, 4H), 7.10 – 7.06 (m, 2H), 2.50 – 2.46 (m, 1H), 2.15 – 2.12 (m, 1H), 1.46 – 1.44
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(m, 2H).13C NMR (150 MHz, CDCl3) δ 144.81, 144.01, 135.18, 131.00, 130.07, 130.01, 
129.55, 128.73, 128.52, 30.56, 29.53, 19.76. IR (neat, cm-1):3026.08, 1063.59, 1497.80, 
1268.18, 1100.36, 1022.23, 930.21, 775.09, 715.70. HPLC analysis: ee (trans)-isomer = 
57%. ADH (100% hexanes, 0.8 mL/min) (trans)-isomer: tmajor = 9.90 min, tminor = 8.96
min. HRMS (ESI) ([M+H]+) Calcd. for C15H14Br+: 273.0273, Found 273.0279.
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CHAPTER 3
ENANTIOSELECTIVE RADICAL CIS-CYCLOPROPANATION OF ALKENES 
WITH IN SITU-GENERATED ALIPHATIC DIAZO COMPOUNDS
3.1 INTRODUCTION
The past decade has witnessed the renaissance of radical chemistry in organic 
synthesis. To address existing challenges associated with radical reactions,1 the newly-
emerged metalloradical catalysis (MRC) offers a conceptually new approach for the 
catalytic generation of metal-supported organic radicals and for commanding both 
reactivity and selectivity of their subsequent homolytic reactions.2,3 As stable open-shell 
metalloradical complexes, Co(II) complexes of D2-symmetric chiral amidoporphyrins 
[Co(D2-Por*)] exhibit the unusual capability of activating various diazo compounds to 
generate α-Co(III)-alkyl radicals for catalytic radical transformations,4,5 including olefin 
cyclopropanation and C–H alkylation, with effective control of diastereoselectivity and 
enantioselectivity. Their exceptional level of stereocontrol in these radical processes is in 
part attributed to the modular chiral porphyrin ligands that have pocket-like environment 
with tunable electronic, steric, as well as chiral properties.
Nevertheless, asymmetric radical alkene cyclopropanation with aliphatic diazo 
compounds,5a which would provide a streamlined synthetic route for optically active alkyl-
substituted cyclopropane analogs, has remained as an unsolved challenge. As depicted in 
Scheme 3.1, it is envisaged that the ineffective metalloradical activation of diazo would
otherwise lead to thermal decomposition of these less stabilized aliphatic diazo compounds 
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upon their accumulation. Also, we questioned that the presence of β-hydrogens in α-
Co(III)-alkyl radicals A might potentially undergo undesired β-H-atom shift to form β-
Co(III)-alkyl radicals A’, which would result in the formation of side olefinic product via 
radical β-scission. Moreover, with the postulated generation of intermediate B, it is unclear 
whether it will selectively lead to the desired cyclopropanation and minimize the 
occurrence of other possible radical side reactions. Mechanistically, it is critical to seek a
suitable catalytic system to effectively induce the enantioselectivity in the subsequent 
radical addition of α-Co(III)-alkyl radical A to olefin substrate. Finally, by taking 
advantage of the stepwise radical mechanism, it would be highly compelling if a cis-
selective radical substitution could be achieved during the final 3-exo-tet radical cyclization 
of the resulting γ-Co(III)-alkyl radicals B . If the above concerns could be 
Scheme 3.1|| Proposed Pathway for Radical Cyclopropanation of Alkenes with 
Aliphatic Diazo Compounds via Co-MRC
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resolved, it would provide an enantioselective catalytic system for the access of optically 
active alkyl-substituted cyclopropanes. Moreover, the development of a cis-selective 
cyclopropanation protocol would also be of importance in expanding the current repertoire, 
which is still rather limited.6
In addition to serving as versatile synthetic building blocks for stereoselective 
organic synthesis, chiral cyclopropanes exist as common structural elements in a wide 
range of naturally occurring compounds and man-made pharmaceuticals.7 Among various 
synthetic methods,8,9 transition metal-catalyzed asymmetric olefin cyclopropanation with
diazo compounds stands for one of the most general methods for stereoselective 
construction of the smallest three-membered carbocycles in optically active form.9,10 While 
tremendous progress has been made, the general methods for approaching enantioenriched 
alkyl-substituted cyclopropanes are rather lacking. In particular, the development of 
asymmetric cyclopropanation with aliphatic diazo compounds, which would give rise to a 
highly attractive pathway for the enantioselective formation of alkyl-substituted three-
membered rings, is largely undocumented.11,12 Aside from the instability of aliphatic diazo 
compounds, the sluggish advancement might be largely due to the decreased 
electrophilicity of formed Fischer carbene intermediates towards olefins. While in the 
context of asymmetric catalysis, the absence of chelating groups at the neighboring site of 
diazo substrates might also pose inherent challenges for the effective stereoinduction. In 
view of the radical pathway of MRC (Scheme 3.1), we envisioned that the asymmetric 
radical cyclopropanation approach might potentially address the aforementioned issues 
because a neutral radical process is generally less sensitive to electronic effects of the 
substrates. Moreover, with the modular design of cavity-like porphyrin catalysts, an 
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enantioselective process might also be highly feasible. As a new synthetic application of 
MRC, we herein wish to report the development of the first asymmetric catalytic system 
that is highly effective for cis-selective cyclopropanation of alkenes with in situ-generated 
aliphatic diazo compounds. The Co(II)-based metalloradical system, which can be operated 
at room temperature, is suitable for various alkenes, allowing for the efficient construction 
of cis-selective cyclopropane rings with excellent control of enantioselectivity. The Co(II)-
catalyzed cyclopropanation is further highlighted by its functional group tolerance and 
heteroarene compatibility.
3.2 RESULTS AND DISCUSSION
3.2.1 Condition Optimization for Asymmetric Radical Cis-Cyclopropanation of 
Styrene with Aliphatic Diazo Precursors
Our efforts towards developing enantioselective radical cis-selective 
cyclopropanation began with the use of a phthalimide-tethered propanal sulfonylhydrazone 
1a as radical precursors, since the resulting cyclopropanes feature an amino functionality
that would be highly attractive. Gratifyingly, it was found that even the simple Co(II) 
complex of tetraphenylporphyrin [Co(TPP)] could be used as an effective metalloradical 
catalyst, delivering the masked aminoethyl cyclopropane 3aa in 94% yield at room 
temperature (Table 3.1, entry 1). The high yield implies that the in situ-generation of the 
corresponding alkyl diazomethane from 1a was facile at ambient conditions and properly 
matched with the rate of its activation by the catalyst toward productive radical 
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cyclopropanation of styrene (2a). However, the reaction predominantly favors the 
formation of thermodynamically more stable trans-cyclopropane as the major isomer with 
a cis/trans ratio of 19/81. Interestingly, when Co(II) complex of D2h-symmetric achiral 
amidoporphyrin [Co(P1)] (P1 = 3,5-DitBu-IbuPhyrin) was used, the catalytic reaction led
Table 3.1|| Asymmetric Cyclopropanation of Styrene with Sulfonylhydrazone 1a by 
Metalloradical Catalysts [Co(Por)]a
  
a Carried out with 1a (0.1 mmol) and 2a (2.0 equiv.) in the presence of Cs2CO3 (1.5 equiv.) 
in toluene (1.0 mL); Tris: 2,4,6-triisopropyl phenylsulfonyl group; PhthN: Phthalimide; 
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DMAP: 4-dimethylaminopyridine; PPY: 4-pyrrolidinopyridine. b Isolated yields. c
Determined by 1H NMR. d Determined by chiral HPLC for the major diastereomer. 
to the formation of 3aa in 89% yield and, remarkably, with almost equal cis- and trans-
isomeric distribution (entry 2). Aimed to devise a enantioselective cis-cyclopropanation 
system by using different chiral amidoporphyrin catalysts, we examined the first generation 
catalyst [Co(P2)] (P2 = 3,5-DitBu-ChenPhyrin) (entry 3). Gratifyingly, a slight 
improvement of diastereoselectivity favoring cis-cyclopropane was observed together with 
a significant level of enantioselectivity. Further ligand evaluation revealed that with 
sterically more encumbered [Co(P3)] (P3 = 3,5-DitBu-QingPhyrin) as the catalyst, the 
enantioinduction of the major isomer was substantially enhanced from 47% to 94%, albeit 
with a similar level of reactivity and diastereoselectivity (entry 4). The stereochemical 
model of intermediate A upon radical activation of diazo was constructed via Spartan 
software and shown in Table 3.1. To further improve both diastereoselectivity and 
enantioselectivity, we hypothesized that the involvement of potential coordinating 
additives13 might have buttressing ligand effect to positively influence the outcome of 
stereoselectivity. Indeed, among different additives evaluated (entries 5-7), a 
substoichiometric amount of 4-dimethylaminopyridine (DMAP) led to the high-yielding 
formation of cyclopropane 3aa with 83/17 cis/trans ratio and 99% ee (entry 6).
Further investigation on solvent effect (Table 3.2) revealed that aromatic solvents 
are relative better reaction medium than polar solvents for this radical cyclopropanation 
system, providing the desired compound 3aa in high yields with varied cis-selectivity and 
enantioselectivity. Overall, the choice of solvent is still toluene.  
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Table 3.2|| Solvent Effect on Asymmetric Cyclopropanation of Styrene with 
Sulfonylhydrazone 1a by [Co(P3)]a
 a Carried out with 1a (0.1 mmol) and 2a (2.0 equiv.) in the presence of Cs2CO3 (1.5 equiv.) 
in solvent (1.0 mL); Tris: 2,4,6-triisopropyl phenylsulfonyl group; PhthN: Phthalimide; 
DMAP: 4-dimethylaminopyridine. b Isolated yields. c Determined by 1H NMR. d 
Determined by chiral HPLC for the major cis diastereomer.  
Preliminary results showcased that the system is also applicable to other aliphatic 
diazo precursors under the optimized reaction conditions, yet with remarkable trans-
selectivity. For example, when sulfonylhydrazone 1b, with an elongated carbon chain by
one more methylene from 1a, was used, a trans-cyclopropanation reaction was observed 
and the desired cyclopropane 3ba was delivered in 62% yield with 88/12 trans/cis and 95% 
ee. Moreover, by switching phthalimide-tethered propanal sulfonylhydrazone 1a to its 
phenyl analogue 1c, the all-carbon cyclopropane product 3ca was also obtained 
predominately as trans-isomer in 89% yield with 94% ee. Finally, with the use of 
hydrazone 1d, the cyclopropanation reaction was also shown to be trans-selective, by 
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affording cyclopropane 3da in 81% yield with 86/14 trans/cis and 84% ee. The selective 
access of both diastereomers signifies the unique stepwise mechanism of Co(II)-based 
MRC and the detailed study of stereochemistry models is still ongoing.  
Scheme 3.2|| Asymmetric Cyclopropanation of Styrene with Sulfonylhydrazones by 
[Co(P3)]a
a Carried out with 1x (0.1 mmol) and 2a (2.0 equiv.) in the presence of Cs2CO3 (1.5 equiv.) 
in toluene (1.0 mL); Tris: 2,4,6-triisopropyl phenylsulfonyl group; PhthN: Phthalimide; 
DMAP: 4-dimethylaminopyridine; Isolated yields; dr was determined by 1H NMR; ee was 
determined by chiral HPLC for the major diastereomer.
3.2.2 Asymmetric Radical Cyclopropanation of Different Alkenes with Aliphatic 
Diazo Precursor 1a
Inspired by the atypical [Co(P3)]/1a-based enantioselective cis-cyclopropanation 
reaction, we further investigated its generality by employing different alkenes. Like styrene, 
its derivatives bearing varied electronic and steric properties (2a–2l) could be 
cyclopropanated with in situ-generated aliphatic diazomethane by [Co(P3)], affording the 
corresponding aminoethyl-substituted cyclopropanes 3aa–3al as cis-predominant 
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stereoisomers in high yields with excellent enantioselectivities (Scheme 3.3). Among them, 
halogenated styrenes such as those substituted with a Cl- or Br-atom at various positions 
(2d–2f) were all shown to be suitable alkene sources for highly enantioselective radical 
process and the resulting compounds containing aryl halide moieties would allow for 
further transformations such as transition metal-catalyzed cross-coupling reactions. As a 
demonstration of functional group tolerance, styrene derivatives bearing p-CH2Cl, p-NO2, 
Scheme 3.3|| Enantioselective Cis-Cyclopropanation of Styrene Derivatives with In 
Situ-Generated Alkyl Diazo Compound 1a Catalyzed by [Co(P3)]a
 
a Carried out with 1a (0.1 mmol) and 2x (2.0 equiv.) in the presence of Cs2CO3 (1.5 equiv.) 
in toluene (1.0 mL); isolated yields; dr was determined by 1H NMR of crude material; ee
of the major cis diastereomer was determined by chiral HPLC; Tris: 2,4,6-triisopropyl 
phenylsulfonyl group; PhthN: Phthalimide; DMAP: 4-dimethylaminopyridine. b
Performed on 1.0 mmol scale. c 3 mol % [Co(P3)] was used. d Absolute configuration was 
determined by X-ray as (1R, 2R).
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m-NO2, m-Bpin, m-CHO groups could all be productively cyclopropanated to form cis-
selective cyclopropanes 3ah–3al with excellent enantioselectivities. Other aromatic olefins 
were also competent in this system, as exemplified by 2-vinyl naphthalene with the high-
yielding formation of cyclopropane 3am with 86/14 cis/trans and 99% ee. It was also 
noteworthy to mention that the one-pot protocol could be scaled up ten-fold, as 
demonstrated with the high-yielding synthesis of cyclopropane 3aa on 1.0 mmol scale in 
88% yield without affecting the excellent stereoselectivity.
In addition to the aromatic olefins, conjugated dienes (2n–2o) and enynes (2p–2q) 
could also be employed as suitable substrates for productive cyclopropanation reactions 
with relatively higher diastereoselectivities and excellent enantioselectivities (Scheme 3.4). 
The relative and absolute configurations of cyclopropanes 3ab and 3aq were both 
established as cis and (1R,2R), respectively. 
Scheme 3.4|| Enantioselective Cis-Cyclopropanation of Dienes and Enynes with In 
Situ-Generated Alkyl Diazo Compound 1a Catalyzed by [Co(P3)]a 
a Carried out with 1a (0.1 mmol) and 2x (2.0 equiv.) in the presence of Cs2CO3 (1.5 equiv.) 
in toluene (1.0 mL); isolated yields; dr was determined by 1H NMR of crude material; ee
of the major cis diastereomer was determined by chiral HPLC; Tris: 2,4,6-triisopropyl 
phenylsulfonyl group; PhthN: Phthalimide; DMAP: 4-dimethylaminopyridine. b Absolute 
configuration was determined by X-ray as (1R,2R).
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Notably, this system was equally effective for enantioselective cyclopropanation of 
heteroaromatic olefins (Scheme 3.5), such as vinylpyridine analogs with different 
substitution patterns (2r–2t), 4-vinylquinoline (2u), 3-vinylindole (2v), 3-vinyl
benzothiophene (2w), 2-vinylthiophene (2x), and 2-vinylbenzofuran (2y), providing 
heteroaryl-tethered cyclopropane derivatives 3ar–3ay in high yields with equally excellent 
enantioselectivities (all 99% ee). Given that heteroarenes and amine functionality are 
prevalent structural elements in natural and synthetic bioactive compounds, the access of 
this family of three-membered carbocycles in high enantiopurity might find valuable 
applications in pharmaceutical research and development.
Scheme 3.5|| Enantioselective Cis-Cyclopropanation of Heteroaromatic Olefins with
In Situ-Generated Alkyl Diazo Compound 1a Catalyzed by [Co(P3)]a
 
a Carried out with 1a (0.1 mmol) and 2x (2.0 equiv.) in the presence of Cs2CO3 (1.5 equiv.) 
in toluene (1.0 mL); isolated yields; dr was determined by 1H NMR of crude material; ee
Chapter 3. Enantioselective cis-Cyclopropanation with In Situ-Generated Alkyldiazomethanes  
 
of the major cis diastereomer was determined by chiral HPLC; Tris: 2,4,6-triisopropyl 
phenylsulfonyl group; PhthN: Phthalimide; DMAP: 4-dimethylaminopyridine. 
3.2.3 Deprotection of Phthalimide Unit in Resulting Optically Active Alkyl-
Substituted Cyclopropane 3aa
As an initial exploration of synthetic applications, the phthalimide unit of the 
resulting chiral aminoethyl cyclopropane 3aa could be readily deprotected to form the 
corresponding compound 4aa with a primary amine group in 99% yield while retaining the 
original high enantiopurity (Eq. 3.1).
3.2.4 Mechanistic Investigation on Asymmetric Radical Cyclopropanation of In 
Situ-Generated Aliphatic Diazo Compounds
To gain insight into the underlying mechanism of this Co(II)-catalyzed asymmetric 
cyclopropanation, a set of mechanistic experiments were conducted. First, both (E)- and 
(Z)-β-deuterostyrenes were employed as substrates to study the stereospecificity of the 
catalytic process by analysis of in the resulting cyclopropane products (Scheme 3.6).5c
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Scheme 3.6|| Cyclopropanation of (E)- and (Z)-β-Deuterostyrenes to Probe Radical 
Reaction Mechanism
  
Using achiral catalyst [Co(P1)], cyclopropanation of (E)-β-deuterostyrene with 
diazo precursor 1a indeed gave a 87:13 ratio of isotopomers I and II in the cis-
cyclopropane products (Scheme 3.6), which might result from the rotation of β-C–C bond 
in the γ-Co(III)-alkyl radical intermediate B before ring closure (Scheme 3.7). Under the 
same conditions, the reaction of (Z)-β-deuterostyrene resulted in almost identical 13:87
ratio of isotopomeric distribution but in favoring II over I.
Scheme 3.7|| The Rationale of both Isotopomers A and B Formation in the Major Cis-
Cyclopropanes 3aa from Cyclopropanation of (E)-β-Deuterostyrene ((E)-β-D-2a)
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Furthermore, the α-Co(III)-benzyl radical species A (vide supra, Scheme 3.1) from 
the reaction of 1a by [Co(P1)] could be directly detected with the loss of 1e from HRMS
(C87H97CoN9O6+, m/z: 1422.6879). In addition, the corresponding intermediate A was also 
trapped by spin trapping reagent phenyl N-tert-butylnitrone (PBN) to give the characteristic 
EPR signal. As shown in Scheme 3.8, the resulting EPR spectrum (in red), which is 
assigned to PBN-trapped Co(III)-supported alkyl radical intermediates, displays the 
characteristic triplet of doublet signal for alkyl radicals that are trapped by phenyl N-tert-
butylnitrone (PBN). The spectrum has been simulated (in blue) with g = 2.0061, AN = 14.89 
G, AH = 2.52 G, which is consistent with the resulting O-centered radical with the hyperfine 
splitting by the neighboring N and H atoms. The values are consistent with those for similar 
species reported in literature.14
Scheme 3.8|| Isotropic X-band EPR Spectrum of Phenyl N-tert-Butylnitrone (PBN)-
Trapped Co(III)-Supported Alkyl Radical Intermediate
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Collectively, these experimental observations convincingly support the proposed 
stepwise radical mechanism of the Co(II)-based cyclopropanation with aliphatic aldehyde-
derived N-arylsulfonyl hydrazones.
3.3 CONCLUSIONS
In summary, aliphatic diazo compounds, generated in situ from aliphatic aldehyde-
derived N-arylsulfonyl hydrazones, have for the first time been applied successfully for 
asymmetric olefin cyclopropanation via Co(II)-based metalloradical catalysis (MRC). 
Co(II) complex of D2-symmetric chiral amidoporphyrin 3,5-DitBu-QingPhyrin [Co(P3)] 
has been identified as an effective metalloradical catalyst for asymmetric cis-selective 
radical cyclopropanation with aliphatic diazo precursors. The Co(II)-based 
cyclopropanation is applicable to a broad range of alkenes at room temperature, affording 
the alkyl-substituted cyclopropane derivatives in high yields with cis-selectivity and 
excellent enantioselectivity. In view of the underdevelopment of aliphatic diazo 
compounds in asymmetric cyclopropanation, the successful development of this catalytic 
radical process will encourage further efforts in applying sulfonylhydrazones as aliphatic 
diazo surrogates for various asymmetric catalytic processes, including cyclopropanation 
and C–H alkylation reactions.




1H NMR spectra were recorded on a Varian INOVA 400 (400 MHz), 500 (500 
MHz) or 600 (600 MHz) spectrometer. Chemical shifts are internally referenced to residual 
CHCl3 signal (δ 7.26 ppm). Data are reported as follows: chemical shift (δ ppm), 
integration, multiplicity (s = singlet, d = doublet, dd = doublet of doublets, t = triplet, q = 
quartet, p = pentet, br = broad, m = multiplet), and coupling constants (Hz). 13C NMR 
spectra were recorded on a Varian INOVA 400 (100 MHz), 500 (125 MHz), or 600 (150 
MHz) spectrometer with complete proton decoupling. Chemical shifts are reported in ppm 
with residual CHCl3 as the internal standard (δ 77.0 ppm). High-resolution mass 
spectrometry was performed on a Micromass LCT ESI-MS and JEOL Accu TOF Dart at 
the Mass Spectrometry Facility, Boston College. Infrared spectra were measured with a 
Nicolet Avatar 320 spectrometer with a Smart Miracle accessory. The X-ray diffraction 
data were collected using Bruker Kappa APEX DUO diffractometer and a Rigaku 
HighFlux Homelab diffractometer. Optical rotations were measured on a Rudolph 
Research Analytical AUTOPOL® IV digital polarimeter. HPLC measurements were 
carried out on a Shimadzu HPLC system with Chiralcel OJ-H, IA, IB, ID, IE, IF. X-band 
EPR spectra were recorded on a Bruker EMX-Plus spectrometer (Bruker BioSpin). 
Unless otherwise noted, all cyclopropanation reactions were performed under an 
atmosphere of dry N2, in oven-dried glassware with standard vacuum line techniques. Gas 
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tight syringes were used to transfer liquid reagents and solvents in catalytic reactions. 
Anhydrous solvents, as well as other commercial reagents were purchased from Sigma-
Aldrich, Acros, Alfa Aesar, Strem, Oakwood Products Inc., TCI, or Matrix Scientific and 
used as received unless otherwise stated. Thin layer chromatography was performed on 
Merck TLC plates (silica gel 60 F254). Flash column chromatography was performed with 
ICN silica gel (60 Å, 230-400 mesh, 32-63 μm).
3.4.2 General Procedure for Preparation of 2,4,6-Triisopropyl Sulfonylhydrazones
 
To a stirred solution of 2,4,6-triisopropyl sulfonylhydrazide (2 mmol) in THF (8 
mL) at room temperature, aldehyde (1 equiv.) was added dropwise (or portionwise if solid). 
The reaction was completed within 0.5 h. After that, the solvent was removed directly 
under reduced pressure, and the crude mixture was further purified by flash 
chromatography. 
N'-(3-(1,3-dioxoisoindolin-2-yl)propylidene)-2,4,6-
triisopropyl benzenesulfonohydrazide 1a. Yield: 92%. Rf = 0.40 (ethyl acetate/hexanes: 
1/3). 1H NMR (500 MHz, CDCl3): a mixture of hydrazone E/Z isomers. δ 7.80 (dd, J = 5.4, 
3.1 Hz, 1H), 7.70 – 7.69 (m, 3H), 7.20 (t, J = 5.2 Hz, 1H), 7.11 (s, 2H), 4.12 – 4.04 (m, 
Chapter 3. Enantioselective cis-Cyclopropanation with In Situ-Generated Alkyldiazomethanes  
 
2H), 3.84 (t, J = 6.9 Hz, 2H), 2.91 – 2.83 (m, 1H), 2.58 – 2.54 (m, 2H), 1.23 and 1.19 (d, J
= 6.9 Hz, 18H). 13C NMR (125 MHz, CDCl3): major isomer. δ 168.12, 153.22, 151.38, 
146.68, 133.98, 131.92, 130.96, 123.73, 123.31, 34.60, 34.08, 31.86, 29.87, 24.75, 23.49.
IR (neat, cm-1): 3134.5, 2957.0, 2359.1, 1776.2, 1699.0, 1397.7, 1313.9, 1152.8, 1041.0, 
881.6, 720.8. HRMS (ESI) ([M+H]+) Calcd. for C26H34N3O4S: 484.2265, Found 484.2252.
N'-(4-(1,3-dioxoisoindolin-2-yl)butylidene)-2,4,6-
triisopropyl benzenesulfonohydrazide 1b. Yield: 89%. Rf = 0.40 (ethyl acetate/hexanes: 
1/3). 1H NMR (600 MHz, CDCl3): a mixture of hydrazone E/Z isomers. δ 7.83 – 7.80 (m, 
2H), 7.72 – 7.68 (m, 2H), 7.22 – 7.19 (m, 2H), 7.15 (s, 2H), 4.18 – 4.14 (m, 2H), 3.59 (t, J
= 7.1 Hz, 2H), 2.90 – 2.85 (m, 1H), 2.25 – 2.17 (m, 2H), 1.84 – 1.78 (m, 2H), 1.25 – 1.22
(m, 18H). 13C NMR (150 MHz, CDCl3): major isomer. δ 168.22, 153.19, 151.21, 148.99, 
133.96, 131.93, 131.13, 123.74, 123.19, 37.01, 34.09, 29.85, 29.68, 25.03, 24.76, 23.47.
IR (neat, cm-1): 3147.8, 2957.7, 2359.4, 1698.3, 1398.0, 1312.6, 1162.4, 898.3, 751.2. 
HRMS (ESI) ([M+H]+) Calcd. for C27H36N3O4S: 498.2421, Found 498.2414. 
2,4,6-triisopropyl-N'-(3-phenylpropylidene) 
benzenesulfonohydrazide 1c. Yield: 75%. Rf = 0.30 (ethyl acetate/hexanes: 1/8). 1H NMR 
(400 MHz, CDCl3): a mixture of hydrazone E/Z isomers. δ 7.53 (br, 1H), 7.22 – 7.13 (m, 
6H), 7.07 – 7.05 (m, 2H), 4.23 – 4.16 (m, 2H), 2.96 – 2.89 (m, 1H), 2.76 (t, J = 7.7 Hz, 
2H), 2.54 – 2.49 (m, 2H), 1.28 – 1.25 (m, 18H). 13C NMR (100 MHz, CDCl3): major 
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isomer. δ 153.29, 151.32, 149.81, 148.96, 140.48, 128.43, 128.28, 126.11, 123.81, 34.17, 
33.83, 32.13, 29.93, 24.82, 23.55. IR (neat, cm-1): 3189.2, 2954.9, 2359.5, 1600.6, 1453.6, 
1275.3, 1154.5, 1036.8, 897.7, 749.57. HRMS (ESI) ([M+H]+) Calcd. for C24H35N2O2S:
415.2414, Found 415.2414.
2,4,6-triisopropyl-N'-(4-phenylbutylidene) 
benzenesulfonohydrazide 1d. Yield: 82%. Rf = 0.25 (ethyl acetate/hexanes: 1/10). 1H
NMR (500 MHz, CDCl3): a mixture of hydrazone E/Z isomers. δ 7.52 (br, 1H), 7.29 – 7.20
(m, 2H), 7.17 (s, 2H), 7.16 – 7.04 (m, 3H), 4.22 – 4.15 (m, 2H), 2.93 – 2.84 (m, 1H), 2.52 
– 2.49 (m, 2H), 2.22 – 2.18 (m, 2H), 1.79 – 1.73 (m, 2H), 1.27 – 1.22 (m, 18H). 13C NMR 
(125 MHz, CDCl3): major isomer. δ 153.30, 151.25, 150.57, 149.05, 141.41, 128.41, 
128.30, 125.88, 123.79, 34.85, 34.15, 31.57, 29.90, 27.57, 24.81, 23.50. IR (neat, cm-1):
3223.0, 2955.8, 2359.4, 1599.4, 1461.7, 1259.8, 1166.6, 1035.4, 885.6, 763.9, 665.7.
HRMS (ESI) ([M+H]+) Calcd. for C25H37N2O2S: 429.2570, Found 429.2555. 
3.4.3 General Procedure for [Co(P3)]-Catalyzed Asymmetric Radical 
Cyclopropanation with In Situ Generated Aliphatic Diazo Compounds 
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An oven-dried Schlenk tube was charged with 1.0 equivalent of sulfonyl hydrazone
1x (0.1 mmol), [Co(P3)] (2 mol %), 4-dimethylaminopyridine (30 mol %) and 1.5 
equivalent of Cs2CO3 (0.15 mmol). The Schlenk tube was then evacuated and back filled 
with nitrogen for 3 times. The Teflon screw cap was replaced with a rubber septum, and 
olefin 2y (0.2 mmol, 2.0 eq) and toluene (1.0 mL) were added. The Schlenk tube was then 
purged with nitrogen for 30 s and the rubber septum was replaced with a Teflon screw cap. 
The mixture was then stirred at room temperature. After 24 h, the reaction mixture was 
concentrated and purified by flash chromatography. The fractions containing product 3xy
were collected and concentrated by rotary evaporation to afford the compound as a mixture 
of trans/cis diastereomers.
2-(2-(2-phenylcyclopropyl)ethyl)isoindoline-1,3-dione 3aa.
Following the general procedure with hydrazone 1a and styrene 2a as starting material.
Yield: 92%. Cis/trans: 83/17. ee: 99%. Hexanes/ethyl acetate = 4/1, Rf = 0.50. [α]20 D =
28.8 (c = 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.78 – 7.78 (m, 2H), 7.68 – 7.67 (m, 
2H), 7.17 – 7.14 (m, 2H), 7.11 – 7.08 (m, 3H), 3.71 – 3.62 (m, 2H), 2.12 (td, J = 8.7, 6.2 
Hz, 1H), 1.63 – 1.56 (m, 1H), 1.33 (td, J = 14.2, 7.1 Hz, 1H), 1.15 – 1.13 (m, 1H), 0.99 (td, 
J = 8.4, 5.2 Hz, 1H), 0.69 (q, J = 5.7 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 168.25,
138.75, 133.66, 132.16, 128.69, 127.87, 125.67, 123.01, 37.75, 27.43, 20.65, 16.86, 9.49.
HPLC analysis: ee = 99%. IE (90% hexanes : 10% isopropanol, 0.8 mL/min) : tmajor =
19.15 min, tminor = 17.57 min. IR (neat, cm-1): 3061.3, 2999.4, 1771.02, 1710.5, 1466.8, 
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1396.7, 1363.3, 1187.0, 1029.3, 721.5. HRMS (ESI) ([M+H]+) Calcd. for C19H18NO2:
292.1332, Found 292.1319. 
2-(3-(2-phenylcyclopropyl)propyl)isoindoline-1,3-dione 3ba.
Following the general procedure with hydrazone 1b and styrene 2a as starting material.
Yield: 62%. Cis/trans: 12/88. ee: 95%. Hexanes/ethyl acetate = 6/1, Rf = 0.40. [α]20 D = -
32.0 (c = 1.0, CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.83 (dd, J = 5.5, 3.1 Hz, 2H), 7.69 
(dd, J = 5.5, 3.0 Hz, 2H), 7.21 (t, J = 7.6 Hz, 2H), 7.14 – 7.09 (m, 1H), 7.03 (d, J = 7.2 Hz, 
2H), 3.72 (t, J = 7.3 Hz, 2H), 1.84 (p, J = 7.6 Hz, 2H), 1.65 – 1.62 (m, 1H), 1.48 – 1.41 (m, 
2H), 1.10 – 1.04 (m, 1H), 0.89 (dt, J = 8.5, 5.0 Hz, 1H), 0.76 (dt, J = 8.6, 5.2 Hz, 1H). 13C
NMR (150 MHz, CDCl3) δ 168.42, 143.49, 133.84, 132.12, 128.19, 125.63, 125.23, 
123.14, 37.84, 31.58, 28.38, 23.13, 22.94, 16.03. HPLC analysis: ee = 95%. IB (95% 
hexanes : 5% isopropanol, 0.8 mL/min) : tmajor = 17.49 min, tminor = 16.78 min. IR (neat, 
cm-1): 2927.4, 1770.8, 1714.9, 1466.9, 1396.9, 1370.7, 1035.1, 755.2, 721.9. HRMS (ESI) 
([M+H]+) Calcd. for C20H20NO2: 306.1489, Found 306.1483. 
(2-phenethylcyclopropyl)benzene 3ca. Following the general procedure 
with hydrazone 1c and styrene 2a as starting material. Yield: 89%. Cis/trans: 15/85. ee:
94%. Hexanes/ethyl acetate = 20/1, Rf = 0.75. [α]20 D = -69.4 (c = 1.0, CHCl3). 1H NMR 
(600 MHz, CDCl3) δ 7.28 – 7.18 (m, 8H), 7.03 – 7.00 (m, 2H), 2.81 – 2.71 (m, 2H), 1.72 
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(dd, J = 14.8, 7.5 Hz, 2H), 1.65 – 1.62 (m, 1H), 1.11 – 1.06 (m, 1H), 0.91 (dt, J = 8.5, 4.9 
Hz, 1H), 0.79 (dt, J = 8.7, 5.3 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 143.72, 142.26, 
128.44, 128.26, 128.17, 125.67, 125.60, 125.19, 36.40, 35.75, 23.39, 23.34, 16.14. HPLC 
analysis: ee = 94%. IA (100% hexanes, 0.6 mL/min) : tmajor = 11.21 min, tminor = 10.38 
min. IR (neat, cm-1): 3025.3, 2921.2, 1603.7, 1495.3, 1453.4, 1218.8, 1089.1, 1030.0, 
747.9, 694.7. HRMS (ESI) ([M+H]+) Calcd. for C17H19: 223.1481, Found 223.1472. 
(3-(2-phenylcyclopropyl)propyl)benzene 3da. Following the 
general procedure with hydrazone 1d and styrene 2a as starting material. Yield: 81%. 
Cis/trans: 14/86. ee: 84%. Hexanes/ethyl acetate = 20/1, Rf = 0.75. [α]20 D = -29.4 (c = 1.0,
CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.30 – 7.22 (m, 4H), 7.20 (d, J = 7.2 Hz, 3H), 7.15 
– 7.12 (m, 1H), 7.08 – 7.05 (m, 2H), 2.69 – 2.65 (m, 2H), 1.83 – 1.77 (m, 2H), 1.64 – 1.61 
(m, 1H), 1.45 (dd, J = 14.9, 7.0 Hz, 2H), 1.07 – 1.01 (m, 1H), 0.90 (dt, J = 8.5, 4.9 Hz, 
1H), 0.79 – 0.75 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 143.89, 142.60, 128.37, 128.25, 
128.20, 125.63, 125.60, 125.17, 35.70, 33.99, 31.14, 23.59, 23.24, 16.09. HPLC analysis: 
ee = 84%. IE (100% hexanes, 1.2 mL/min) : tmajor = 9.85 min, tminor = 10.49 min. IR (neat, 
cm-1): 3025.1, 2925.2, 2853.4, 1603.6, 1495.6, 1452.6, 1217.8, 1076.8, 1028.8, 874.7, 
746.3. HRMS (ESI) ([M+H]+) Calcd. for C18H21: 237.1638, Found 237.1628.
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2-(2-(2-(4-methoxyphenyl)cyclopropyl)ethyl)
isoindoline-1,3-dione 3ab. Following the general procedure with hydrazone 1a and 4-
methoxyl styrene 2b as starting material in the presence of 3 mol % [Co(P3)]. Yield: 89%. 
Cis/trans: 85/15. ee: 98%. Hexanes/ethyl acetate = 5/1, Rf = 0.45. [α]20 D = 3.2 (c = 0.5, 
CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.78 (dd, J = 5.4, 3.1 Hz, 2H), 7.68 (dd, J = 5.4, 
3.0 Hz, 2H), 7.02 (d, J = 8.6 Hz, 2H), 6.70 (d, J = 8.6 Hz, 2H), 3.74 (s, 3H), 3.71 – 3.64
(m, 2H), 2.05 (td, J = 8.6, 6.1 Hz, 1H), 1.62 – 1.57 (m, 1H), 1.31 – 1.25 (m, 1H), 1.11 –
1.04 (m, 1H), 0.96 (td, J = 8.4, 5.1 Hz, 1H), 0.60 (q, J = 5.6 Hz, 1H). 13C NMR (150 MHz, 
CDCl3) δ 170.93, 160.35, 136.31, 134.85, 132.33, 129.28, 125.64, 116.03, 57.80, 40.49, 
30.23, 22.47, 19.13, 12.22. HPLC analysis: ee = 98%. IE (90% hexanes : 10% isopropanol, 
0.8 mL/min) : tmajor = 25.57 min, tminor = 22.40 min. IR (neat, cm-1): 2996.9, 2933.8, 1770.4, 
1708.9, 1513.7, 1393.0, 1247.4, 1034.4, 830.7, 720.8. HRMS (ESI) ([M+H]+) Calcd. for 
C20H20NO3: 322.1438, Found 322.1434.
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2-(2-(2-(4-trifluoromethylphenyl)cyclopropyl)ethyl) 
isoindoline-1,3-dione 3ac. Following the general procedure with hydrazone 1a and 4-
trifluoromethyl styrene 2c as starting material. Yield: 96%. Cis/trans: 86/14. ee: 99%. 
Hexanes/ethyl acetate = 4/1, Rf = 0.50. [α]20 D = 11.8 (c = 1.0, CHCl3). 1H NMR (600 MHz, 
CDCl3) δ 7.76 (dd, J = 5.4, 3.1 Hz, 2H), 7.68 (dd, J = 5.5, 3.0 Hz, 2H), 7.34 (d, J = 8.2 Hz, 
2H), 7.16 (d, J = 8.1 Hz, 2H), 3.67 (t, J = 6.7 Hz, 2H), 2.16 – 2.12 (m, 1H), 1.61 – 1.55 (m, 
1H), 1.44 – 1.39 (m, 1H), 1.27 – 1.21 (m, 1H), 1.08 (td, J = 8.4, 5.4 Hz, 1H), 0.74 (d, J =
5.7 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 168.20, 143.31, 133.78, 132.08, 128.71, 
127.89 (q, J = 32.3 Hz), 125.54, 124.76 (q, J = 3.6 Hz), 123.05, 37.68, 27.14, 20.75, 17.87, 
10.22. HPLC analysis: ee = 99%. ID (90% hexanes : 10% isopropanol, 0.8 mL/min) : tmajor
= 15.01 min, tminor = 14.19 min. IR (neat, cm-1): 3067.2, 2939.3, 1771.8, 1713.9, 1394.5, 
1327.9, 1164.6, 1122.4, 1070.3, 721.3. HRMS (ESI) ([M+H]+) Calcd. for C20H17F3NO2:
360.1206, Found 360.1192. 
2-(2-(2-(4-chlorophenyl)cyclopropyl)ethyl)isoindoline-
1,3-dione 3ad. Following the general procedure with hydrazone 1a and 4-chlorostyrene 
2d as starting material. Yield: 95%. Cis/trans: 82/18. ee: 99%. Hexanes/ethyl acetate = 5/1, 
Rf = 0.50. [α]20 D = 19.1 (c = 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.77 (dd, J = 5.5, 
3.0 Hz, 2H), 7.68 (dd, J = 5.5, 3.0 Hz, 2H), 7.06 (d, J = 8.5 Hz, 2H), 6.99 (d, J = 8.2 Hz, 
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2H), 3.65 (d, J = 6.8 Hz, 2H), 2.06 (td, J = 8.6, 6.2 Hz, 1H), 1.60 – 1.53 (m, 1H), 1.39 –
1.32 (m, 1H), 1.19 – 1.11 (m, 1H), 1.01 (td, J = 8.4, 5.3 Hz, 1H), 0.65 – 0.62 (m, 1H). 13C
NMR (125 MHz, CDCl3) δ 168.22, 137.43, 133.73, 132.07, 129.83, 127.95, 126.78, 
123.01, 37.69, 27.26, 20.19, 17.20, 9.92. HPLC analysis: ee = 99%. IE (95% hexanes : 5% 
isopropanol, 0.8 mL/min) : tmajor = 36.30 min, tminor = 24.84 min. IR (neat, cm-1): 2999.4, 
1935.9, 1770.1, 1707.2, 1493.5, 1391.6, 1089.4, 1012.8, 826.9, 720.8. HRMS (ESI) 
([M+H]+) Calcd. for C19H17ClNO2: 326.0942, Found 326.0937.
2-(2-(2-(4-bromophenyl)cyclopropyl)ethyl)isoindoline-
1,3-dione 3ae. Following the general procedure with hydrazone 1a and 4-bromostyrene 2d
as starting material. Yield: 94%. Cis/trans: 85/15. ee: 99%. Hexanes/ethyl acetate = 5/1, Rf
= 0.50. [α]20 D = 4.0 (c = 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.77 (dd, J = 5.4, 3.0 
Hz, 2H), 7.69 (dd, J = 5.4, 3.0 Hz, 2H), 7.20 (d, J = 8.4 Hz, 2H), 6.93 (d, J = 8.3 Hz, 2H), 
3.66 (t, J = 6.7 Hz, 2H), 2.04 (td, J = 8.6, 6.2 Hz, 1H), 1.59 – 1.52 (m, 1H), 1.40 – 1.33 (m, 
1H), 1.19 – 1.12 (m, 1H), 1.04 – 0.99 (m, 1H), 0.63 (q, J = 5.8 Hz, 1H). 13C NMR (125 
MHz, CDCl3) δ 168.23, 137.99, 133.74, 132.07, 130.89, 130.21, 123.03, 119.43, 37.70, 
27.24, 20.28, 17.27, 9.94. HPLC analysis: ee = 99%. IE (90% hexanes : 10% isopropanol, 
0.8 mL/min) : tmajor = 27.09 min, tminor = 20.85 min. IR (neat, cm-1): 3000.7, 2936.6, 1705.5, 
1489.1, 1434.9, 1390.3, 1360.9, 1177.7, 1073.3, 1008.5, 822.3, 718.8. HRMS (ESI) 
([M+H]+) Calcd. for C19H17BrNO2: 370.0437, Found 370.0428.
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2-(2-(2-(3-bromophenyl)cyclopropyl)ethyl)isoindoline-
1,3-dione 3af. Following the general procedure with hydrazone 1a and 3-bromostyrene 2f
as starting material. Yield: 95%. Cis/trans: 83/17. ee: 99%. Hexanes/ethyl acetate = 7/1, Rf
= 0.40. [α]20 D = 19.5 (c = 1.0, CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.78 (dd, J = 5.4, 3.1 
Hz, 2H), 7.68 (dd, J = 5.5, 3.0 Hz, 2H), 7.26 (s, 1H), 7.23 – 7.21 (m, 1H), 7.03 – 7.02 (m, 
2H), 3.71 – 3.63 (m, 2H), 2.08 (td, J = 8.6, 6.1 Hz, 1H), 1.63 – 1.56 (m, 1H), 1.32 (td, J =
14.3, 7.0 Hz, 1H), 1.19 – 1.13 (m, 1H), 1.02 (td, J = 8.4, 5.3 Hz, 1H), 0.66 (q, J = 5.8 Hz,
1H). 13C NMR (150 MHz, CDCl3) δ 168.23, 141.47, 133.77, 132.07, 131.83, 129.40, 
128.86, 127.27, 123.06, 122.16, 37.65, 27.46, 20.46, 17.13, 9.95. HPLC analysis: ee =
99%. IE (90% hexanes : 10% isopropanol, 0.8 mL/min) : tmajor = 22.37 min, tminor = 21.43 
min. IR (neat, cm-1): 3063.3, 3001.8, 2936.6, 1770.3, 1708.7, 1435.4, 1393.7, 1041.7, 
755.1, 720.9. HRMS (ESI) ([M+H]+) Calcd. for C19H17BrNO2: 370.0437, Found 370.0422. 
2-(2-(2-(2-methylphenyl)cyclopropyl)ethyl)isoindoline-1,3-
dione 3ag. Following the general procedure with hydrazone 1a and 2-methyl styrene 2g as 
starting material. Yield: 94%. Cis/trans: 65/35. ee: 99%. Hexanes/ethyl acetate = 6/1, Rf =
0.45. [α]20 D = 105.0 (c = 1.0, CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.79 (dd, J = 5.4, 3.0 
Hz, 2H), 7.68 (dd, J = 5.5, 3.0 Hz, 2H), 7.11 – 7.05 (m, 3H), 7.03 – 7.02 (m, 1H), 3.72 –
3.64 (m, 2H), 2.36 (s, 3H), 2.05 – 2.00 (m, 1H), 1.70 – 1.62 (m, 1H), 1.25 – 1.19 (m, 1H), 
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1.03 – 0.99 (m, 1H), 0.91 – 0.83 (m, 1H), 0.77 – 0.73 (m, 1H). 13C NMR (150 MHz, CDCl3)
δ 170.91, 141.02, 139.66, 136.39, 134.79, 132.15, 130.58, 128.62, 128.12, 125.71, 40.51, 
30.41, 22.25, 21.86, 18.30, 11.84. HPLC analysis: ee = 99%. IE (90% hexanes : 10% 
isopropanol, 0.8 mL/min) : tmajor = 18.06 min, tminor = 16.79 min. IR (neat, cm-1): 2990.4, 
2858.0, 1704.9, 1432.4, 1396.1, 1361.9, 1178.9, 1030.5, 945.6, 864.3, 768.0, 717.3. HRMS
(ESI) ([M+H]+) Calcd. for C20H20NO2: 306.1489, Found 306.1485.
2-(2-(2-(2-methylchrolophenyl)cyclopropyl)ethyl) 
isoindoline-1,3-dione 3ah. Following the general procedure with hydrazone 1a and 4-
methylchloro styrene 2h as starting material. Yield: 90%. Cis/trans: 82/18. ee: 99%. 
Hexanes/ethyl acetate = 4/1, Rf = 0.50. [α]20 D = 8.2 (c = 1.0, CHCl3). 1H NMR (600 MHz, 
CDCl3) δ 7.77 (dd, J = 5.4, 3.0 Hz, 2H), 7.68 (dd, J = 5.4, 3.0 Hz, 2H), 7.15 (d, J = 8.1 Hz, 
2H), 7.07 (d, J = 8.1 Hz, 2H), 4.50 (s, 2H), 3.67 (td, J = 6.8, 2.7 Hz, 2H), 2.10 (dd, J =
14.8, 8.6 Hz, 1H), 1.61 – 1.57 (m, 1H), 1.37 – 1.31 (m, 1H), 1.19 – 1.15 (m, 1H), 1.01 (td, 
J = 8.4, 5.3 Hz, 1H), 0.69 (q, J = 5.7 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 168.24,
139.35, 134.73, 133.70, 132.13, 128.91, 128.13, 123.04, 46.14, 37.75, 27.35, 20.47, 17.20, 
9.82. HPLC analysis: ee = 99%. IE (90% hexanes : 10% isopropanol, 0.8 mL/min) : tmajor
= 27.11 min, tminor = 22.97 min. IR (neat, cm-1): 3002.7, 2926.4, 1770.5, 1712.5, 1435.7, 
1397.2, 1363.0, 1266.0, 1186.9, 1045.3, 756.9, 721.2. HRMS (ESI) ([M+H]+) Calcd. for 
C20H19ClNO2: 340.1099, Found 340.1105.
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2-(2-(2-(4-nitrophenyl)cyclopropyl)ethyl)isoindoline-
1,3-dione 3ai. Following the general procedure with hydrazone 1a and 4-nitrostyrene 2i as 
starting material in the presence of 3 mol % [Co(P3)]. Yield: 85%. Cis/trans: 69/31. ee:
99%. Hexanes/ethyl acetate = 3/1, Rf = 0.35. [α]20 D = 48.0 (c = 1.0, CHCl3). 1H NMR (500 
MHz, CDCl3) δ 7.93 (d, J = 8.8 Hz, 2H), 7.74 – 7.67 (m, 4H), 7.17 (d, J = 8.7 Hz, 2H), 
3.69 – 3.60 (m, 2H), 2.18 (td, J = 8.6, 6.3 Hz, 1H), 1.57 – 1.50 (m, 2H), 1.37 – 1.29 (m, 
1H), 1.20 – 1.15 (m, 1H), 0.81 (q, J = 6.0 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 168.11, 
147.53, 133.89, 131.97, 128.86, 125.74, 123.10, 122.99, 37.52, 26.93, 21.18, 19.01, 11.12.
HPLC analysis: ee = 99%. ID (85% hexanes : 15% isopropanol, 0.8 mL/min) : tmajor =
62.39 min, tminor = 39.21 min. IR (neat, cm-1): 3003.7, 2939.2, 1739.3, 1706.0, 1507.5, 
1335.6, 1184.8, 1039.4, 853.2, 716.9. HRMS (ESI) ([M+H]+) Calcd. for C19H17N2O4:
337.1183, Found 337.1181. 
2-(2-(2-(3-nitrophenyl)cyclopropyl)ethyl)isoindoline-
1,3-dione 3aj. Following the general procedure with hydrazone 1a and 3-nitrostyrene 2j
as starting material in the presence of 3 mol % [Co(P3)]. Yield: 52%. Cis/trans: 82/18. ee:
99%. Hexanes/ethyl acetate = 3/1, Rf = 0.45. [α]20 D = 20.8 (c = 1.0, CHCl3). 1H NMR (600 
MHz, CDCl3) δ 7.95 – 7.93 (m, 2H), 7.75 (dd, J = 5.3, 3.1 Hz, 2H), 7.67 (dd, J = 5.3, 3.1 
Hz, 2H), 7.41 (d, J = 7.7 Hz, 1H), 7.35 – 7.30 (m, 1H), 3.69 – 3.61 (m, 2H), 2.20 (td, J =
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8.6, 6.2 Hz, 1H), 1.59 – 1.53 (m, 1H), 1.47 – 1.41 (m, 1H), 1.28 – 1.25 (m, 1H), 1.16 –
1.12 (m, 1H), 0.78 (q, J = 5.8 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 170.77, 150.60, 
144.01, 137.08, 136.51, 134.60, 131.43, 126.20, 125.70, 123.52, 40.16, 29.84, 23.29, 
20.44, 13.05. HPLC analysis: ee = 99%. ID (90% hexanes : 10% isopropanol, 0.8 mL/min) 
: tmajor = 48.12 min, tminor = 40.84 min. IR (neat, cm-1): 3071.1, 2922.1, 1770.3, 1707.1, 
1527.0, 1393.6, 1349.2, 1040.9, 806.4, 721.6. HRMS (ESI) ([M+H]+) Calcd. for 
C19H17N2O4: 337.1183, Found 337.1181.
2-(2-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl) phenyl)cyclopropyl)ethyl)isoindoline-1,3-dione 3ak. Following the general 
procedure with hydrazone 1a and 4,4,5,5-tetramethyl-2-(3-vinylphenyl)-1,3,2-
dioxaborolane 2k as starting material. Yield: 80%. Cis/trans: 86/14. ee: 97%. 
Hexanes/ethyl acetate = 5/1, Rf = 0.40. [α]20 D = 10.2 (c = 1.0, CHCl3). 1H NMR (600 MHz, 
CDCl3) δ 7.78 (dd, J = 5.4, 3.1 Hz, 2H), 7.67 (dd, J = 5.4, 3.0 Hz, 2H), 7.60 (s, 1H), 7.56 
(d, J = 7.1 Hz, 1H), 7.23 (d, J = 7.7 Hz, 1H), 7.19 (t, J = 7.4 Hz, 1H), 3.72 – 3.64 (m, 2H), 
2.16 – 2.11 (m, 1H), 1.69 – 1.63 (m, 1H), 1.34 (s, 12H), 1.19 – 1.09 (m, 2H), 0.98 (td, J =
8.2, 5.3 Hz, 1H), 0.74 (q, J = 5.5 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 168.27, 138.08, 
135.35, 133.68, 132.28, 132.17, 131.69, 128.44, 127.32, 123.03, 83.67, 37.84, 27.83, 
24.88, 20.49, 16.49, 9.60. HPLC analysis: ee = 97% (estimated). OJH (99.5% hexanes : 
0.5% isopropanol, 1.0 mL/min) : tmajor = 45.62 min, tminor = 50.73 min. IR (neat, cm-1):
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2977.9, 2931.0, 2359.8, 1771.5, 1713.2, 1390.5, 1362.3, 1145.2, 965.3, 739.8, 720.9. 
HRMS (ESI) ([M+H]+) Calcd. for C25H29BNO4: 418.2184, Found 418.2175. 
3-(2-(2-(1,3-dioxoisoindolin-2-yl)ethyl)cyclopropyl) 
benzaldehyde 3al. Following the general procedure with hydrazone 1a and 3-vinyl 
benzaldehyde 2l as starting material. Yield: 93%. Cis/trans: 80/20. ee: 99%. Hexanes/ethyl 
acetate = 4/1, Rf = 0.55. [α]20 D = 29.8 (c = 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ 9.86 
(s, 1H), 7.74 (dd, J = 5.5, 3.0 Hz, 2H), 7.66 (dd, J = 5.4, 3.1 Hz, 2H), 7.60 – 7.58 (m, 2H), 
7.37 – 7.30 (m, 2H), 3.69 – 3.60 (m, 2H), 2.17 (td, J = 8.6, 6.2 Hz, 1H), 1.59 – 1.52 (m, 
1H), 1.43 – 1.36 (m, 1H), 1.26 – 1.19 (m, 1H), 1.08 (td, J = 8.4, 5.4 Hz, 1H), 0.76 (q, J =
5.8 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 192.31, 168.14, 140.22, 136.13, 134.59, 
133.78, 132.02, 129.88, 128.59, 127.19, 123.03, 37.61, 27.26, 20.50, 17.36, 9.98. HPLC 
analysis: ee = 99%. IE (85% hexanes : 5% isopropanol, 0.8 mL/min) : tmajor = 55.31 min, 
tminor = 48.89 min. IR (neat, cm-1): 3005.0, 2940.1, 1770.0, 1702.9, 1435.8, 1392.2, 1173.3, 
1036.9, 751.4, 718.1. HRMS (ESI) ([M+H]+) Calcd. For C20H18NO3: 320.1281, Found 
320.12.70.
2-(2-(2-(naphthalen-2-yl)cyclopropyl)ethyl)isoindoline-
1,3-dione 3am. Following the general procedure with hydrazone 1a and 2-vinyl 
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naphthelene 2m as starting material. Yield: 94%. Cis/trans: 86/14. ee: 99%. Hexanes/ethyl 
acetate = 4/1, Rf = 0.50. [α]20 D = 31.2 (c = 1.0, CHCl3).1H NMR (600 MHz, CDCl3) δ 7.73 
– 7.59 (m, 7H), 7.49 (s, 1H), 7.41 – 7.35 (m, 2H), 7.32 – 7.29 (m, 1H), 3.71 – 3.64 (m, 2H), 
2.29 – 2.25 (m, 1H), 1.70 – 1.64 (m, 1H), 1.40 – 1.34 (m, 1H), 1.25 – 1.20 (m, 1H), 1.11 –
1.07 (m, 1H), 0.84 (q, J = 5.6 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 168.23, 136.63, 
133.59, 133.22, 131.99, 131.90, 127.66, 127.46, 127.44, 127.39, 126.63, 125.76, 124.99, 
122.87, 37.82, 27.48, 20.99, 17.26, 9.89. HPLC analysis: ee = 99%. IE (90% hexanes : 
10% isopropanol, 0.8 mL/min) : tmajor = 25.17 min, tminor = 22.45 min. IR (neat, cm-1):
3057.4, 3000.7, 2934.2, 1769.7, 1705.7, 1391.5, 1360.6, 1039.3, 819.0, 750.6, 718.3. 
HRMS (ESI) ([M+H]+) Calcd. for C23H20NO2: 342.1489, Found 342.1498. 
(E)-2-(2-(2-styrylcyclopropyl)ethyl)isoindoline-1,3-
dione 3an. Following the general procedure with hydrazone 1a and (E)-buta-1,3-dien-1-
ylbenzene 2n as starting material. Yield: 91%. Cis/trans: 91/9. ee: 99%. Hexanes/ethyl 
acetate = 6/1, Rf = 0.35. [α]20 D = -66.4 (c = 1.0, CHCl3). 1H NMR (600 MHz, CDCl3) δ 
7.59 (dd, J = 5.3, 3.0 Hz, 2H), 7.49 (dd, J = 5.4, 3.0 Hz, 2H), 7.19 (t, J = 7.5 Hz, 2H), 7.13 
– 7.07 (m, 3H), 6.13 (d, J = 15.7 Hz, 1H), 5.80 (dd, J = 15.7, 9.5 Hz, 1H), 3.84 – 3.77 (m, 
2H), 1.94 (dq, J = 16.2, 5.4 Hz, 1H), 1.77 – 1.71 (m, 1H), 1.60 – 1.55 (m, 1H), 1.16 – 1.10
(m, 1H), 1.00 – 0.97 (m, 1H), 0.31 (dd, J = 10.9, 5.4 Hz, 1H). 13C NMR (150 MHz, CDCl3)
δ 168.49, 137.23, 133.37, 132.04, 129.68, 129.53, 128.20, 126.46, 125.52, 122.84, 37.97, 
28.22, 19.53, 17.52, 12.75. HPLC analysis: ee = 99%. IE (90% hexanes : 10% isopropanol, 
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0.8 mL/min) : tmajor = 23.31 min, tminor = 18.79 min. IR (neat, cm-1): 3023.3, 2937.6, 1770.9, 
1703.6, 1435.5, 1392.6, 1174.1, 1068.5, 953.8, 748.2, 691.1. HRMS (ESI) ([M+H]+)
Calcd. for C21H20NO2: 318.1489, Found 318.1500. 
(E)-2-(2-(2-(2-methoxystyryl)cyclopropyl)ethyl)
isoindoline-1,3-dione 3ao. Following the general procedure with hydrazone 1a and (E)-1-
(buta-1,3-dien-1-yl)-2-methoxybenzene 2o as starting material. Yield: 92%. Cis/trans:
89/11. ee: 99%. Hexanes/ethyl acetate = 5/1, Rf = 0.40. [α]20 D = -29.6 (c = 1.0, CHCl3). 1H
NMR (500 MHz, CDCl3) δ 7.62 (dd, J = 5.4, 3.1 Hz, 2H), 7.49 (dd, J = 5.4, 3.0 Hz, 2H), 
7.24 (d, J = 8.8 Hz, 1H), 7.10 (t, J = 8.5 Hz, 1H), 6.84 (t, J = 7.5 Hz, 1H), 6.73 (d, J = 8.2 
Hz, 1H), 6.50 (d, J = 15.9 Hz, 1H), 5.84 (dd, J = 15.9, 9.5 Hz, 1H), 3.82 – 3.75 (m, 2H), 
3.75 (s, 3H), 1.93 – 1.88 (m, 1H), 1.75 (td, J = 15.1, 8.2 Hz, 1H), 1.65 – 1.58 (m, 1H), 1.15 
– 1.08 (m, 1H), 0.97 (td, J = 8.3, 4.8 Hz, 1H), 0.31 (dd, J = 10.8, 5.4 Hz, 1H). 13C NMR 
(125 MHz, CDCl3) δ 168.51, 155.85, 133.69, 133.24, 132.08, 130.41, 127.35, 126.10, 
124.14, 122.77, 120.43, 110.50, 55.21, 38.02, 28.30, 20.02, 17.52, 12.87. HPLC analysis: 
ee = 99%. IE (90% hexanes : 10% isopropanol, 0.8 mL/min) : tmajor = 29.91 min, tminor =
26.81 min. IR (neat, cm-1): 2995.9, 2935.8, 1770.5, 1704.8, 1488.8, 1435.2, 1392.6, 1241.2, 
1027.9, 970.8, 750.0. HRMS (ESI) ([M+H]+) Calcd. for C22H22NO3: 348.1594, Found 
348.1585.
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2-(2-(2-(phenylethynyl)cyclopropyl)ethyl)isoindoline-1,3-
dione 3ap. Following the general procedure with hydrazone 1a and but-3-en-1-yn-1-
ylbenzene 2p as starting material. Yield: 91%. Cis/trans: 94/6. ee: 99%. Hexanes/ethyl 
acetate = 8/1, Rf = 0.35. [α]20 D = -79.8 (c = 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ 
7.70 (dd, J = 5.5, 3.0 Hz, 2H), 7.60 (dd, J = 5.5, 3.0 Hz, 2H), 7.27 – 7.24 (m, 2H), 7.24 –
7.21 (m, 3H), 3.91 – 3.88 (m, 2H), 1.98 (dq, J = 14.2, 5.8 Hz, 1H), 1.94 – 1.87 (m, 1H), 
1.55 (td, J = 8.3, 5.4 Hz, 1H), 1.18 – 1.11 (m, 1H), 1.05 – 1.01 (m, 1H), 0.49 – 0.46 (m, 
1H). 13C NMR (125 MHz, CDCl3) δ 168.47, 133.53, 132.21, 131.52, 127.95, 127.28, 
123.72, 123.00, 90.16, 78.75, 37.64, 29.22, 17.25, 14.40, 6.07. HPLC analysis: ee = 99%. 
IE (90% hexanes : 10% isopropanol, 0.8 mL/min) : tmajor = 23.56 min, tminor = 19.83 min.
IR (neat, cm-1): 2921.6, 2849.3, 1771.2, 1712.0, 1467.1, 1398.5, 1365.2, 1188.0, 1065.5, 
758.1. HRMS (ESI) ([M+H]+) Calcd. for C21H18NO2: 316.1332, Found 316.1330. 
2-(2-(2-((3-fluorophenyl)ethynyl)cyclopropyl)ethyl) 
isoindoline-1,3-dione 3aq. Following the general procedure with hydrazone 1b and 1-
(but-3-en-1-yn-1-yl)-3-fluorobenzene 2q as starting material. Yield: 84%. Cis/trans: 91/9. 
ee: 99%. Hexanes/ethyl acetate = 8/1, Rf = 0.35. [α]20 D = -48.8 (c = 1.0, CHCl3). 1H NMR 
(500 MHz, CDCl3) δ 7.71 (dd, J = 5.4, 3.1 Hz, 2H), 7.62 (dd, J = 5.4, 3.0 Hz, 2H), 7.20 –
7.15 (m, 1H), 7.04 (d, J = 7.7 Hz, 1H), 6.94 – 6.90 (m, 2H), 3.91 – 3.87 (m, 2H), 2.04 –
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1.97 (m, 1H), 1.90 – 1.83 (m, 1H), 1.54 (td, J = 8.3, 5.4 Hz, 1H), 1.20 – 1.14 (m, 1H), 1.07 
– 1.02 (m, 1H), 0.48 (dd, J = 10.9, 5.3 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 168.45, 
162.19 (d, J = 245.6 Hz), 133.57, 132.21, 129.45 (d, J = 8.7 Hz), 127.39 (d, J = 2.8 Hz), 
125.58 (d, J = 9.6 Hz), 123.01, 118.27 (d, J = 22.6 Hz), 114.61 (d, J = 21.2 Hz), 91.42, 
77.65, 37.60, 29.24, 17.47, 14.44, 6.03. HPLC analysis: ee = 99%. IE (90% hexanes : 10% 
isopropanol, 0.8 mL/min) : tmajor = 20.92 min, tminor = 17.59 min. IR (neat, cm-1): 2924.8, 
2854.1, 1709.6, 1608.1, 1571.0, 1392.9, 1263.7, 1153.7, 1059.9, 862.5, 734.6. HRMS 
(ESI) ([M+H]+) Calcd. for C21H17FNO2: 334.1238, Found 334.1240. 
2-(2-(2-(pyridin-2-yl)cyclopropyl)ethyl)isoindoline-1,3-
dione 3ar. Following the general procedure with hydrazone 1a and 2-vinyl pyridine 2r as 
starting material. Yield: 92%. Cis/trans: 60/40. ee: 99%. Hexanes/ethyl acetate = 2/1, Rf =
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0.35. [α]20 D value was not stable for some unknown reason. 1H NMR (600 MHz, CDCl3)
δ 8.37 – 8.36 (m, 1H), 7.73 (dd, J = 5.4, 3.1 Hz, 2H), 7.64 (dd, J = 5.5, 3.0 Hz, 2H), 7.29 
(td, J = 7.7, 1.8 Hz, 1H), 7.03 (d, J = 7.8 Hz, 1H), 6.94 – 6.92 (m, 1H), 3.63 – 3.55 (m, 
2H), 2.17 (td, J = 8.5, 5.9 Hz, 1H), 1.78 – 1.72 (m, 2H), 1.30 – 1.25 (m, 1H), 1.04 (td, J =
8.4, 4.7 Hz, 1H), 0.82 (ddd, J = 8.5, 5.7, 4.5 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 
168.12, 159.38, 148.65, 135.31, 133.56, 132.19, 123.49, 122.92, 120.30, 37.83, 25.92, 
22.31, 19.31, 10.75. HPLC analysis: ee = 99%. IE (75% hexanes : 25% isopropanol, 1.0 
mL/min) : tmajor = 34.33 min, tminor = 17.60 min. IR (neat, cm-1): 3010.5, 2938.3, 1770.5, 
1704.8, 1434.6, 1392.1, 1361.1, 1187.0, 1011.8, 900.5, 749.3. HRMS (ESI) ([M+H]+)
Calcd. for C18H17N2O2: 293.1285, Found: 293.1290.
2-(3-(2-phenylcyclopropyl)propyl)isoindoline-1,3-dione 3as.
Following the general procedure with hydrazone 1a and 3-vinyl pyridine 2s as starting 
material. Yield: 73%. Cis/trans: 75/25. ee: 99%. Hexanes/ethyl acetate = 2/1, Rf = 0.35. 
[α]20 D = 25.8 (c = 1.0, CHCl3). 1H NMR (600 MHz, CDCl3) δ 8.43 – 8.37 (m, 2H), 7.78 
(dd, J = 5.4, 3.0 Hz, 2H), 7.68 (dd, J = 5.3, 3.1 Hz, 2H), 7.40 (d, J = 7.8 Hz, 1H), 7.15 –
7.12 (m, 1H), 3.70 – 3.61 (m, 2H), 2.09 (dd, J = 14.7, 8.5 Hz, 1H), 1.60 – 1.54 (m, 1H), 
1.29 (td, J = 14.4, 7.2 Hz, 1H), 1.24 – 1.17 (m, 1H), 1.11 – 1.05 (m, 1H), 0.71 (q, J = 5.7 
Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 170.84, 153.26, 149.81, 138.39, 136.58, 136.48, 
134.68, 125.74, 125.48, 40.17, 30.20, 20.78, 19.43, 12.18. HPLC analysis: ee = 99%. IE 
(75% hexanes : 25% isopropanol, 0.8 mL/min) : tmajor = 42.84 min, tminor = 44.89 min. IR 
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(neat, cm-1): 3002.3, 2936.9, 2359.8, 1769.8, 1702.1, 1435.0, 1390.2, 1360.9, 1175.7, 
1034.7, 751.0. HRMS (ESI) ([M+H]+) Calcd. for C18H17N2O2: 293.1285, Found: 293.1276.
2-(2-(2-(pyridin-4-yl)cyclopropyl)ethyl)isoindoline-1,3-
dione 3at. Following the general procedure with hydrazone 1a and 4-vinyl pyridine 2t as 
starting material. Yield: 93%. Cis/trans: 84/16. ee: 99%. Hexanes/ethyl acetate = 2/1, Rf =
0.35. [α]20 D = 29.0 (c = 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ 8.32 (s, 2H), 7.76 (dd, 
J = 5.4, 3.1 Hz, 2H), 7.68 (dd, J = 5.4, 3.0 Hz, 2H), 6.97 (d, J = 4.9 Hz, 2H), 3.70 – 3.60
(m, 2H), 2.06 (dt, J = 8.6, 6.4 Hz, 1H), 1.57 – 1.45 (m, 2H), 1.29 – 1.23 (m, 1H), 1.09 (td, 
J = 8.4, 5.4 Hz, 1H), 0.77 (q, J = 5.9 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 168.15, 
148.96, 148.63, 133.82, 132.00, 123.73, 123.07, 37.48, 26.81, 20.29, 18.39, 10.25. HPLC 
analysis: ee = 99%. IE (75% hexanes : 25% isopropanol, 0.8 mL/min) : tmajor = 40.14 min, 
tminor = 33.22 min. IR (neat, cm-1): 3004.6, 2937.3, 2359.7, 1769.5, 1703.0, 1598.5, 1391.6, 
1186.3, 1039.1, 898.4, 751.1. HRMS (ESI) ([M+H]+) Calcd. for C18H17N2O2: 293.1285, 
Found: 293.1292. 
2-(2-(2-(quinolin-4-yl)cyclopropyl)ethyl)isoindoline-1,3-
dione 3au. Following the general procedure with hydrazone 1a and 4-vinyl quinoline 2u
as starting material. Yield: 83%. Cis/trans: 82/18. ee: 99%. Hexanes/ethyl acetate = 1/1, Rf
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= 0.45. [α]20 D = 66.8 (c = 1.0, CHCl3). 1H NMR (600 MHz, CDCl3) δ 8.80 (d, J = 4.4 Hz, 
1H), 8.28 (d, J = 8.4 Hz, 1H), 8.06 (d, J = 8.3 Hz, 1H), 7.73 (dd, J = 5.4, 3.0 Hz, 2H), 7.68 
– 7.64 (m, 3H), 7.56 – 7.53 (m, 1H), 7.12 (d, J = 4.3 Hz, 1H), 3.66 – 3.57 (m, 2H), 2.56 –
2.53 (m, 1H), 1.61 – 1.49 (m, 2H), 1.25 – 1.22 (m, 1H), 0.97 – 0.90 (m, 2H). 13C NMR 
(150 MHz, CDCl3) δ 168.19, 150.07, 147.91, 145.45, 133.79, 131.94, 129.89, 129.12, 
126.44, 124.18, 123.07, 120.43, 116.48, 37.63, 27.78, 17.87, 17.10, 9.48. HPLC analysis:
ee = 99%. IE (75% hexanes : 25% isopropanol, 1.0 mL/min) : tmajor = 39.47 min, tminor =
36.90 min. IR (neat, cm-1): 3057.4, 2926.7, 2358.7, 1770.3, 1707.8, 1591.0, 1396.9, 1362.7, 
1264.9, 1032.4, 792.2, 737.3. HRMS (ESI) ([M+H]+) Calcd. for C22H19N2O2: 343.1441, 
Found: 343.1440. 
tert-butyl 3-(2-(2-(1,3-dioxoisoindolin-2-
yl)ethyl)cyclopropyl)-1H-indole-1-carboxylate 3av. Following the general procedure 
with hydrazone 1a and tert-butyl 3-vinyl-1H-indole-1-carboxylate 2v as starting material.
Yield: 84%. Cis/trans: 83/17. ee: 99%. Hexanes/ethyl acetate = 4/1, Rf = 0.25. [α]20 D value 
was not stable for some unknow reason. 1H NMR (500 MHz, CDCl3) δ 8.04 (s, 1H), 7.73 
(dd, J = 5.4, 3.1 Hz, 2H), 7.66 – 7.63 (m, 3H), 7.23 – 7.16 (m, 3H), 3.70 – 3.60 (m, 2H), 
2.05 – 2.00 (m, 1H), 1.67 (s, 9H), 1.34 – 1.18 (m, 3H), 1.07 (td, J = 8.2, 4.9 Hz, 1H), 0.59 
(dd, J = 10.7, 5.5 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 168.29, 149.70, 133.68, 132.01, 
131.54, 124.32, 123.19, 122.95, 122.37, 121.02, 119.39, 119.31, 115.06, 83.35, 37.92, 
28.22, 27.75, 15.57, 10.87, 9.66. HPLC analysis: ee = 99%. IF (90% hexanes : 10% 
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isopropanol, 0.8 mL/min) : tmajor = 34.41 min, tminor = 20.41 min. IR (neat, cm-1): 2978.2, 
2933.2, 1771.0, 1705.9, 1450.3, 1367.3, 1253.0, 1367.3, 1253.0, 1154.1, 1082.2, 1021.3, 
856.4, 716.4. HRMS (ESI) ([M+H]+) Calcd. for C26H27N2O4: 431.1965, Found 431.1978. 
2-(2-(2-(benzo[b]thiophen-3-yl)cyclopropyl)ethyl)
isoindoline-1,3-dione 3aw. Following the general procedure with hydrazone 1a and 3-
vinylbenzo[b]thiophene 2w as starting material. Yield: 94%. Cis/trans: 78/22. ee: 99%. 
Hexanes/ethyl acetate = 4/1, Rf = 0.30. [α]20 D = 141.2 (c = 1.0, CHCl3). 1H NMR (500 
MHz, CDCl3) δ 7.91 (d, J = 7.9 Hz, 1H), 7.79 – 7.77 (m, 1H), 7.73 (dd, J = 5.3, 3.2 Hz, 
2H), 7.63 (dd, J = 5.5, 3.0 Hz, 2H), 7.35 – 7.27 (m, 2H), 6.96 (s, 1H), 3.68 – 3.57 (m, 2H), 
2.20 (dd, J = 14.8, 8.0 Hz, 1H), 1.69 – 1.62 (m, 1H), 1.32 – 1.26 (m, 1H), 1.24 – 1.17 (m, 
1H), 1.13 (td, J = 8.3, 4.9 Hz, 1H), 0.72 (q, J = 5.5 Hz, 1H). 13C NMR (125 MHz, CDCl3)
δ 168.24, 140.35, 139.95, 137.70, 133.67, 132.00, 124.27, 123.88, 122.97, 122.65, 122.08, 
122.00, 37.86, 27.58, 15.90, 14.44, 9.66. HPLC analysis: ee = 99%. ID (95% hexanes : 
10% isopropanol, 0.8 mL/min) : tmajor = 31.98 min, tminor = 33.42 min. IR (neat, cm-1):
3061.3, 2934.5, 1769.7, 1704.2, 1431.8, 1392.7, 1359.7, 1174.6, 1080.1, 1030.9, 896.7, 
763.0, 717.6. HRMS (ESI) ([M+H]+) Calcd. for C21H18NO2S: 348.1053, Found 348.1040. 
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2-(2-(2-(thiophen-2-yl)cyclopropyl)ethyl)isoindoline-1,3-
dione 3ax. Following the general procedure with hydrazone 1a and 3-vinylthiophene 2x
as starting material. Yield: 93%. Cis/trans: 82/18. ee: 99%. Hexanes/ethyl acetate = 4/1, Rf
= 0.50. [α]20 D = 61.1 (c = 1.0, CHCl3). 1H NMR (600 MHz, cdcl3) δ 7.79 (dd, J = 5.4, 3.1 
Hz, 2H), 7.67 (dd, J = 5.5, 3.0 Hz, 2H), 7.02 (dd, J = 5.2, 1.1 Hz, 1H), 6.82 (dd, J = 5.1, 
3.5 Hz, 1H), 6.68 – 6.67 (m, 1H), 3.78 – 3.63 (m, 2H), 2.21 – 2.17 (m, 1H), 1.74 – 1.67
(m, 1H), 1.44 – 1.38 (m, 1H), 1.15 – 1.10 (m, 2H), 0.66 – 0.61 (m, 1H). 13C NMR (150 
MHz, cdcl3) δ 168.27, 143.23, 133.72, 132.17, 126.61, 125.09, 123.13, 123.05, 37.62, 
27.64, 17.41, 15.46, 12.46. HPLC analysis: ee = 99%. IE (90% hexanes : 10% isopropanol, 
0.8 mL/min) : tmajor = 22.80 min, tminor = 20.50 min. IR (neat, cm-1): 2998.7, 2920.0, 1772.1, 
1702.4, 1397.3, 1364.5, 1341.3, 1177.8, 1086.4, 1041.2, 1024.8, 852.7, 717.6. HRMS 
(ESI) ([M+H]+) Calcd. for C17H16NO2S: 298.0896, Found 298.0898. 
2-(2-(2-(benzofuran-2-yl)cyclopropyl)ethyl)isoindoline-
1,3-dione 3ay. Following the general procedure with hydrazone 1a and 2-vinylbenzofuran 
2y as starting material. Yield: 82%, Cis/trans: 84/16. ee: 99%. Hexanes/ethyl acetate = 4/1, 
Rf = 0.35. [α]20 D = 1.2 (c = 1.0, CHCl3).1H NMR (500 MHz, cdcl3) δ 7.68 – 7.65 (m, 2H), 
7.63 – 7.60 (m, 2H), 7.30 – 7.28 (m, 1H), 7.21 (d, J = 8.1 Hz, 1H), 7.14 – 7.06 (m, 2H), 
6.21 (s, 1H), 3.74 (t, J = 6.6 Hz, 2H), 2.11 (td, J = 8.5, 6.1 Hz, 1H), 1.85 – 1.79 (m, 1H), 
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1.74 – 1.68 (m, 1H), 1.34 – 1.28 (m, 1H), 1.17 (dt, J = 8.5, 4.3 Hz, 1H), 0.83 – 0.79 (m, 
1H). 13C NMR (125 MHz, cdcl3) δ 168.23, 157.55, 154.42, 133.58, 132.02, 128.62, 122.96, 
122.85, 122.29, 119.88, 110.59, 103.04, 37.72, 27.64, 18.09, 14.29, 10.90. HPLC analysis: 
ee = 99%. IE (90% hexanes : 10% isopropanol, 0.8 mL/min) : tmajor = 27.76 min, tminor =
23.07 min. IR (neat, cm-1): 2935.3, 2856.0, 1770.1, 1706.7, 1600.0, 1454.6, 1392.7, 1363.2, 
1254.9, 1185.4, 1036.5, 954.5, 794.2, 751.2. HRMS (ESI) ([M+H]+) Calcd. for C21H18NO3:
332.1281, Found 332.1282.
  
3.4.4 Deprotection of Phthalimide Unit in Cyclopropane 3aa
To a 10 mL round-bottom flask, optically active cyclopropane 3aa (0.5 mmol) was 
dissolved in ethanol (2 mL), then 3.0 equivalent of hydrazine monohydrate (1.5 mmol) was 
added. The resulting mixture was heat at 80 oC for 4 hrs with the disappearance of starting 
material from TLC. During the reaction, white solid was precipitated. The reaction mixture 
was then filtrated and the residue was washed with ethanol (2 x 2 mL). The filtrate was 
then concentrated and purified by flash chromatography. The fractions containing product 
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4aa were collected and concentrated by rotary evaporation to afford the compound as a 
mixture of trans/cis diastereomers. 
2-(2-phenylcyclopropyl)ethan-1-amine 4aa. Yield: 99%. Cis/trans:
83/17. ee: 99%. DCM/MeOH = 4/1, Rf = 0.20. [α]20 D = 22.2 (c = 1.0, CHCl3). 1H NMR 
(500 MHz, CDCl3) δ 7.27 – 7.23 (m, 2H), 7.19 – 7.14 (m, 3H), 2.69 – 2.60 (m, 2H), 2.14 
(dt, J = 14.5, 7.3 Hz, 1H), 1.56 – 1.52 (m, 3H), 1.33 – 1.28 (m, 1H), 1.07 – 0.98 (m, 2H), 
0.70 (dd, J = 10.9, 5.6 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 139.29, 128.94, 127.88, 
125.67, 42.03, 32.60, 20.54, 16.66, 9.35. IR (neat, cm-1): 3061.3, 1924.3, 2359.4, 1496.4, 
1312.0, 1027.3, 768.3, 726.2. HRMS (ESI) ([M+H]+) Calcd. for C11H16N: 162.1277, Found 
162.1274.
4-methyl-N-(2-(2-phenylcyclopropyl)ethyl)benzenesulfonamide 
4aa’. In 10 mL tube, Et3N (1.5 equiv.) was added into the solution of 4aa (0.1 mmol) in 
DCM (0.6 mL). followed by tosyl chloride (0.15 mmol, 1.5 equiv.). The reaction was 
monitored by TLC. Upon the completion, the solution was concentrated and purified by 
flash chromatography to deliver the desired compound 4aa’. Yield: 92%. Cis/trans: 83/17. 
ee: 99%. Hexanes/ethyl acetate = 4/1, Rf = 0.30. [α]20 D = 13.8 (c = 1.0, CHCl3). 1H NMR 
(500 MHz, CDCl3) δ 7.65 (d, J = 8.3 Hz, 2H), 7.29 – 7.22 (m, 5H), 7.09 (d, J = 7.3 Hz, 
2H), 4.26 (t, J = 5.9 Hz, 1H), 2.88 (dd, J = 13.2, 6.8 Hz, 1H), 2.43 (s, 3H), 2.12 (td, J =
8.6, 6.3 Hz, 1H), 1.59 – 1.54 (m, 1H), 1.30 – 1.23 (m, 1H), 1.15 – 1.09 (m, 1H), 1.01 –
0.93 (m, 1H), 0.66 – 0.63 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 143.20, 138.50, 136.96, 
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129.59, 128.78, 128.06, 127.04, 125.94, 43.00, 28.48, 21.50, 20.53, 16.18, 9.18. HPLC 
analysis: ee = 99%. OJH (90% hexanes : 10% isopropanol, 0.8 mL/min) : tmajor = 42.16 
min, tminor = 39.78 min. IR (neat, cm-1): 3271.6, 3004.6, 2918.2, 2359.7, 1597.3, 1320.5,
1160.4, 1090.5, 812.1, 764.6, 701.4. HRMS (ESI) ([M+H]+) Calcd. for C18H22NO2S:
316.1366, Found 316.1368.  
 
3.4.5 Procedure for HRMS Experiment
To an over-dried Schlenk tube, hydrazone 1a (0.05 mmol) and Cs2CO3 (1.5 equiv.) 
were added. The Schlenk tube was then evacuated and backfilled with nitrogen for 3 times. 
The Teflon screw cap was replaced with a rubber septum, CH3CN (0.5 mL) was added via 
a gas-tight syringe. The mixture was then stirred at 40 oC for 0.5 h. The resulting light 
yellow solution was then passed through a short pad of Celite (to get rid of base and salt) 
under the flow of nitrogen and the filtrate was collected in a HPLC vial (vial A, degassed 
and backfilled with argon). During the time, [Co(P1)] (2 mol %) was charged into another 
HPLC vial (vial B, degassed and backfilled with argon) and dissolved in CH3CN (0.5 mL). 
After mixing equal amount of solutions from vial A (0.1 mL) and vial B (0.1 mL), the 
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sample was further diluted with CH3CN and immediately injected into HRMS instrument. 
The HRMS experiment was carried out in the absence of any additives such as formic acid,
commonly act as electron carriers for ionization, allowing the detection of the molecular 
ion signals corresponding to Co(III)-alkyl radical (C87H97CoN9O6·) by the loss of one 
electron.
3.4.6 Procedure for EPR Experiment
To an oven-dried Schlenk tube A, sulfonylhydrazone 1a (0.05 mmol), and Cs2CO3
(1.5 equiv.) were added. The Schlenk tube was then evacuated and backfilled with nitrogen 
for 3 times. The Teflon screw cap was replaced with a rubber septum, benzene (0.5 mL) 
was added via a gas-tight syringe. The mixture was then stirred at 40 oC for 0.5 h. During 
the time, [Co(P1)] (2 mol %) was charged into another oven-dried Schlenk tube B. The 
Schlenk tube B was then evacuated and backfilled with nitrogen for 3 times. After 0.5 h, 
the resulting light yellow solution from tube A was passed through a short pad of Celite (to 
get rid of base and salt) under the flow of nitrogen and transferred to Schlenk tube B. The 
mixture was stirred for 1 min, followed by the addition of phenyl N-tert-butylnitrone (PBN, 
0.05 mmol). The reaction mixture was stirred for 2 min and transferred into a degassed 
EPR tube (filled with argon) through a gas tight syringe. The sample was then carried out 
for EPR experiment at room temperature (EPR settings: T = 298 K; microwave frequency: 
9.37762 GHz; power: 20 mW; modulation amplitude: 1.0 G).
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CHAPTER 4
ENANTIOSELECTIVE RADICAL CYCLIZATION FOR CONSTRUCTION OF 
5-MEMBERED RING STRUCTURES BY METALLORADICAL C–H
ALKYLATION
4.1 INTRODUCTION 
Carbon-centered radicals, specifically alkyl radicals, have been extensively 
explored as versatile intermediates for chemical synthesis because of their potent reactivity 
and diverse pathway.1 Among important synthetic applications, alkyl radicals have been 
well demonstrated to undergo radical cyclization for construction of various ring structures 
via C–C bond formation.1 While numerous radical cyclization reactions have been 
elegantly implemented with alkyl radicals,2 they are predominantly based on the utilization 
of radical addition as the key cyclization step, followed by further radical transformations 
such as H-atom abstraction to deliver cyclic products (Scheme 4.1a). Consequently, 
traditional radical cyclization reactions necessarily involve the use of substrates containing 
unsaturated bonds, such as alkenes, imines, and carbonyls. 
In addition to the well-established cyclization sequence of radical addition and H-
atom abstraction (RA-HAA) for unsaturated substrates, it is conceivable that the 
combination of H-atom abstraction and radical substitution (HAA-RS) could give rise to 
an alternative C–C bond forming pathway for radical cyclization that could employ 
saturated C–H substrates (Scheme 4.1b). While intramolecular H-atom abstraction is 
normally facile, the subsequent key cyclization step of intramolecular radical substitution 
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at the carbon center has been recognized as an inherently challenging pathway due to the 
requirement of a highly organized linear transition state involving three multi-substituted 
sp3-carbon centers.1a,3 For this reason, this alternative radical cyclization, although 
seemingly tenable, is largely undocumented for typical alkyl radicals. 
Scheme 4.1|| Different Radical Cyclization Pathways for the Formation of Ring 
Structures via C–C Bond Formation
 
One potential solution to address the problem would be the introduction of α-
metalloalkyl radicals R2(LnM)C•, where one of the substituents of common alkyl radicals 
is replaced by a metal complex unit (MLn) (Scheme 4.1c). Since M–C bonds are typically 
more polar and weaker than C–C bonds, the radical substitution pathway would become 
both thermodynamically possible and kinetically feasible, especially with stable 
metalloradicals LnM• as outgoing radicals.4 Furthermore, this metalloradical-based new 
mode of radical cyclization could be potentially rendered as a catalytic process while 
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offering the possibility of controlling enantioselectivity, allowing for stereoselective 
construction of cyclic compounds from linear C–H substrates.
To harness the vast potential of homolytic radical reactions for stereoselective 
organic synthesis,5 metalloradical catalysis (MRC) has recently been introduced as a 
conceptually new approach for addressing some enduring challenges in the field.6,7 MRC 
aims at the development of metalloradical complexes as open-shell catalysts for generation 
of metal-supported organic radicals as key intermediates and for control of their subsequent 
homolytic reactions. 
Scheme 4.2|| Asymmetric C–H Alkylation with Acceptor/Acceptor-Type Diazo
Compounds via Co(II)-Based MRC
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As stable metalloradicals, Co(II) complexes of D2-symmetric chiral 
amidoporphyrins [Co(D2-Por*)] exhibit the unusual capability of activating diazo 
compounds to generate α-Co(III)-alkyl radicals.8 The α-metalloalkyl radicals can undergo 
radical addition and H-atom abstraction as well as subsequent radical substitution, leading 
to the invention of new catalytic systems for various stereoselective radical 
transformations.9 Among them, we recently illustrated the aforementioned radical 
cyclization strategy with stereoselective formation of sulfolanes from α-methoxycarbonyl-
α-diazosulfones (Scheme 4.2).9b To demonstrate the generality of this new mode of radical 
cyclization and broaden its synthetic utility, we were intrigued if Co(II)-based MRC could 
be applied for the asymmetric synthesis of more common ring structures, such as 
pyrrolidines, tetrahydrofurans, and other important 5-membered cyclic compounds, from 
linear aliphatic diazo compounds (Scheme 4.3), which are typically generated in situ from 
sulfonyl hydrazones of the corresponding carbonyl precursors due to their instability. 
Scheme 4.3|| Proposed Radical Cyclization Mechanism via Metalloradical C–H 
Alkylation
 
Chapter 4. Enantioselective C–H Alkylation with In Situ-Generated Alkyldiazomethanes   
Mechanistically, it was unclear if aliphatic diazo compounds could be activated by 
metalloradical [Co(D2-Por*)] to form the corresponding α-Co(III)-alkyl radicals I (Scheme 
4.3). If so, could the rate of metalloradical activation of aliphatic diazo compounds be 
effectively matched with their in situ-generation to avoid unwanted thermal 
decomposition? Furthermore, it was uncertain whether α-Co(III)-alkyl radicals I, which 
possess accessible β-H atoms, could proceed subsequent 1,5-H atom abstraction for 
generation of -Co(III)-alkyl radicals II competitively over the potential β-H-atom shift, 
which would lead to olefin side products. Additional questions arose from the flexible 
nature of the linear alkyl chain that could pose extra challenges in achieving the 
intramolecular radical substitution of -Co(III)-alkyl radicals II for stereoselective 
construction of the 5-membered structures. Without conformational rigidity, would the 
intermediate II be capable of undergoing effective 5-exo-tet radical cyclization? What 
determinant factors could be explored for controlling the enantioselectivity of C–C bond 
forming process? We reasoned that the key to address these and related challenges is to
develop suitable D2-symmetric chiral amidoporphyrin ligands that direct the Co(II)-based 
catalysis for productive cyclization. If realized, it would provide a general catalytic strategy 
for stereoselective radical synthesis of five-membered cyclic molecules from aliphatic 
aldehyde-derived tosylhydrazones.
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This new mode of radical cyclization based on metalloradical C–H alkylation 
would offer a new retrosynthetic paradigm for construction of ring structures where C–C
bond can be disconnected as common C=O and C–H units of linear aldehydes (Equation 
4.1).
Chiral pyrrolidines containing α-substituent are recurring core structures in a wide 
range of natural products and bioactive compounds (Scheme 4.4). Accordingly, 
considerable efforts have been devoted to devise effective strategies for their asymmetric 
synthesis. While most of the existing catalytic systems involve C–H functionalization of 
preformed pyrrolidine ring structures,10 there has been no previous report on asymmetric 
construction of α-substituted chiral pyrrolidines via catalytic C–H alkylation with acyclic 
aliphatic diazo compounds.11
Scheme 4.4|| Selected Biologically Active Compounds Containing α-Substituted 
Pyrrolidine Moiety
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As a demonstration of the aforementioned mode of radical cyclization (HAA-RS) 
for construction of common 5-membered ring structures, we have demonstrated a new 
Co(II)-based catalytic system that is highly efficient for stereoselective synthesis of α-
substituted pyrrolidines. Supported by a new D2-symmetric chiral amidoporphyrin, the 
Co(II) metalloradical catalyst is able to activate aliphatic diazo compounds for 
enantioselective intramolecular radical alkylation of a broad range of C(sp3)–H bonds, 
constructing α-substituted chiral pyrrolidines in high yields with excellent 
enantioselectivities. In addition to chemoselective alkylation of allylic and propargylic C–
H bonds and regioselective 1,5-alkylation, the new catalytic radical cyclization is 
highlighted by its tolerance of various functionalities, including compatibility with a 
variety of heteroaryl groups. 
4.2 RESULTS AND DISCUSSIONS 
4.2.1 Condition Optimization for Enantioselective Radical Cyclization of Aliphatic 
Diazo Precursor
At the outset of our effort, we chose aliphatic aldehyde-derived tosylhydrazone 1a
as the model substrate for proof-of-concept experiments to test the proposed radical 
cyclization via Co(II)-MRC (Table 4.1). Using the Co(II) complex of achiral 
amidoporphyrin 3,5-DitBu-IbuPhyrin [Co(P1)]12 as the metalloradical catalyst, we were 
gratified to observe that the catalytic reaction could afford 2-phenylpyrrolidine (2a) in 81% 
yield (entry 1), demonstrating the feasibility of the HAA-RS pathway for productive radical 
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cyclization without complication from competitive olefin formation. The high yield of the 
radical cyclization also indicated that the aliphatic diazo compound generated in situ could 
be effectively incorporated into the catalytic cycle without accumulation to cause side 
reactions. 
Table 4.1|| Ligand Effect on Co(II)-Catalyzed Enantioselective Radical Cyclization of 
Aliphatic Diazo Precursora
 
a Reactions were carried out with 1a (0.1 mmol) in the presence of Cs2CO3 (1.5 equiv.) by 
[Co(Por)] (3 mol %) in dioxane (0.6 mL) at 60 oC for 24 h; Yields refer to isolated yields 
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of purified products; Enantiomeric excess (ee) was determined by chiral HPLC analysis. 
Ts: 4-toluenesulfonyl; Boc: tert-butyloxycarbonyl.
When the first-generation chiral metalloradical catalyst [Co(P2)] (P2 = 3,5-DitBu-
ChenPhyrin) was employed,9g which has been shown to be effective for asymmetric radical 
cyclopropanation, it was found that the catalytic radical cyclization exhibited almost no 
asymmetric induction despite the high-yielding formation of desired 2a (Table 4.1, entry 
2). Considering the flexible nature of the linear alkyl chain, we were disappointed but not 
completely surprised by this negative result. 
Without the hydrogen-bonding interaction at disposal to rigidify the Co(III)-alkyl 
radical intermediates, we decided to crowd the steric environment of the ligand pocket.
Indeed, the employment of [Co(P3)] (P3 = 2,6-DiMeO-ChenPhyrin) bearing more 
sterically hindered achiral meso-aryl groups resulted in observation of significant 
asymmetric induction without affecting the reactivity (entry 3). 
To further augment this positive buttressing effect, we then turned our attention to 
D2-symmetric chiral amidoporphyrin 3,5-DitBu-ZhuPhyrin (P4), which was previously 
shown to have a more rigid conformation and polar chiral environment because of the 
intramolecular O···H–N hydrogen-bonding interactions in the (S)-(-)-2-
tetrahydrofurancarboxamide units,9e As expected, [Co(P4)] could catalyze the radical 
cyclization reaction to form 2a in similarly high yield with substantially improved 
enantioselectivity (entry 4). Subsequent use of [Co(P5)] (P5 = 2,6-DiMeO-ZhuPhyrin) as 
the catalyst resulted in further increase in both yield and enantioselectivity (entry 5). 
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Encouraged by the positive direction of ligand buttressing effect, we synthesized 
2,4,6-TriMe-ZhuPhyrin ligand (P6), a new derivative of ZhuPhyrin series, where even 
more sterically demanding mesityl groups are attached at the two achiral meso-positions. 
We were exhilarated to find that [Co(P6)] could effectively catalyze the enantioselective 
radical C–H alkylation reaction, affording the desired cyclization product 2a in 93% yield 
with 92% ee (entry 6). Also, the detailed study of solvent and base effects disclosed that 
dioxane and cesium carbonate are the optimal choice, respectively (Table 4.2).
Table 4.2|| Solvent and Base Effects on Co(II)-Catalyzed Enantioselective Radical 
Cyclization of Aliphatic Diazo Precursor 1aa
 
a Carried out with 1a (0.1 mmol) in the presence of base (1.5 equiv.) by [Co(P6)] (3 mol 
%) in solvent (0.6 mL) at 60 oC for 24 h. b NMR yields with (CHCl2)2 as internal standard. 
c ee was determined by chiral HPLC analysis. d Isolated yield in the parenthesis. n/d: not 
detected. n/a: not applicable.
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4.2.2 Enantioselective Radical Alkylation of Various C–H Bonds
Under the optimized conditions, the substrate scope of [Co(P6)]-catalyzed radical 
cyclization was then evaluated by employing aliphatic aldehyde-derived tosylhydrazone 
substrates 1 containing different types of C–H bonds (Table 4.3). As demonstrated by 
substrates 1a–1j, benzylic C–H bonds with varied electronic and steric properties could all 
be intramolecularly alkylated, affording corresponding 2-arylpyrrolidines 2a–2j in high 
yields with excellent enantioselectivities. The absolute configuration of the major 
enantiomer of 2f was established by X-ray as (S). In addition to CN, NO2, and halogen 
functionalities, it is noteworthy to mention that the metalloradical C–H alkylation system 
could tolerate vinyl groups without complication from the competitive cyclopropanation 
of the C=C bonds as exemplified with the reaction of substrate 1k, forming the desired 
pyrrolidine 2k in 81% yield with 93% ee. In a similar way, the Co(II)-based 
enantioselective radical system could undergo allylic C–H alkylation with high 
chemoselectivity, as demonstrated by the reaction of substrate 1l to form 2-vinylpyrrolidine 
(2l) in good yield and excellent enantioselectivity. Likewise, propargylic C–H substrate 1m 
also underwent the radical alkylation chemoselectively, giving 2-
(phenylethynyl)pyrrolidine (2m) in a good yield with promising enantioselectivity. 
Furthermore, this metalloradical system was shown applicable for substrates even with 
non-activated C–H bonds. For example, when tosylhydrazone 1n, which possesses 
accessible hydrogens at both benzylic and homobenzylic positions, was used as the 
substrate, [Co(P6)] could regioselectively alkylate the stronger homobenzylic over the 
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weaker benzylic C–H bonds, resulting in exclusive formation of five-membered 
pyrrolidine 2n in 96% yield albeit with moderate enantioselectivity. This remarkable 
Table 4.3|| Enantioselective Radical Cyclization for Synthesis of α-Substituted 
Pyrrolidines via [Co(P6)]-Catalyzed C–H Alkylationa
 
a Carried out with 1 (0.1 mmol) in the presence of Cs2CO3 (1.5 equiv.) by [Co(P6)] (3 mol 
%) in dioxane (0.6 mL) at 60 oC for 24 h; isolated yields; ee was determined by chiral 
HPLC analysis. b Absolute configuration was determined by X-ray as (S).
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regioselectivity indicated that the corresponding α-Co(III)-alkyl radicals I (Scheme 4.3) 
within the ligand pocket highly favors 1,5- over 1,6-H abstraction under the influence of 
the steric environment. In a similar fashion, the Co(II)-based catalytic system could 
undergo regioselective 1,5-alkylation of stronger secondary C–H bonds in the presence of 
weaker tertiary C–H bond as illustrated with the reaction of substrate 1o, forming 2-
cyclohexylpyrrolidine (2o) in good yield with high enantioselectivity. Notably, this radical 
cyclization strategy was even applicable for electron-deficient C–H substrates, as 
demonstrated by the productive formation of the benzyl ester of naturally occurring L-
proline (2p) from diazo precursor 1p in 56% yield with 82% ee. This result clearly 
manifested that the Co(II)-catalyzed alkylation is less sensitive to electronic property of C–
H bonds, which is in good agreement with the underlying radical mechanism.
Scheme 4.5|| Enantioselective Radical Cyclization for Synthesis of α-
Heteroarylpyrrolidines via [Co(P6)]-Catalyzed C–H Alkylation
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In addition to the tolerance for common functionalities, the Co(II)-based 
enantioselective radical cyclization was found to be compatible with substrates containing 
various heteroarenes, allowing for stereoselective construction of α-heteroarylpyrrolidines, 
which are prevalent structure motifs in natural products and synthetic compounds with 
wide biological activities (Scheme 4.5).10 For example, 3-pyridine-based diazo precursor 
1q could be effectively activated by [Co(P6)] under the same condition to construct the 
nicotine derivative 2q in 73% yield with 92% ee. The major enantiomer of 2q was 
confirmed to have the same (S) absolute configuration as naturally occurring nicotine.10c
By simply using 2- and 4-pyridine-tethered hydrazones 1r and 1s, the Co(II)-based radical 
cyclization permitted the streamlined synthesis of α- and γ-nicotine derivatives 2r and 2s, 
respectively, in high optical purity. 
Likewise, this catalytic protocol could also be successfully applied for both 
quinoline- and indole-based C–H substrates 1t and 1u to form the corresponding optically 
active α-heteroarylpyrrolidines in high yields with excellent enantioselectivities. 
Furthermore, chiral pyrrolidine derivatives containing α-thiophene (2v) and α-
benzothiophene (2w) groups were efficiently constructed in high optical purity from the 
corresponding hydrazone precursors 1v and 1w. Notably, the reaction could be scaled up 
20-fold as demonstrated with the high-yielding synthesis of 2w on 2.0 mmol scale without 
affecting the excellent enantioselectivity. It was evident that the Co(II)-based catalytic 
system could be well suited to substrates containing potentially coordinating heteroaryl 
groups without poisoning the catalytic activity or diminishing the high enantioselectivity, 
a common challenge that plagues many transition metal-catalyzed reactions.
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The broad substrate scope and high functionality tolerance observed for the Co(II)-
catalyzed radical alkylation prompted us to evaluate its potential applicability to C–H
substrates beyond organic molecules, such as organometallic compounds. Considering the
resulting product has potential applications as a chiral ligand in asymmetric catalysis,13 we 
were specifically intrigued to find out whether this radical cyclization system would allow 
for construction of a chiral pyrrolidine ring structure directly onto ferrocene, the 
representative member of metallocene family of organometallic compounds. Accordingly, 
ferrocene-based C–H substrate 1x was prepared and tested under the standard conditions. 
It was found that the C–H bond adjacent to one of the two cyclopentadienyl rings was
selectively alkylated by catalyst [Co(P6)] for radical cyclization to form the chiral α-
ferrocenylpyrrolidine 2x in 53% yield with 92% ee (Equation 4.2), indicating the cavity-
like environment of the ligand could accommodate relatively large substrates.
While our initial effort was focused on stereoselective formation of chiral 
pyrrolidine structures, preliminary results showed this radical cyclization strategy could 
also be applied for construction of other common five-membered ring structures (Scheme 
4.6). For example, [Co(P6)] could successfully catalyze intramolecular C–H alkylation of 
both ether- and thioether-linked diazo precursors 1y and 1z for enantioselective radical 
cyclization, forming α-phenyltetrahydrofuran (2y) and α-phenyltetrahydrothiophene (2z), 
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respectively, in good yields with high enantioselectivities. Furthermore, the Co(II)-based 
radical cyclization protocol even allowed for direct formation of cycloalkanes from diazo 
precursors with highly flexible all-methylene linkers, as exemplified by the high-yielding 
synthesis of phenylcyclopentane (2aa) from easily accessible 5-phenylpentanal 
tosylhydrazone (1aa). In fact, 5-membered cyclic compounds with varied substitution 
patterns could be accessed in a similar fashion from diazo precursors derived from aliphatic 
aldehydes with different linear linkers, as demonstrated in the catalytic reaction of substrate 
1ab by [Co(P6)], forming β-substituted pyrrolidine 2ab in 50% yield with 67% ee under 
the same conditions.
Scheme 4.6|| Enantioselective Construction of Different Five-Membered Cyclic 
Compounds via [Co(P6)]-Catalyzed C–H Alkylation
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4.2.3 Mechanistic Evidences for the Proposed Stepwise Radical Pathway
To shed light on the underlying stepwise radical mechanism of the Co(II)-catalyzed 
intramolecular C–H alkylation, several mechanistic experiments were performed. First, 
mono-deuterated tosylhydrazone 1a-D was synthesized to measure the intramolecular 
kinetic isotope effect (KIE) of the C–H alkylation process (Equation 4.3). Under the 
standard conditions by the achiral catalyst [Co(P1)], both C–H (2a-H) and C–D (2a-D) 
alkylation products were formed in a combined yield of 65%. 1H-NMR analysis of the 
product mixture revealed an intramolecular KIE ratio of kH/kD = 9.2/1. This high level of 
primary KIE was in well accordance with the proposed direct C–H bond breaking via H-
atom abstraction by α-Co(III)-alkyl radical intermediate I (Scheme 4.3). 
 
Second, the effect of radical scavenger TEMPO on the Co(II)-catalyzed C–H 
alkylation was examined with the use of substrate 1t (Scheme 4.7). In the presence of 2.0 
equivalent of TEMPO, the catalytic reaction by [Co(P1)] resulted in no formation of the 
alkylation product 2t. Instead, the TEMPO-trapped compound 3t was isolated in 20% yield, 
which was characterized to contain two TEMPO units at the 1- and 5-positions via C–O 
bonds. The observation of 3t supports the existence of -Co(III)-alkyl radical intermediate 
II, which was apparently trapped by one molecule of TEMPO at the pendant ε-carbon 
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radical center via radical hetero-dimerization and then reacted with the second molecule of 
TEMPO at the α-carbon center via radical substitution to cleave the Co(III)–C bond. 
Scheme 4.7|| The Rationale for the Formation of Di-TEMPO Trapped Intermediate 
3t
 
Third, the enantiopure substrate 4a containing (R)-tertiary stereogenic carbon 
center was prepared to evaluate the stereochemistry outcome of the Co(II)-catalyzed 
radical C–H alkylation (Scheme 4.8). Under the standard conditions, it was shown that 
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even the tertiary C–H bond in (R)-4a could be productively alkylated by the achiral catalyst 
[Co(P1)] to form the corresponding α,α-disubstituted pyrrolidine 5a in 55% yield as a 
mixture of enantiomers (S)-5a and (R)-5a. Chiral HPLC analysis showed that the 
enantiopurity of the chiral product 5a was 81% ee with (S)-5a as the major enantiomer, 
which was established by X-ray crystallographic analysis. The results indicated that the 
resulting pro-(R) -Co(III)-alkyl radical intermediate II from 1,5-H atom abstraction of the 
enantiopure (R)-tertiary C–H bond by radical intermediate I underwent subsequent radical 
substitution stereospecifically at a much faster rate than its racemization. 
Scheme 4.8|| The Rationale for the ee Erosion via [Co(P1)]-Catalyzed Radical C–H
Alkylation with Optically Active Tertiary C–H Substrate 4a
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Last, the Co(III)-supported alkyl radical intermediates from the cyclization reaction 
of substrate 1a by [Co(P1)] could be directly detected by HRMS and trapped by phenyl N-
tert-butylnitrone (PBN) to give the characteristic EPR signal (Scheme 4.9). 
Scheme 4.9|| Isotropic X-band EPR Spectrum of Phenyl N-tert-Butylnitrone (PBN)-
Trapped Co(III)-Supported Alkyl Radical Intermediate
  
Together, these experimental results established the detailed mechanism for radical 
cyclization through Co(II)-based metalloradical C–H alkylation (vide supra, Scheme 4.3). 
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4.3 CONCLUSIONS
In summary, we have demonstrated the broad applicability of the newly emerged 
radical cyclization mode, which involves sequential radical H-atom abstraction and radical 
substitution (HAA-RS) via metalloradical catalysis (MRC), as a catalytic C–C bond 
forming strategy for stereoselective construction of common cyclic compounds from C–H 
substrates. This alternative strategy of radical cyclization, which is fundamentally different 
from the traditional radical cyclization of unsaturated substrates involving sequential 
radical addition and H-atom abstraction (RA-HAA), will provide a new retrosynthetic 
paradigm to synthesize five-membered chiral cyclic molecules from readily available 
linear aldehydes via enantioselective C–C bond formation through the union of C–H and 
C=O units.   
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4.4 EXPERIMENTAL SECTION
4.4.1 General Considerations
1H NMR spectra were recorded on a Varian INOVA 400 (400 MHz), 500 (500 
MHz) or 600 (600 MHz) spectrometer. Chemical shifts are internally referenced to residual 
CHCl3 signal (δ 7.26 ppm). Data are reported as follows: chemical shift (δ ppm), 
integration, multiplicity (s = singlet, d = doublet, dd = doublet of doublets, t = triplet, q = 
quartet, p = pentet, br = broad, m = multiplet), and coupling constants (Hz). 13C NMR 
spectra were recorded on a Varian INOVA 400 (100 MHz), 500 (125 MHz), or 600 (150 
MHz) spectrometer with complete proton decoupling. Chemical shifts are reported in ppm 
with residual CHCl3 as the internal standard (δ 77.0 ppm). High-resolution mass 
spectrometry was performed on a Micromass LCT ESI-MS and JEOL Accu TOF Dart at 
the Mass Spectrometry Facility, Boston College. Infrared spectra were measured with a 
Nicolet Avatar 320 spectrometer with a Smart Miracle accessory. Optical rotations were 
measured on a Rudolph Research Analytical AUTOPOL® IV digital polarimeter. HPLC 
measurements were carried out on a Shimadzu HPLC system with Chiralcel AD-H, OD-H
and OJ-H. The UV-Vis absorption spectra in the range 200 – 700 nm were measured with 
an Evolution 300 UV-VIS spectrophotometer using quartz cuvettes with 1.0 cm optical 
path length. X-band EPR spectra were recorded on a Bruker EMX-Plus spectrometer 
(Bruker BioSpin).
Unless otherwise noted, all C–H alkylation reactions were performed under an 
atmosphere of dry N2, in oven-dried glassware with standard vacuum line techniques. Gas 
tight syringes were used to transfer liquid reagents and solvents in catalytic reactions. 
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Anhydrous solvents as well as other commercial reagents were purchased from Sigma-
Aldrich, Acros, Alfa Aesar, Strem, Oakwood Products Inc., TCI, or Matrix Scientific and 
used as received unless otherwise stated. Thin layer chromatography was performed on 
Merck TLC plates (silica gel 60 F254). Flash column chromatography was performed with 
ICN silica gel (60 Å, 230-400 mesh, 32-63 μm)
4.4.2 Synthesis of Catalyst [Co(P6)]
 
 
[H2(P6)] was synthesized according to our previous reported procedure9g with 78% 
yield. The 5,15-bis(2,6-dibromophenyl)-10,20-bis(2,4,6-trimethyl-phenyl)-porphyrin A9g
(0.2 mmol), (S)-tetrahydrofuran-2-carboxamide B (3.2 mmol), 4 Å molecular sieves, 
Pd(OAc)2 (0.08 mmol), Xantphos (0.16 mmol), and Cs2CO3 (3.2 mmol) were placed in an 
oven-dried, resealable Schlenk tube. The tube was capped with a Teflon screwcap, 
evacuated, and backfilled with nitrogen for three times. After that, the screwcap was 
replaced with a rubber septum, and dioxane (10 mL) was added via gas-tight syringe. The 
tube was purged with nitrogen for 2 minutes, and then the septum was replaced with the 
Teflon screwcap. The tube was sealed and stirred at 100 oC for 72 hrs. The resulting mixture 
was cooled to room temperature, diluted in ethyl acetate, filtrated through a silica pad and 
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concentrated in vacuo. The pure compound was obtained as a purple solid after purification 
by flash column chromatography (ethyl acetate/hexanes 1/1 to 2/1). 1H NMR (600 MHz, 
CDC13): 8.71 (br, 8H), 8.58 (d, J = 8.5 Hz, 4H), 7.91 (s, 4H), 7.86 (t, J = 8.5 Hz, 2H), 
7.29 (s, 4H), 3.70 (dd, J = 7.7, 5.0 Hz, 4H), 2.63 (s, 6H), 1.83 (s, 12H), 1.62 – 1.57 (m, 
12H), 0.74 (m, br, 4H), 0.43 (m, br, 8H), -2.38 (s, 2H). 13C NMR (125 MHz, CDC13):
171.23, 138.85, 138.40, 137.00, 130.71, 128.05, 121.48, 119.64, 116.43, 109.99, 107.82, 
77.77, 67.41, 29.54, 24.19, 21.69, 21.42. IR (neat, cm-1): 3348.56, 2973.34, 1693.80, 
1585.76, 1495.59, 1343.31, 1062.41, 965.80, 802.86. HRMS (ESI) ([M+H]+) Calcd. for 
C70H71N8O8: 1151.5389, found 1151.5378. UV–vis (CH2Cl2), λmax nm (log ε): 419(5.52), 
514(4.27), 546(3.70), 590(3.74), 645(3.48).
 
[Co(P6)] was synthesized according to our previous reported procedure9g with 90% 
yield. Free base porphyrin [H2(P6)] and anhydrous CoCl2 (8 equiv.) were placed in an 
oven-dried, resealable Schlenk tube. The tube was capped with a Teflon screwcap, 
evacuated, and backfilled with nitrogen. The screwcap was then replaced with a rubber 
septum, 2,6-lutidine (4 equiv.) and anhydrous THF were added via gas-tight syringe. The 
tube was purged with nitrogen for 2 minutes, and then the septum was replaced with the 
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Teflon screwcap. The reaction was conducted at 80 oC for 12 hrs. The resulting mixture 
was cooled to room temperature, diluted with ethyl acetate, and transferred to a separatory 
funnel. The reaction mixture was washed with water for 2 times and concentrated in vacuo.
The target compound [Co(P6)] was isolated as a purple solid after purification by flash 
column chromatography (ethyl acetate/hexanes 1/1 to 2/1). IR (neat, cm-1): 3345.37, 
2975.30, 1691.41, 1584.59, 1496.60, 1343.08, 1291.12, 1163.92, 1062.85, 995.07, 796.97. 
HRMS (ESI) (M*+) Calcd. for C70H68CoN8O8:1207.4492, found 1207.4480. UV–vis
(CH2Cl2), λmax nm (log ε): 412(5.40), 529(4.18).
4.4.3 General Procedure for Preparation of 3-Aminopropan-1-ol Derivative s1
  
To a solution of aldehyde (10 mmol) in anhydrous methanol (20.0 mL) was added 
3-amino-1-propanol (10 mmol) dropwise at room temperature. The reaction was stirred for 
overnight. After that, the reaction mixture was cooled down to 0 °C in an ice bath. Sodium 
borohydride (15 mmol) was added portionwise. After the bubbling stopped, the solvent 
was then evaporated. The resulting residue was then partitioned between H2O (30 mL) and 
EtOAc (30 mL). The aqueous layer was extracted with EtOAc (2 x 20 mL). The combined 
organic extracts were then dried and concentrated under vacuum. The desired product s1
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was then purified by flash chromatography (unless otherwise noted, the column conditions 
are: ethyl acetate, then dichloromethane/methanol 10/1 to 5/1).
3-(benzylamino)propan-1-ol s1-a, known compound.14
Following the general procedure with benzaldehyde as starting material. Yield: 75%. 1H
NMR (500 MHz, CDCl3) δ 7.34 – 7.24 (m, 5H), 3.82 – 3.80 (m, 4H), 3.13 (br, 2H), 2.90 ( 
t, J = 5.6 Hz, 2H), 1.73 (p, J = 5.6 Hz, 2H). 13C NMR (125 MHz, CDCl3) δ 139.06, 128.45, 
128.16, 127.18, 63.87, 53.76, 49.01, 30.66. IR (neat, cm-1): 3292.27, 2928.78, 1453.11, 
1068.01, 1026.71, 733.97, 697.39. HRMS (ESI) ([M+H]+) Calcd. for C10H16NO: 166.1226,
found 166.1233.
3-((4-methylbenzyl)amino)propan-1-ol s1-b. Following the 
general procedure with 4-methyl benzaldehyde as starting material. Yield: 76%. 1H NMR 
(400 MHz, CDCl3) δ 7.16 (d, J = 8.0 Hz, 2H), 7.10 (d, J = 7.9 Hz, 2H), 3.76 (t, J = 5.3 Hz, 
2H), 3.71 (s, 2H), 3.23 (br, 2H), 2.84 (t, J = 5.8 Hz, 2H), 2.31 (s, 3H), 1.71 – 1.66 (m, 2H). 
13C NMR (125 MHz, CDCl3) δ 136.62, 136.28, 129.03, 128.00, 63.67, 53.47, 48.80, 30.75, 
20.96. IR (neat, cm-1): 3260.20, 2920.68, 1515.68, 1455.33, 1182.33, 1067.94, 879.23, 
803.45. HRMS (ESI) ([M+H]+) Calcd. for C11H18NO: 180.1383, found 180.1390.
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3-((3-methoxybenzyl)amino)propan-1-ol s1-c. Following 
the general procedure with 3-methoxy benzaldehyde as starting material. Yield: 70%. 1H
NMR (500 MHz, CDCl3) δ 7.23 (t, J = 7.9 Hz, 1H), 6.87 (d, J = 7.6 Hz, 1H), 6.83 (s, 1H), 
6.79 (d, J = 8.2 Hz, 1H), 3.79 –3.76 (m, br, 7H), 3.43 (br, 2H), 2.87 (t, J = 5.7 Hz, 2H), 
1.72 (p, J = 5.6 Hz, 2H). 13C NMR (125 MHz, CDCl3) δ 159.71, 140.78, 129.44, 120.39, 
113.56, 112.68, 63.84, 55.12, 53.72, 48.95, 30.70. IR (neat, cm-1): 3294.57, 2934.71, 
1589.83, 1585.04, 1454.58, 1262.23, 1154.06, 1040.91, 855.67, 778.62, 693.43. HRMS 
(ESI) ([M+H]+) Calcd. for C11H18NO2: 196.1332, found 196.1338.
3-((2-methoxybenzyl)amino)propan-1-ol s1-d. Following the 
general procedure with 2-methoxy benzaldehyde as starting material.Yield: 73%. 1H NMR 
(500 MHz, CDCl3) δ 7.30 – 7.26 (m, 2H), 6.94 – 6.86 (m, 2H), 4.93 (br, 2H), 3.88 – 3.83
(m, 5H), 3.78 (t, J = 5.4 Hz, 2H), 2.90 (t, J = 5.4 Hz, 2H), 1.76 (p, J = 5.4 Hz, 2H). 13C
NMR (125 MHz, CDCl3) δ 157.66, 130.02, 128.44, 127.57, 120.34, 110.21, 64.66, 55.18, 
49.31, 49.25, 30.48. IR (neat, cm-1): 3306.05, 2936.56, 1601.41, 1493.10, 1463.17, 
1241.02, 1026.73, 855.05. HRMS (ESI) ([M+H]+) Calcd. for C11H18NO2: 196.1332, found
196.1339.
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3-((3,5-bis(trifluoromethyl)benzyl)amino)propan-1-ol s1-
e, Following the general procedure with 3,5-bis(trifluoromethyl) benzaldehyde as starting 
material. Yield: 63%. 1H NMR (500 MHz, CDCl3) δ 7.79 (s, 2H), 7.78 (s, 1H), 3.93 (s, 
2H), 3.80 (t, J = 5.3 Hz, 2H), 2.88 (t, J = 5.8 Hz, 2H), 2.77 (br, 2H), 1.77 (p, J = 5.6 Hz, 
2H). 13C NMR (125 MHz, CDCl3) δ 142.12, 131.75 (q, J = 33.1 Hz), 128.19, 123.29 (q, J
= 272.4 Hz), 121.21, 63.35, 53.05, 48.78, 31.18. IR (neat, cm-1): 3262.88, 2943.83, 
1622.66, 1467.68, 1372.90, 1276.12, 1155.57, 1061.61, 903.41, 842.38, 730.76. HRMS 
(ESI) ([M+H]+) Calcd. for C12H14F6NO: 302.0974, found 302.0985. 
3-((4-bromobenzyl)amino)propan-1-ol s1-f. Following the 
general procedure with 4-bromobenzaldehyde as starting material. Yield: 77%. 1H NMR 
(500 MHz, CDCl3) δ 7.44 (d, J = 8.3 Hz, 2H), 7.18 (d, J = 8.3 Hz, 2H), 3.81 (t, J = 5.4 Hz, 
2H), 3.75 (s, 2H), 2.88 (t, J = 5.7 Hz, 2H), 2.76 (br, 2H), 1.73 (p, J = 5.6 Hz, 2H). 13C NMR 
(125 MHz, CDCl3) δ 138.32, 131.52, 129.82, 120.95, 63.92, 53.19, 49.04, 30.79. IR (neat, 
cm-1): 3294.51, 3084.01, 2909.99, 1590.67, 1444.98, 1189.24, 1065.62, 1002.84, 846.05, 
799.05. HRMS (ESI) ([M+H]+) Calcd. for C10H15BrNO: 244.0332, found 244.0341.
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3-((2,4,6-trifluorobenzyl)amino)propan-1-ol s1-g.
Following the general procedure with 2,4,6-trifluorobenzaldehyde as starting material. 
Yield: 95%. 1H NMR (400 MHz, CDCl3) δ 6.64 (t, J = 7.8 Hz, 2H), 3.83 (s, 2H), 3.75 (t, J
= 5.0 Hz, 2H), 2.95 (br, 2H), 2.79 (t, J = 5.7 Hz, 2H), 1.68 (p, J = 5.3 Hz, 2H). 13C NMR 
(100 MHz, CDCl3) δ 163.04 (d, J = 15.2 Hz), 160.57 (d, J = 15.0 Hz), 111.43 (t, J = 20.4 
Hz), 100.07 (t, J = 27.3 Hz), 63.59, 48.27, 39.99, 30.80. IR (neat, cm-1): 3301.00, 2937.96, 
1625.85, 1439.90, 1169.08, 1114.84, 997.09, 839.38, 736.80. HRMS (ESI) ([M+H]+)
Calcd. for C10H13F3NO: 220.0944, found 220.0951.
3-((4-nitrilebenzyl)amino)propan-1-ol s1-h. Following the 
general procedure with 4-nitrilebenzaldehyde as starting material. Yield: 89%. 1H NMR 
(500 MHz, CDCl3) δ 7.58 (d, J = 8.2 Hz, 2H), 7.40 (d, J = 8.1 Hz, 2H), 3.82 (s, 2H), 3.75 
(t, J = 5.5 Hz, 2H), 2.94 (br, 2H), 2.83 (t, J = 5.9 Hz, 2H), 1.70 (p, J = 5.7 Hz, 2H). 13C
NMR (125 MHz, CDCl3) δ 144.69, 131.84, 128.27, 118.38, 110.48, 63.08, 53.02, 48.48, 
30.65. IR (neat, cm-1): 3244.62, 2808.20, 2228.96, 1607.81, 1460.45, 1357.12, 1064.78, 
982.87, 835.02. HRMS (ESI) ([M+H]+) Calcd. for C11H15N2O: 191.1179, found 191.1186.
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3-((4-nitrobenzyl)amino)propan-1-ol s1-i. Following the 
general procedure with 4-nitrobenzaldehyde as starting material. Yield: 86%. 1H NMR 
(500 MHz, CDCl3) δ 8.15 (d, J = 8.5 Hz, 2H), 7.45 (d, J = 8.5 Hz, 2H), 3.88 (s, 2H), 3.77 
(t, J = 5.4 Hz, 2H), 2.87 – 2.84 (m, 4H), 1.73 (p, J = 5.7 Hz, 2H). 13C NMR (125 MHz, 
CDCl3) δ 147.23, 147.08, 128.65, 123.67, 63.69, 53.21, 49.07, 31.07. IR (neat, cm-1):
3262.72, 3110.15, 2941.77, 1607.40, 1517.26, 1343.05, 1095.26, 966.70, 851.28. HRMS 
(ESI) ([M+H]+) Calcd. for C10H15N2O3: 211.1077, found 211.1086.
3-((2-chloro-4-nitrobenzyl)amino)propan-1-ol s1-j.
Following the general procedure with 2-chloro-4-nitrobenzaldehyde as starting material. 
Yield: 66%. 1H NMR (600 MHz, CDCl3) δ 8.23 (d, J = 2.5 Hz, 1H), 8.00 (dd, J = 8.7, 2.7 
Hz, 1H), 7.47 (d, J = 8.7 Hz, 1H), 3.90 (s, 2H), 3.73 (t, J = 5.6 Hz, 2H), 2.82 (t, br, J = 6.1 
Hz, 4H), 1.72 (p, J = 5.8 Hz, 2H). 13C NMR (150 MHz, CDCl3) δ 146.45, 140.35, 139.23, 
130.21, 124.33, 122.99, 62.68, 50.63, 48.17, 31.29. IR (neat, cm-1): 3270.58, 2946.16, 
1608.98, 1519.29, 1341.61, 1181.61, 1075.65, 830.25, 739.10. HRMS (ESI) ([M+H]+)
Calcd. for C10H14ClN2O3: 245.0693, found 245.0703.
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3-((3-vinylbenzyl)amino)propan-1-ol s1-k. Following the 
general procedure with 3-vinylbenzaldehyde as starting material. Yield: 85%. 1H NMR 
(400 MHz, CDCl3) δ 7.31 – 7.24 (m, 3H), 7.17 (d, J = 6.9 Hz, 1H), 6.68 (dd, J = 17.6, 10.9 
Hz, 1H), 5.73 (d, J = 17.6 Hz, 1H), 5.25 (d, J = 10.9 Hz, 1H), 3.79 – 3.77 (m, 4H), 3.21 
(br, 2H), 2.88 (t, J = 5.6 Hz, 2H), 1.71 (p, J = 5.5 Hz, 2H). 13C NMR (125 MHz, CDCl3) δ
139.43, 137.80, 136.64, 128.72, 127.69, 126.08, 125.13, 114.10, 63.93, 53.78, 49.09, 
30.75. IR (neat, cm-1): 3293.63, 2930.19, 1629.77, 1441.56, 1066.59, 990.42, 906.35, 
796.77, 713.63. HRMS (ESI) ([M+H]+) Calcd. for C12H18NO: 192.1383, found 192.1389.
(E)-3-((2-methyl-3-phenylallyl)amino)propan-1-ol s1-l.
Following the general procedure with α-methyl-trans-cinnamaldehyde as starting material. 
Yield: 73%. 1H NMR (600 MHz, CDCl3) δ 7.32 (t, J = 7.6 Hz, 2H), 7.25 (d, J = 7.1 Hz, 
2H), 7.21 (t, J = 7.3 Hz, 1H), 6.43 (s, 1H), 3.83 (t, J = 5.3 Hz, 2H), 3.57 (br, 2H), 3.34 (s, 
2H), 2.91 (t, J = 5.8 Hz, 2H), 1.91 (s, 3H), 1.75 (p, J = 5.6 Hz, 2H). 13C NMR (150 MHz, 
CDCl3) δ 137.57, 135.69, 128.80, 128.06, 126.91, 126.35, 64.07, 58.16, 48.95, 30.58, 
16.52. IR (neat, cm-1):  3289.52, 2932.76, 1489.80, 1442.46, 1070.76, 916.93, 743.02. 
HRMS (ESI) ([M+H]+) Calcd. for C13H20NO: 206.1544, found 206.1545.
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3-((3-phenylprop-2-yn-1-yl)amino)propan-1-ol s1-m.
Following the general procedure with 3-phenylpropiolaldehyde as starting material. Yield: 
70%. 1H NMR (600 MHz, CDCl3) δ 7.42 – 7.40 (m, 2H), 7.30 – 7.28 (m, 3H), 3.81 (t, J =
5.3 Hz, 2H), 3.66 (s, 2H), 3.14 (br, 2H), 3.00 (t, J = 6.0 Hz, 2H), 1.75 (p, J = 5.7 Hz, 2H). 
13C NMR (150 MHz, CDCl3) δ 131.62, 128.27, 128.15, 122.94, 86.65, 83.98, 63.54, 48.08, 
38.68, 30.77. IR (neat, cm-1):  3300.49, 2932.66, 1597.88, 1489.63, 1331.61, 1070.10, 
758.97. HRMS (ESI) ([M+H]+) Calcd. for C12H16NO: 190.1238, found 190.1232.
3-(phenethylamino)propan-1-ol s1-n. Following the general 
procedure with 2-phenylacetaldehyde as starting material. Yield: 93%. 1H NMR (500 
MHz, CDCl3) δ 7.31 – 7.18 (m, 5H), 3.79 (t, J = 5.1 Hz, 2H), 3.54 (br, 2H), 2.91 – 2.87
(m, 4H), 2.80 (t, J = 6.9 Hz, 2H), 1.69 (p, J = 5.3 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ
139.39, 128.61, 128.48, 126.25, 63.83, 50.70, 49.44, 35.90, 30.45. IR (neat, cm-1): 3290.02, 
3026.79, 2931.95, 1602.66, 1453.40, 1110.09, 1067.97, 735.08, 698.60. HRMS (ESI) 
([M+H]+) Calcd. for C11H18NO: 180.1383, found 180.1388.
3-((cyclohexylmethyl)amino)propan-1-ol s1-o. Following the 
general procedure with cyclohexanecarbaldehyde as starting material. Yield: 59%. 1H
Chapter 4. Enantioselective C–H Alkylation with In Situ-Generated Alkyldiazomethanes   
NMR (600 MHz, CDCl3) δ 3.80 (t, J = 5.2 Hz, 2H), 3.49 (br, 2H), 2.87 (t, J = 5.6 Hz, 2H), 
2.44 (d, J = 6.6 Hz, 2H), 1.72 – 1.63 (m, 7H), 1.44 – 1.39 (m, 1H), 1.25 – 1.10 (m, 3H), 
0.93 – 0.87 (m, 2H). 13C NMR (150 MHz, CDCl3) δ 64.54, 56.53, 50.38, 37.72, 31.31, 
30.30, 26.55, 25.97. IR (neat, cm-1): 3255.27, 2920.26, 1447.79, 1264.73, 1068.06, 890.14, 
733.69. HRMS (ESI) ([M+H]+) Calcd. for C10H22NO: 172.1696, found 172.1703.
benzyl N-(tert-butoxycarbonyl)-N-(3-hydroxypropyl)
glycinate s1-p. Prepared according to the literature15 from benzyl 2-bromoacetate (6.0 
mmol) and 3-aminopropan-1-ol (7.2 mmol) in two steps. Rf = 0.32 (ethyl acetate/hexanes: 
1/2). Yield: 71%. 1H NMR (500 MHz, CDCl3) a mixture of amide rotamers. δ 7.35 – 7.33 
(m, br, 5H), 5.17 and 5.14 (s, 2H), 4.01 and 3.89 (s, 2H), 3.66 – 3.58 (m, 2H), 3.47 – 3.37 
(m, 3H), 1.65 – 1.63 (m, 2H), 1.48 and 1.36 (s, 9H). 13C NMR (125 MHz, CDCl3) major 
amide rotamer. δ 172.43, 159.13, 137.99, 131.28, 131.19, 131.16, 83.62, 69.54, 61.00, 
52.57, 47.32, 33.28, 30.73. IR (neat, cm-1): 3465.51, 2976.12, 1753.43, 1693.74, 1404.40, 
1251.90, 1171.16, 756.23. HRMS (ESI) ([M+H]+) Calcd. for C17H26NO5: 324.1811, found
324.1821.
3-((pyridin-3-ylmethyl)amino)propan-1-ol s1-q. Following the 
general procedure with nicotinaldehyde as starting material. Yield: 85%. 1H NMR (500 
MHz, CDCl3) δ 8.50 (s, 1H), 8.48 (d, J = 4.7 Hz, 1H), 7.63 (d, J = 7.8 Hz, 1H), 7.32 – 7.16
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(m, 1H), 3.78 (s, 2H), 3.76 (t, J = 5.5 Hz, 2H), 2.96 (br, 2H), 2.85 (t, J = 5.9 Hz, 2H), 1.72 
(p, J = 5.4 Hz, 2H).  13C NMR (125 MHz, CDCl3) δ 149.54, 148.62, 135.77, 134.91, 123.46, 
63.65, 51.24, 48.99, 31.03. IR (neat, cm-1): 3262.41, 2933.04, 1577.84, 1425.22, 1288.33, 
1060.69, 791.05, 710.90. HRMS (ESI) ([M+H]+) Calcd. for C9H15N2O: 167.1179, found
167.1186.
3-((pyridin-2-ylmethyl)amino)propan-1-ol s1-r. Following the 
general procedure with picolinaldehyde as starting material. Yield: 82%. 1H NMR (500 
MHz, CDCl3) δ 8.51 (d, J = 4.7 Hz, 1H), 7.61 (td, J = 7.7, 1.7 Hz, 1H), 7.24 (d, J = 7.8 Hz, 
1H), 7.13 (dd, J = 7.1, 5.3 Hz, 1H), 3.87 (s, 2H), 3.77 (t, J = 5.4 Hz, 2H), 3.52 (br, 2H), 
2.86 (t, J = 5.9 Hz, 2H), 1.71 (p, J = 5.5 Hz, 2H). 13C NMR (125 MHz, CDCl3) δ 158.91, 
149.18, 136.51, 122.30, 122.03, 63.44, 54.77, 48.85, 30.94. IR (neat, cm-1): 3375.78, 
2952.78, 1595.26, 1437.42, 1219.35, 1153.47, 1066.09, 999.69, 767.24. HRMS (ESI) 
([M+H]+) Calcd. for C9H15N2O: 167.1179, found 167.1182.
3-((pyridin-4-ylmethyl)amino)propan-1-ol s1-s. Following the 
general procedure with isonicotinaldehyde as starting material. Yield: 65%. 1H NMR (600 
MHz, CDCl3) δ 8.53 (d, J = 5.8 Hz, 2H), 7.22 (d, J = 5.6 Hz, 2H), 3.80 – 3.78 (m, 4H), 
3.03 (br, 2H), 2.86 (t, J = 5.9 Hz, 2H), 1.74 (p, J = 5.7 Hz, 2H). 13C NMR (125 MHz, 
CDCl3) δ 149.80, 148.59, 122.89, 63.52, 52.68, 48.95, 31.11. IR (neat, cm-1): 3270.90, 
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2928.93, 1602.93, 1415.46, 1220.16, 1063.87, 1001.81, 796.89. HRMS (ESI) ([M+H]+)
Calcd. for C9H15N2O: 167.1179, found 167.1186.
3-((quinolin-4-ylmethyl)amino)propan-1-ol s1-t. Following 
the general procedure with quinoline-4-carbaldehyde as starting material. Yield: 93%. 1H
NMR (400 MHz, CDCl3) δ 8.76 (d, J = 4.4 Hz, 1H), 8.05 (d, J = 8.4 Hz, 1H), 7.94 (d, J =
8.3 Hz, 1H), 7.63 (t, J = 7.6 Hz, 1H), 7.49 (t, J = 7.6 Hz, 1H), 7.30 (d, J = 4.3 Hz, 1H), 
4.15 (s, 2H), 3.73 (t, J = 5.5 Hz, 2H), 3.09 (br, 2H), 2.88 (t, J = 6.0 Hz, 2H), 1.72 (p, J =
5.7 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 150.03, 147.93, 144.95, 129.91, 129.08, 
126.67, 126.53, 122.89, 119.61, 62.87, 49.92, 49.00, 31.34. IR (neat, cm-1): 3271.45, 
2929.27, 1592.97, 1424.22, 1239.68, 1067.21, 842.69, 752.92. HRMS (ESI) ([M+H]+)
Calcd. for C13H17N2O: 217.1335, found 217.1346.
tert-butyl 3-(((3-hydroxypropyl)amino)methyl)-1H-indole-
1-carboxylate s1-u. Following the general procedure with tert-butyl 3-formyl-1H-indole-
1-carboxylate as starting material. Yield: 95%. 1H NMR (400 MHz, CDCl3) δ 8.13 (d, J =
7.5 Hz, 1H), 7.57 (d, J = 7.7 Hz, 1H), 7.50 (s, 1H), 7.32 (t, J = 7.6 Hz, 1H), 7.23 (t, J = 7.4 
Hz, 1H), 3.91 (s, 2H), 3.81 (t, J = 5.3 Hz, 2H), 3.00 – 2.93 (m, 4H), 1.76 – 1.66 (m, 11H). 
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13C NMR (100 MHz, CDCl3) δ 149.66, 135.64, 129.74, 124.49, 123.61, 122.59, 118.92, 
118.76, 115.29, 83.60, 64.06, 49.45, 44.51, 30.84, 28.17. IR (neat, cm-1): 3301.59, 
2977.45, 1727.67, 1475.02, 1450.57, 1368.04, 1253.96, 1154.95, 1076.59, 855.37, 744.24. 
HRMS (ESI) ([M+H]+) Calcd. for C17H25N2O3: 305.1860, found 305.1875.
3-((thiophen-3-ylmethyl)amino)propan-1-ol s1-v. Following 
the general procedure with thiophene-3-carbaldehyde as starting material. Yield: 72%. 1H
NMR (600 MHz, CDCl3) δ 7.28 (dd, J = 4.9, 3.0 Hz, 1H), 7.11 (d, J = 2.2 Hz, 1H), 7.03 
(d, J = 4.9 Hz, 1H), 3.81 – 3.79 (m, 4H), 3.14 (br, 2H), 2.88 (t, J = 5.8 Hz, 2H), 1.71 (p, J
= 5.5 Hz, 2H). 13C NMR (150 MHz, CDCl3) δ 140.57, 127.44, 125.89, 121.73, 64.18, 
49.25, 48.73, 30.76. IR (neat, cm-1): 3276.04, 3101.66, 2932.17, 1440.79, 1235.84, 
1064.68, 913.06, 855.68, 771.00. HRMS (ESI) ([M+H]+) Calcd. for C8H14NOS: 172.0791,
found 172.0794.
3-((benzo[b]thiophen-3-ylmethyl)amino)propan-1-ol s1-w.
Following the general procedure with benzo[b]thiophene-3-carbaldehyde as starting 
material. Yield: 99%. 1H NMR (500 MHz, CDCl3) δ 7.86 (d, J = 7.7 Hz, 1H), 7.78 (d, J =
7.9 Hz, 1H), 7.41 – 7.29 (m, 2H), 7.29 (s, 1H), 4.02 (s, 2H), 3.80 (t, J = 5.3 Hz, 2H), 3.14 
(br, 2H), 2.95 (t, J = 5.8 Hz, 2H), 1.74 (p, J = 5.5 Hz, 2H). 13C NMR (125 MHz, CDCl3) δ
140.56, 138.09, 134.23, 124.36, 124.06, 123.26, 122.84, 121.46, 63.89, 49.41, 47.43, 
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30.84. IR (neat, cm-1): 3292.69, 2925.84, 1495.15, 1426.29, 1255.62, 1067.71, 836.00, 
752.78. HRMS (ESI) ([M+H]+) Calcd. for C12H16NOS: 222.0947, found 222.0958.
3-((ferrocenyl)amino)propan-1-ol s1-x. Following the general 
procedure with ferrocenecarboxaldehyde as starting material. Yield: 45%. 1H NMR (500 
MHz, CDCl3) δ 4.15 – 4.09 (m, 9H), 3.79 (t, J = 5.2 Hz, 2H), 3.50 (s, 2H), 3.22 (br, 2H), 
2.88 (t, J = 5.6 Hz, 2H), 1.69 (p, J = 5.4 Hz, 2H). 13C NMR (125 MHz, CDCl3) δ 86.16, 
68.33, 68.19, 67.74, 64.22, 49.44, 48.67, 30.59. IR (neat, cm-1): 3274.40, 2942.31, 2360.19, 
1450.25, 1341.97, 1272.79, 1162.09, 1041.03, 913.33, 801.98. HRMS (ESI) ([M+H]+)
Calcd. for C14H20FeNO: 274.0889, found 274.0891.
3-(benzyloxy)propan-1-ol s1-y, known compound.16 Prepared 
from benzyl bromide (10 mmol) and propane 1,3-diol (10 mmol) according to the 
literature.16 Rf = 0.35 (ethyl acetate/hexanes: 1/3).Yield: 71%. 1H NMR (400 MHz, CDCl3)
δ 7.37 – 7.27 (m, 5H), 4.53 (s, 2H), 3.78 (s, 2H), 3.78 – 3.65 (m, 2H), 2.33 (s, 1H), 1.87 
(p, J = 5.6 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 138.04, 128.41, 127.67, 127.61, 73.24, 
69.34, 61.85, 32.09.
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2-(phenethylamino)ethan-1-ol s1-z. Following the general 
procedure with 2-phenylacetaldehyde and 2-aminoethan-1-ol as starting material. Yield: 
45%. 1H NMR (600 MHz, CDCl3) δ 7.30 (t, J = 7.6 Hz, 2H), 7.22 – 7.20 (m, 3H), 3.63 (t, 
J = 5.2 Hz, 2H), 2.91 (t, J = 7.2 Hz, 2H), 2.81 (t, J = 7.1 Hz, 2H), 2.78 (t, J = 5.2 Hz, 2H), 
2.51 (br, 2H). 13C NMR (150 MHz, CDCl3) δ 139.72, 128.66, 128.47, 126.20, 60.67, 50.87, 
50.56, 36.28. HRMS (ESI) ([M+H]+) Calcd. for C10H16NO: 166.1232, found 166.1231.
(R)-3-((1-phenylethyl)amino)propan-1-ol s1-aa, known 
compound.17 Prepared according to the literature17 from optically pure (R)-(+)-1-
phenylethylamine. Yield: 78%. 1H NMR (500 MHz, CDCl3) δ 7.35 – 7.23 (m, 5H), 3.80 –
3.72 (m, 3H), 3.18 (br, 2H), 2.79 – 2.74 (m, 1H), 2.67 – 2.63 (m, 1H), 1.75 – 1.67 (m, 1H), 
1.64 – 1.57 (m, 1H), 1.36 (d, J = 6.7 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 144.76, 
128.54, 127.08, 126.44, 64.34, 58.61, 47.78, 31.18, 24.17.
Chapter 4. Enantioselective C–H Alkylation with In Situ-Generated Alkyldiazomethanes   
4.4.4 General Procedure for Preparation of tert-Butyl (3-Oxopropyl)carbamate 
Derivative s2
Step 1: To a solution of s1 (5 mmol) and triethylamine (1.5 equiv.) in DCM (30.0 
mL), di-tert-butyl dicarbonate (1.1 equiv.) was added portionwise at 0 oC. The reaction was 
then stirred at room temperature and monitored by TLC. After the reaction was completed, 
the mixture was filtrated through a short pad of silica and eluted with ethyl acetate. The 
filtrate was then evaporated and concentrated under vacuum. The obtained raw compound 
was directly used without further purification.
Step 2 (Swern oxidation via the standard procedure18): To a solution of oxalyl 
chloride (1.5 equiv.) in DCM (30 mL) at -78 oC was added dimethyl sulfoxide (3.0 equiv.) 
dropwise via syringe. After stirring for 20 min at -78 oC, a solution of N-Boc protected s1
(crude product from previous amine protecting step) in DCM (5.0 mL) was added dropwise 
via syringe pump at a rate of 10 mL/hr. The solution was then stirred for 30 min at -78 oC, 
followed by the dropwise addition of triethylamine (4.5 equiv.). After 10 min, the reaction 
mixture was warmed up to room temperature, poured into brine (30 mL) and stirred for 
another 10 min. The layers were then separated and the aqueous layer was extracted with 
DCM (3 x 20 mL). The combined organic layers were dried over anhydrous Na2SO4,
Chapter 4. Enantioselective C–H Alkylation with In Situ-Generated Alkyldiazomethanes   
filtered and concentrated under vacuum. The oxidized product s2 was further purified by 
flash chromatography.
tert-butyl benzyl(3-oxopropyl)carbamate s2-a. Following the 
general procedure with s1-a as starting material. Yield: 77%. Rf = 0.38 (ethyl 
acetate/hexanes: 1/5). 1H NMR (500 MHz, CDCl3): a mixture of amide rotamers. δ 9.73 
(br, 1H), 7.34 – 7.22 (m, 5H), 4.44 (s, 2H), 3.52 – 3.47 (m, br, 2H), 2.65 – 2.59 (m, br, 2H), 
1.45 (s, 9H). 13C NMR (125 MHz, CDCl3): major isomer δ 201.01, 155.53, 138.19, 128.58, 
127.77, 127.34, 80.27, 51.35, 43.05, 40.82, 28.38. IR (neat, cm-1): 2976.59, 1722.96, 
1686.92, 1454.19, 1413.06, 1365.85, 1244.53, 1162.92, 1126.53, 874.73, 734.29, 699.92. 
HRMS (ESI) ([M+H]+) Calcd. for C15H22NO3: 264.1594, found 264.1598.
tert-butyl (4-methylbenzyl)(3-oxopropyl)carbamate s2-b.
Following the general procedure with s1-b as starting material. Yield: 83%. Rf = 0.52 (ethyl 
acetate/hexanes: 1/3). 1H NMR (400 MHz, CDCl3): a mixture of amide rotamers. δ 9.71 
(br, 1H), 7.11 (m, 4H), 4.39 (s, 2H), 3.48 (m, br, 2H), 2.62 (m, br, 2H), 2.32 (s, 3H), 1.45 
(s, 9H). 13C NMR (100 MHz, CDCl3): major isomer δ 201.02, 155.51, 136.99, 135.00, 
129.23, 127.23, 80.19, 50.97, 43.02, 40.63, 28.37, 21.04. IR (neat, cm-1): 2975.20, 1722.62, 
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1687.11, 1463.61, 1407.44, 1365.32, 1243.63, 1162.95, 1126.59, 877.69, 772.39. HRMS 
(ESI) ([M+H]+) Calcd. for C16H24NO3: 278.1751, found 278.1751.
tert-butyl (3-methoxybenzyl)(3-oxopropyl)carbamate s2-
c. Following the general procedure with s1-c as starting material. Yield: 71%. Rf = 0.24 
(ethyl acetate/hexanes: 1/5). 1H NMR (500 MHz, CDCl3): a mixture of amide rotamers. δ 
9.73 (br, 1H), 7.23 (t, J = 7.9 Hz, 1H), 6.82 – 6.80 (m, 3H), 4.42 (s, 2H), 3.79 (s, 3H), 3.52 
– 3.47 (m, br, 2H), 2.66 – 2.59 (m, br, 2H), 1.46 (s, 9H). 13C NMR (125 MHz, CDCl3): 
major isomer δ 201.01, 159.85, 155.50, 139.86, 129.58, 119.50, 112.82, 112.70, 80.27, 
55.16, 51.30, 43.04, 41.03, 28.38. IR (neat, cm-1): 2974.55, 1721.94, 1686.89, 1463.46, 
1410.88, 1365.52, 1245.63, 1161.91, 1048.31, 860.09, 773.10. HRMS (ESI) ([M+H]+)
Calcd. for C16H24NO4: 294.1700, found 294.1702.
tert-butyl (2-methoxybenzyl)(3-oxopropyl)carbamate s2-d.
Following the general procedure with s1-d as starting material. Yield: 81%. Rf = 0.35 (ethyl 
acetate/hexanes: 1/2). 1H NMR (500 MHz, CDCl3): a mixture of amide rotamers. δ 9.75 
(br, 1H), 7.26 – 7.14 (m, 2H), 6.94 – 6.83 (m, 2H), 4.43 (s, 2H), 3.81 (s, 3H), 3.57 – 3.29
(m, 2H), 2.65 – 2.49 and 1.84 – 1.81 (m, 2H), 1.43 (s, 9H). 13C NMR (125 MHz, CDCl3): 
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major isomer δ 201.29, 157.11, 155.81, 129.09, 128.37, 126.11, 120.42, 110.18, 80.00, 
55.20, 45.98, 43.04, 41.17, 28.38. IR (neat, cm-1):  2974.99, 1726.38, 1687.07, 1462.64, 
1412.92, 1365.61, 1239.92, 1159.50, 1028.62, 877.77, 751.50. HRMS (ESI) ([M+H]+)
Calcd. for C16H24NO4: 294.1700, found 294.1703. 
tert-butyl (3,5-bis(trifluoromethyl)benzyl)(3-oxopropyl) 
carbamate s2-e. Following the general procedure with s1-e as starting material. Yield: 
80%. Rf = 0.54 (ethyl acetate/hexanes: 1/3). 1H NMR (400 MHz, CDCl3): a mixture of 
amide rotamers. δ 9.77 (br, 1H), 7.77 – 7.66 (m, 3H), 4.54 (s, 2H), 3.70 – 3.52 (m, br, 2H), 
2.75 – 2.63 (m, br, 2H), 1.40 (s, 9H). 13C NMR (100 MHz, CDCl3): major isomer δ 200.57, 
155.38, 141.27, 133.88 (q, J = 33.2 Hz), 127.25, 123.18 (q, J = 272.6 Hz), 121.27, 81.11,
51.08, 43.29, 41.44, 28.17. IR (neat, cm-1): 2979.02, 1692.92, 1469.97, 1368.25, 1276.14, 
1165.47, 1126.56, 901.45, 705.93, 681.71. HRMS (ESI) ([M+H]+) Calcd. for 
C17H20F6NO3: 400.1342, found 400.1351.
tert-butyl (4-bromobenzyl)(3-oxopropyl)carbamate s2-f.
Following the general procedure with s1-f as starting material. Yield: 79%. Rf = 0.36 (ethyl 
acetate/hexanes: 1/5). 1H NMR (400 MHz, CDCl3): a mixture of amide rotamers. δ 9.73 
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(br, 1H), 7.43 (d, J = 8.3 Hz, 2H), 7.09 (d, br, 2H), 4.38 (s, 2H), 3.47 and 3.25 (br, 2H), 
2.66 and 2.49 (br, 2H), 1.44 (s, 9H). 13C NMR (100 MHz, CDCl3): major isomer δ 200.78,
155.42, 137.26, 131.68, 128.79, 121.16, 80.49, 50.92, 43.17, 40.91, 28.35. IR (neat, cm-1):  
2974.88, 1723.02, 1686.67, 1487.44, 1401.05, 1365.44, 1244.47, 1161.47, 1127.02, 
1010.80, 877.52, 771.38. HRMS (ESI) ([M+H]+) Calcd. for C15H21BrNO3: 342.0699,
found 342.0698.
tert-butyl (2,4,6-trifluorobenzyl)(3-oxopropyl)carbamate s2-
g. Following the general procedure with s1-g as starting material. Yield: 63%. Rf = 0.35 
(ethyl acetate/hexanes: 1/5). 1H NMR (500 MHz, CDCl3): a mixture of amide rotamers. δ 
9.74 (br, 1H), 6.65 (t, J = 8.2 Hz, 2H), 4.49 (s, 2H), 3.52 (br, 2H), 2.65 (br, 2H), 1.42 (s, 
9H). 13C NMR (125 MHz, CDCl3): major isomer δ 200.86, 175.22, 161.86 (d, J = 248.9 
Hz), 154.85, 110.20, 100.27 (t, J = 27.4 Hz), 80.57, 42.90, 40.89, 39.22, 28.21. IR (neat, 
cm-1): 2978.33, 1690.07, 1495.83, 1414.50, 1366.58, 1247.18, 1164.64, 1118.48, 1046.76, 
998.68, 840.75, 737.30. HRMS (ESI) ([M+H]+) Calcd. for C15H19F3NO3: 318.1312, found 
318.1311.
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tert-butyl (4-nitrilebenzyl)(3-oxopropyl)carbamate s2-h.
Following the general procedure with s1-h as starting material. Yield: 82%. Rf = 0.28 (ethyl 
acetate/hexanes: 1/3). 1H NMR (500 MHz, CDCl3): a mixture of amide rotamers. δ 9.65 
(br, 1H), 7.62 (d, J = 8.0 Hz, 2H), 7.32 (br, 2H), 4.49 (s, 2H), 3.52 and 3.47 (br, 2H), 2.70 
(br, 2H), 1.48 and 1.39 (s, 9H). 13C NMR (125 MHz, CDCl3): major isomer δ 200.70,
155.23, 144.13, 132.40, 127.51, 118.68, 111.13, 80.76, 51.39, 43.19, 41.34, 28.28. IR (neat, 
cm-1):  2976.97, 2228.94, 1721.65, 1687.14, 1464.06, 1407.89, 1366.59, 1246.91, 1162.56, 
911.52, 729.82. HRMS (ESI) ([M+Na]+) Calcd. for C16H20NaN2O3: 311.1366, found
311.1365.
tert-butyl (4-nitrobenzyl)(3-oxopropyl)carbamate s2-i.
Following the general procedure with s1-i as starting material. Yield: 75%. Rf = 0.17 (ethyl 
acetate/hexanes: 1/3). 1H NMR (500 MHz, CDCl3): a mixture of amide rotamers. δ 9.77 
(br, 1H), 8.18 (d, J = 8.4 Hz, 2H), 7.37 (br, 2H), 4.54 (s, 2H), 3.54 and 3.49 (br, 2H), 2.75 
and 2.69 (br, 2H), 1.49 and 1.39 (s, 9H). 13C NMR (125 MHz, CDCl3): major isomer δ
200.66, 155.19, 147.24, 145.88, 127.50, 123.85, 80.88, 51.27, 43.24, 41.42, 28.30. IR (neat, 
cm-1): 2976.04, 1687.82, 1519.17, 1407.08, 1343.25, 1245.80, 1161.45, 1129.70, 857.77, 
736.67. HRMS (ESI) ([M+H]+) Calcd. for C15H21N2O5: 309.1445, found 309.1442.
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tert-butyl (2-chloro-4-nitrobenzyl)(3-oxopropyl)
carbamate s2-j. Following the general procedure with s1-j as starting material. Yield: 
63%. Rf = 0.28 (ethyl acetate/hexanes: 1/3). 1H NMR (600 MHz, CDCl3): a mixture of 
amide rotamers. δ 9.80 (br, 1H), 8.08 – 8.07 (m, br, 2H), 7.53 (d, J = 8.3 Hz, 1H), 4.60 (s, 
2H), 3.60 (br, 2H), 2.79 (br, 2H), 1.52 and 1.39 (s, 9H). 13C NMR (150 MHz, CDCl3): 
major isomer δ 200.01, 155.06, 146.88, 139.53, 137.63, 130.52, 123.19, 122.72, 81.12, 
48.74, 43.16, 41.64, 28.26. IR (neat, cm-1):  2974.99, 2358.32, 1721.79, 1690.64, 1524.76, 
1345.34, 1165.17, 1050.10, 925.45, 742.97. HRMS (ESI) ([M+H]+) Calcd. for 
C15H20ClN2O5: 343.1060, found 343.1061. 
tert-butyl (3-vinylbenzyl)(3-oxopropyl)carbamate s2-k.
Following the general procedure with s1-k as starting material.Yield: 75%. Rf = 0.33 (ethyl 
acetate/hexanes: 1/5). 1H NMR (400 MHz, CDCl3): a mixture of amide rotamers. δ 9.72 
(br, 1H), 7.29 – 7.10 (m, 4H), 6.68 (dd, J = 17.6, 10.9 Hz, 1H), 5.72 (d, J = 17.6 Hz, 1H), 
5.23 (d, J = 10.9 Hz, 1H), 4.42 (s, 2H), 3.50 (br, 2H), 2.64 (br, 2H), 1.44 (s, 9H). 13C NMR 
(100 MHz, CDCl3): major isomer δ 200.94, 155.51, 138.46, 137.87, 136.58, 128.76, 
126.61, 125.58, 125.22, 114.13, 80.29, 51.24, 43.08, 40.84, 28.36. IR (neat, cm-1): 2975.95, 
1721.79, 1686.69, 1464.52, 1411.79, 1365.50, 1245.58, 1162.14, 1125.68, 990.63, 713.79. 
HRMS (ESI) ([M+H]+) Calcd. for C17H24NO3: 290.1751, found 290.1754.
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tert-butyl (E)-(2-methyl-3-phenylallyl)(3-oxopropyl)
carbamate s2-l. Following the general procedure with s1-l as starting material. Yield: 
76%. Rf = 0.43 (ethyl acetate/hexanes: 1/3). 1H NMR (600 MHz, CDCl3): a mixture of 
amide rotamers. δ 9.80 (br, 1H), 7.33 (t, J = 7.6 Hz, 2H), 7.26 – 7.21 (m, 3H), 6.32 (s, 1H), 
3.98 and 3.93 (br, 2H), 3.56 (br, 2H), 2.72 (br, 2H), 1.82 (s, 3H), 1.47 (s, 9H). 13C NMR 
(150 MHz, CDCl3): major isomer δ 201.07, 155.52, 137.35, 134.47, 128.82, 128.15, 
126.94, 126.50, 80.09, 55.66, 43.09, 40.49, 28.38, 15.57. IR (neat, cm-1):  2974.97, 
2361.33, 1721.79, 1687.60, 1415.91, 1365.91, 1248.45, 1163.36, 1021.08, 746.89. HRMS 
(ESI) ([M+H]+) Calcd. for C18H26NO3: 304.1926, found 304.1913.
tert-butyl (3-oxopropyl)(3-phenylprop-2-yn-1-yl)carbamate 
s2-m. Following the general procedure with s1-m as starting material.Yield: 57%. Rf =
0.48 (ethyl acetate/hexanes: 1/3). 1H NMR (600 MHz, CDCl3): a mixture of amide 
rotamers. δ 9.82 (br, 1H), 7.41 – 7.29 (m, 5H), 4.32 and 4.25 (br, 2H), 3.70 (t, J = 6.7 Hz, 
2H), 2.82 – 2.80 (m, 2H), 1.48 (s, 9H). 13C NMR (150 MHz, CDCl3): major isomer δ
200.73, 154.80, 131.63, 130.08, 128.34, 122.65, 84.82, 83.41, 80.71, 43.14, 40.89, 38.27, 
28.35. IR (neat, cm-1):  2976.09, 1721.79, 1689.02, 1409.36, 1366.66, 1248.77, 1160.17, 
862.86, 758.50. HRMS (ESI) ([M+H]+) Calcd. for C17H22NO3: 288.1611, found 288.1600. 
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tert-butyl (3-oxopropyl)(phenethyl)carbamate s2-n.
Following the general procedure with s1-n as starting material. Yield: 58%. Rf = 0.48 (ethyl 
acetate/hexanes: 1/3). 1H NMR (400 MHz, CDCl3): a mixture of amide rotamers. δ 9.73 
(br, 1H), 7.29 – 7.16 (m, 5H), 3.40 (br, 4H), 2.80 (br, 2H), 2.63 and 2.57 (br, 2H), 1.41 (s, 
9H). 13C NMR (100 MHz, CDCl3): major isomer δ 201.03, 155.33, 139.04, 128.85, 128.49, 
126.32, 79.82, 49.94, 43.33, 41.49, 35.28, 28.35. IR (neat, cm-1):  2975.04, 1721.62, 
1685.77, 1454.24, 1413.22, 1365.29, 1248.67, 1161.74, 1123.58, 880.75, 736.43, 700.08. 
HRMS (ESI) ([M+H]+) Calcd. for C16H24NO3: 278.1751, found 278.1753. 
tert-butyl (cyclohexylmethyl)(3-oxopropyl)carbamate s2-o.
Following the general procedure with s1-o as starting material. Yield: 87%. Rf = 0.55 (ethyl 
acetate/hexanes: 1/3). 1H NMR (500 MHz, CDCl3): a mixture of amide rotamers. δ 9.78 (t, 
J = 1.4 Hz, 1H), 3.49 (br, 2H), 3.01 (br, 2H), 2.69 (br, 2H), 1.72 – 1.62 (m, 6H), 1.43 (s, 
9H), 1.24 – 1.12 (m, 3H), 0.89 (br, 2H). 13C NMR (125 MHz, CDCl3): major isomer δ
201.16, 155.75, 79.59, 53.97, 43.10, 41.52, 37.36, 30.81, 28.38, 26.44, 25.89. IR (neat, cm-
1):  2923.55, 1723.08, 1684.57, 1415.73, 1365.14, 1170.37, 1147.59, 961.17, 877.61, 
771.73. HRMS (ESI) ([M+H]+) Calcd. for C15H28NO3: 270.2064, found 270.2066. 
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benzyl N-(tert-butoxycarbonyl)-N-(3-oxopropyl)glycinate 
s2-p. Prepared from PCC (1.5 equiv.) oxidation of corresponding alcohol (2 mmol) in 
DCM (10 mL) at room temperature according to the literature.19 Rf = 0.40 (ethyl 
acetate/hexanes: 1/3). Yield: 68%. 1H NMR (500 MHz, CDCl3): a mixture of amide 
rotamers. δ 9.75 (br, 1H), 7.35 (m, br, 5H), 5.15 (s, 2H), 4.06 and 3.99 (s, 2H), 3.58 – 3.55 
(m, 2H), 2.81 and 2.74 (t, J = 6.1 Hz, 2H), 1.47 and 1.34 (s, 9H). 13C NMR (125 MHz, 
CDCl3): major isomer δ 201.22, 170.10, 155.06, 135.41, 128.58, 128.42, 128.24, 80.57, 
66.79, 50.88, 43.41, 42.50, 28.09. IR (neat, cm-1): 2926.99, 1750.26, 1700.34, 1457.77, 
1367.63, 1173.24, 914.23, 736.59. HRMS (ESI) ([M+H]+) Calcd. for C17H24NO5:
322.1659, found 322.1654. 
tert-butyl (3-oxopropyl)(pyridin-3-ylmethyl)carbamate s2-q.
Following the general procedure with s1-q as starting material. Yield: 71%. Rf = 0.20 (ethyl 
acetate/hexanes: 2/1). 1H NMR (500 MHz, CDCl3): a mixture of amide rotamers. δ 9.75 
(br, 1H), 8.52 – 8.50 (m, br, 2H), 7.57 (br, 1H), 7.26 (dd, J = 7.4, 5.1 Hz, 1H), 4.45 (s, 2H), 
3.51 (br, 2H), 2.71 and 2.66 (br, 2H), 1.44 (s, 9H). 13C NMR (125 MHz, CDCl3): major 
isomer δ 200.70, 155.38, 148.84, 135.48, 134.83, 133.83, 123.52, 80.70, 49.19, 43.21, 
41.07, 28.33. IR (neat, cm-1):  2975.77, 1720.62, 1686.85, 1478.44, 1409.44, 1365.81, 
1249.38, 1162.07, 1129.97, 875.86, 713.32. HRMS (ESI) ([M+H]+) Calcd. for 
C14H21N2O3: 265.1547, found 265.1556. 
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tert-butyl (3-oxopropyl)(pyridin-2-ylmethyl)carbamate s2-r.
Following the general procedure with s1-r as starting material. Yield: 74%. Rf = 0.20 (ethyl 
acetate/hexanes: 2/1). 1H NMR (500 MHz, CDCl3): a mixture of amide rotamers. δ 9.75 
(br, 1H), 8.50 (br, 1H), 7.64 (t, J = 7.7, 1H), 7.17 – 7.15 (m, 2H), 4.55 and 4.51 (s, 2H), 
3.65 and 3.59 (br, 2H), 2.72 and 2.65 (br, 2H), 1.47 and 1.36 (s, 9H). 13C NMR (125 MHz, 
CDCl3): major isomer δ 201.01, 158.37, 155.43, 149.18, 136.60, 122.13, 120.89, 80.28, 
53.53, 43.05, 41.91, 28.28. IR (neat, cm-1):  2975.74, 1687.60, 1591.29, 1475.96, 1408.49, 
1365.67, 1246.26, 1163.19, 994.89, 878.62, 754.68. HRMS (ESI) ([M+H]+) Calcd. for 
C14H21N2O3: 265.1547, found 265.1550.
tert-butyl (3-oxopropyl)(pyridin-2-ylmethyl)carbamate s2-s.
Following the general procedure with s1-s as starting material. Yield: 35%. Rf = 0.17 (ethyl 
acetate/hexanes: 2/1). 1H NMR (500 MHz, CDCl3): a mixture of amide rotamers. δ 9.76 
(br, 1H), 8.55 – 8.53 (br, 2H), 7.11 (br, 2H), 4.44 (s, 2H), 3.54 and 3.48 (br, 2H), 2.74 and 
2.67 (br, 2H), 1.48 and 1.37 (s, 9H). 13C NMR (125 MHz, CDCl3): major isomer δ 200.66,
155.26, 149.70, 147.77, 121.70, 80.74, 50.85, 43.21, 41.52, 28.24. IR (neat, cm-1):
2976.19, 1688.57, 1601.34, 1464.30, 1409.61, 1366.01, 1249.42, 1162.43, 1065.77, 
879.94, 734.18. HRMS (ESI) ([M+H]+) Calcd. for C14H21N2O3: 265.1547, found 265.1552.
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tert-butyl (3-oxopropyl)(quinolin-4-ylmethyl)carbamate s2-t.
Following the general procedure with s1-t as starting material. Yield: 45%. Rf = 0.30 (ethyl 
acetate/hexanes: 2/1). 1H NMR (500 MHz, CDCl3): a mixture of amide rotamers. δ 9.76 
(br, 1H), 8.87 (br, 1H), 8.14 (br, 1H), 8.01 (br, 1H), 7.72 (br, 1H), 7.57 (br, 1H), 7.20 (br, 
1H), 4.96 (s, 2H), 3.60 and 3.50 (br, 2H), 2.76 and 2.63 (br, 2H), 1.51 and 1.37 (s, 9H). 13C
NMR (125 MHz, CDCl3): major isomer δ 200.21, 155.30, 150.18, 148.21, 143.20, 130.30, 
129.39, 126.82, 126.35, 122.52, 118.08, 80.89, 48.51, 43.31, 41.42, 28.32. IR (neat, cm-1):  
2975.18, 1687.63, 1509.19, 1461.66, 1409.40, 1365.69, 1161.94, 1129.36, 840.48, 756.69. 
HRMS (ESI) ([M+H]+) Calcd. for C18H23N2O3: 315.1703, found 315.1713. 
tert-butyl 3-(((tert-butoxycarbonyl)(3-oxopropyl)amino)
methyl)-1H-indole-1-carboxylate s2-u. Following the general procedure with s1-u as 
starting material. Yield: 60%. Rf = 0.41 (ethyl acetate/hexanes: 1/3). 1H NMR (500 MHz, 
CDCl3): a mixture of amide rotamers. δ 9.72 (br, 1H), 8.13 (br, 1H), 7.64 (br, 1H), 7.52 
(br, 1H), 7.33 (t, J = 7.6 Hz, 1H), 7.24 (t, J = 7.4 Hz, 1H), 4.59 (s, 2H), 3.52 and 3.46 (br, 
2H), 2.64 and 2.58 (br, 2H), 1.68 (s, 9H), 1.52 (s, 9H). 13C NMR (125 MHz, CDCl3): major 
isomer δ 200.70, 155.22, 149.54, 135.67, 129.39, 124.64, 122.70, 119.77, 119.06, 117.23, 
115.23, 83.80, 80.35, 43.30, 41.64, 39.53, 28.43, 28.16. IR (neat, cm-1):  2973.32, 1726.91, 
1673.40, 1455.50, 1363.02, 1234.48, 1153.78, 1081.96, 874.61, 752.43. HRMS (ESI) 
([M+H]+) Calcd. for C22H31N2O5: 403.2227, found 403.2234. 
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tert-butyl (3-oxopropyl)(thiophen-3-ylmethyl)carbamate s2-v. 
Following the general procedure with s1-v as starting material. Yield: 88%. Rf = 0.40 (ethyl 
acetate/hexanes: 1/4). 1H NMR (600 MHz, CDCl3): a mixture of amide rotamers. δ 9.73 
(br, 1H), 7.28 (d, br, 1H), 7.10 (br, 1H), 7.00 (br, 1H), 4.41 (s, 2H), 3.51 (br, 2H), 2.65 and 
2.58 (br, 2H), 1.47 (s, 9H). 13C NMR (150 MHz, CDCl3): major isomer δ 201.01, 155.27, 
139.20, 127.09, 126.28, 121.98, 80.27, 46.76, 43.10, 40.86, 28.39. IR (neat, cm-1):
2976.16, 1721.34, 1683.78, 1463.63, 1365.71, 1248.80, 1162.47, 1123.44, 854.76, 735.58. 
HRMS (ESI) ([M+H]+) Calcd. for C13H20NO3S: 270.1158, found 270.1162. 
tert-butyl (benzo[b]thiophen-3-ylmethyl)(3-oxopropyl)
carbamate s2-w. Following the general procedure with s1-w as starting material. Yield: 
89%. Rf = 0.29 (ethyl acetate/hexanes: 1/4). 1H NMR (500 MHz, CDCl3): a mixture of 
amide rotamers. δ 9.68 (br, 1H), 7.92 – 7.85 (m, br, 2H), 7.40 – 7.26 (m, 3H), 4.72 (s, 2H), 
3.54 and 3.47 (br, 2H), 2.62 and 2.51 (br, 2H), 1.50 (s, 9H). 13C NMR (125 MHz, CDCl3): 
major isomer δ 200.61, 155.24, 140.66, 137.92, 132.86, 124.91, 124.58, 124.26, 122.88, 
122.29, 80.49, 44.46, 43.29, 39.67, 28.43. IR (neat, cm-1):  2974.69, 1720.93, 1683.07, 
1413.06, 1364.83, 1243.88, 1162.81, 862.20, 754.75. HRMS (ESI) ([M+H]+) Calcd. for 
C17H22NO3S: 320.1315, found 320.1312.
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tert-butyl (ferrocenyl)(3-oxopropyl)carbamate s2-x. Following 
the general procedure with s1-x as starting material. Yield: 89%. Rf = 0.32 (ethyl 
acetate/hexanes: 1/3). 1H NMR (600 MHz, CDCl3): a mixture of amide rotamers. δ 9.70 
(br, 1H), 4.20 – 4.11 (m, br, 11H), 3.42 (br, 2H), 2.61 and 2.51 (br, 2H), 1.49 and 1.45 (s, 
9H). 13C NMR (150 MHz, CDCl3): major isomer δ 200.90, 155.04, 84.18, 79.97, 69.40, 
69.05, 68.59, 46.22, 43.54, 40.01, 28.45. IR (neat, cm-1): 3049.39, 2937.10, 1720.99, 
1684.63, 1414.52, 1365.01, 1249.79, 1159.30, 1105.13, 864.27, 819.97. HRMS (ESI) 
([M]+) Calcd. for C19H25FeNO3: 371.1184, found 371.1180. 
3-(benzyloxy)propanal s2-y, known compound.20 Following the 
procedure of Swern oxidation with corresponding alcohol s1-y as starting material. Yield: 
75%. Rf = 0.42 (ethyl acetate/hexanes: 1/10). 1H NMR (400 MHz, CDCl3) δ 9.80 (s, 1H), 
7.37 – 7.28 (m, 5H), 4.54 (s, 2H), 3.82 (t, J = 6.1 Hz, 2H), 2.70 (td, J = 6.1, 1.8 Hz, 2H). 
13C NMR (100 MHz, CDCl3) δ 201.08, 137.82, 128.43, 127.76, 127.68, 73.25, 63.82, 
43.86.
3-(benzylthio)propanal s2-z, known compound.21 Prepared via 
Michael addition of benzenemethanethiol (10 mmol) and 2-propenal (12 mmol) according 
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to the literature.21 Yield: 85%. Rf = 0.20 (ethyl acetate/hexanes: 1/10). 1H NMR (600 MHz, 
CDCl3) δ 9.71 (s, 1H), 7.34 – 7.24 (m, 5H), 3.74 (s, 2H), 2.71 – 2.69 (m, 2H), 2.67 – 2.64 
(m, 2H).13C NMR (150 MHz, CDCl3) δ 200.43, 137.93, 128.80, 128.58, 127.16, 43.33, 
36.54, 23.65.
tert-butyl (2-oxoethyl)(phenethyl)carbamate s2-aa. Following the 
general procedure with s1-aa as starting material. Yield: 62%. Rf = 0.40 (ethyl 
acetate/hexanes: 1/4). 1H NMR (400 MHz, CDCl3): a mixture of amide rotamers. δ 9.46 
and 9.36 (br, 1H), 7.29 – 7.13 (m, 5H), 3.81 and 3.66 (s, 2H), 3.51 and 3.47 (t, J = 7.3 Hz, 
2H), 2.82 and 2.80 (t, J = 7.3 Hz, 2H), 1.44 and 1.40 (s, 9H). 13C NMR (100 MHz, CDCl3): 
major isomer δ 198.97, 155.68, 138.62, 128.79, 128.58, 126.49, 80.57, 57.68, 50.70, 35.26, 
28.21. IR (neat, cm-1): 2975.58, 1262.42, 1735.84, 1694.64, 1455.37, 1418.21, 1367.11, 
1249.56, 1168.88, 890.59, 701.75. HRMS (ESI) ([M+H]+) Calcd. for C15H22NO3:
264.1601, found 264.1600.
tert-butyl (R)-(3-oxopropyl)(1-phenylethyl)carbamate s2-ab.
Following the general procedure with s1-ab as starting material. Yield: 61%. Rf = 0.32 
(ethyl acetate/hexanes: 1/4). 1H NMR (400 MHz, CDCl3) δ 9.59 (br, 1H), 7.32 (m, br, 5H), 
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5.47 and 5.37 (br, 1H), 3.32 (br, 2H), 2.51 and 2.37 (br, 2H), 1.53 and 1.48 (br, 12H). 13C
NMR (100 MHz, CDCl3): major isomer δ 200.95, 155.46, 141.24, 128.18, 127.40, 126.85, 
80.20, 53.41, 44.50, 36.72, 28.33, 17.02. IR (neat, cm-1): 2975.06, 2360.16, 1722.75, 
1687.41, 1409.88, 1366.82, 1168.47, 1024.73, 863.41, 701.54. HRMS (ESI) ([M+Na]+)
Calcd. for C16H23NO3Na: 300.1570, found 300.1574. 
4.4.5 General Procedure for Preparation of Tosylhydrazone Derivative 1
 
To a stirred solution of pure tosylhydrazide (1 mmol) in THF (2.0 mL) at room 
temperature, aldehyde s2 (1 equiv.) was added dropwise (or portionwise if solid). The 
reaction was completed within 0.5 h. After that, the solvent was removed directly under 
reduced pressure, and the crude mixture was further purified by flash chromatography.
tert-butyl benzyl(3-(2-tosylhydrazono)propyl)carbamate 
1a. Following the general procedure with s2-a as starting material. Yield: 67%. Rf = 0.36 
(ethyl acetate/hexanes: 1/2). 1H NMR (600 MHz, CDCl3): a mixture of amide rotamers and 
hydrazone E/Z isomers. δ 7.84 and 7.70 (d, J = 8.0 Hz, 2H), 7.71 – 7.63 (br, 1H), 7.30 –
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7.26 (m, 5H), 7.17 – 7.15 (m, 2H), 7.08 and 6.68 (br, 1H), 4.37 and 4.32 (s, 2H), 3.33 –
3.17 (m, 2H), 2. 41 – 2.25 (m, br, 5H), 1.49 – 1.40 (br, 9H). 13C NMR (150 MHz, CDCl3): 
major isomer δ 155.58, 149.67, 144.10, 137.69, 129.57, 128.53, 127.85, 127.27, 126.68, 
125.91, 80.09, 50.31, 43.61, 31.34, 28.37, 21.57. IR (neat, cm-1):  2977.07, 1686.89, 
1415.35, 1365.70, 1162.58, 873.32, 733.31, 700.98. HRMS (ESI) ([M+H]+) Calcd. for 
C22H30N3O4S: 432.1952, found 432.1947.
tert-butyl (4-methylbenzyl)(3-(2-tosylhydrazono)propyl) 
carbamate 1b. Following the general procedure with s2-b as starting material. Yield: 81%. 
Rf = 0.41 (ethyl acetate/hexanes: 1/2). 1H NMR (500 MHz, CDCl3): a mixture of amide 
rotamers and hydrazone E/Z isomers. δ 7.95 – 7.77 (m, 3H), 7.30 – 7.26 (m, 2H), 7.13 –
6.67 (m, 5H), 4.32 and 4.27 (s, 2H), 3.42 – 3.04 (m, 2H), 2.54 – 2.16 (m, 8H), 1.49 – 1.40 
(br, 9H). 13C NMR (125 MHz, CDCl3): major isomer δ 155.59, 149.77, 143.95, 136.94, 
135.45, 135.04, 129.57, 129.21, 127.84, 127.25, 80.04, 50.45, 43.41, 31.29, 28.39, 21.58, 
21.08. IR (neat, cm-1):  3122.77, 2973.91, 1665.43, 1430.9, 1365.17, 1166.33, 879.82, 
732.50. HRMS (ESI) ([M+H]+) Calcd. for C23H32N3O4S: 446.2108, found 446.2125.
tert-butyl (3-methoxybenzyl)(3-(2-tosylhydrazono)
propyl) carbamate 1c. Following the general procedure with s2-c as starting material. 
Yield: 61%. Rf = 0.28 (ethyl acetate/hexanes: 1/2). 1H NMR (500 MHz, CDCl3): a mixture 
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of amide rotamers and hydrazone E/Z isomers. δ 7.94 – 7.77 (m, 3H), 7.30 – 6.99 (m, 4H), 
6.81 – 6.69 (m, 3H), 4.33 and 4.29 (s, 2H), 3.79 (s, 3H), 3.32 – 3.17 (m, 2H), 2.42 – 2.27 
(m, 5H), 1.49 (s, 9H). 13C NMR (125 MHz, CDCl3): major isomer δ 159.81, 155.57, 
149.69, 143.98, 139.82, 135.43, 129.58, 129.54, 127.83, 119.52, 113.15, 112.55, 80.11, 
55.18, 50.72, 43.54, 31.30, 28.38, 21.57. IR (neat, cm-1):  2968.78, 2854.76, 1688.47, 
1413.13, 1253.95, 1162.12, 1047.56, 872.20. HRMS (ESI) ([M+H]+) Calcd. for 
C23H32N3O5S: 462.2057, found 462.2049.
tert-butyl (2-methoxybenzyl)(3-(2-tosylhydrazono)propyl) 
carbamate 1d. Following the general procedure with s2-d as starting material. Yield: 65%. 
Rf = 0.40 (ethyl acetate/hexanes: 1/2). 1H NMR (500 MHz, CDCl3): a mixture of amide 
rotamers and hydrazone E/Z isomers. δ 7.96 – 7.77 (m, 3H), 7.36 – 7.11 (m, 5H), 6.99 –
6.69 (m, 2H), 4.39 and 4.35 (s, 2H), 3.81 (s, 3H), 3.40 – 3.07 (m, 2H), 2.45 – 2.25 (m, 5H), 
1.48 – 1.37 (s, 9H). 13C NMR (125 MHz, CDCl3): major isomer δ 157.15, 155.88, 149.93, 
146.65, 143.88, 135.49, 129.56, 128.79, 127.83, 126.09, 120.38, 110.16, 79.86, 55.05, 
45.38, 43.76, 31.41, 28.40, 21.57. IR (neat, cm-1): 2977.19, 1660.24, 1464.33, 1358.72, 
1162.73, 1026.93, 885.05, 755.96. HRMS (ESI) ([M+H]+) Calcd. for C23H32N3O5S: 
462.2057, found 462.2048.
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tert-butyl (3,5-bis(trifluoromethyl)benzyl)(3-(2-
tosylhydrazono)propyl)carbamate 1e. Following the general procedure with s2-e as 
starting material. Yield: 85%. Rf = 0.40 (ethyl acetate/hexanes: 1/3). 1H NMR (500 MHz, 
CDCl3): a mixture of amide rotamers and hydrazone E/Z isomers. δ 8.12 (br, 1H), 7.78 (d, 
J = 7.7 Hz, 3H), 7.63 (s, 2H), 7.31 – 7.20 (m, 3H), 4.45 and 4.42 (s, 2H), 3.41 – 3.30 (m, 
2H), 2.48 – 2.40 (m, 5H), 1.44 and 1.36 (s, 9H). 13C NMR (125 MHz, CDCl3): major isomer 
δ 155.18, 148.84, 144.24, 141.40, 135.27, 131.83 (q, J = 33.2 Hz), 129.63, 127.81, 127.15, 
123.21 (q, J = 272.8 Hz), 121.21, 80.90, 50.48, 44.06, 31.44, 28.20, 21.51. IR (neat, cm-1):
3194.52, 2978.63, 1694.05, 1668.00, 1367.42, 1276.06, 1161.98, 900.41, 680.93. HRMS 
(ESI) ([M+H]+) Calcd. for C24H28F6N3O4S: 568.1699, found 568.1710.
tert-butyl (4-bromobenzyl)(3-(2-tosylhydrazono)
propyl) carbamate 1f. Following the general procedure with s2-f as starting material. 
Yield: 75%. Rf = 0.37 (ethyl acetate/hexanes: 1/2). 1H NMR (500 MHz, CDCl3): a mixture 
of amide rotamers and hydrazone E/Z isomers. δ 8.09 (br, 1H), 7.86 – 7.76 (m, 2H), 7.43 
(m, br, 2H), 7.31 – 7.26 (m, 2H), 7.14 – 7.04 (m, 3H), 4.30 (s, 2H), 3.33 and 3.24 (br, 2H), 
2.43 – 2.31 (m, 5H), 1.44 (s, br, 9H). 13C NMR (125 MHz, CDCl3): major isomer δ 155.49, 
149.34, 144.16, 137.31, 135.45, 131.62, 129.61, 128.83, 127.84, 121.03, 80.34, 50.34, 
43.65, 31.47, 28.36, 21.60. IR (neat, cm-1): 3130.31, 2975.16, 1666.19, 1427.70, 1339.69, 
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1166.46, 813.79, 723.12. HRMS (ESI) ([M+H]+) Calcd. for C22H29BrN3O4S: 510.1057, 
found 510.1033.
tert-butyl (2,4,6-trifluorobenzyl)(3-(2-tosylhydrazono)
propyl) carbamate 1g. Following the general procedure with s2-g as starting material. 
Yield: 67%. Rf = 0.45 (ethyl acetate/hexanes: 1/2). 1H NMR (500 MHz, CDCl3): a mixture 
of amide rotamers and hydrazone E/Z isomers. δ 8.02 (br, 1H), 7.78 (d, J = 7.8 Hz, 2H), 
7.28 (d, J = 7.9 Hz, 2H), 7.15 (br, 1H), 6.71 – 6.62 (m, 2H), 4.42 and 4.34 (s, 2H), 3.35 –
3.18 (m, 2H), 2.40 – 2.26 (m, 5H), 1.47 – 1.37 (s, 9H). 13C NMR (125 MHz, CDCl3): major 
isomer δ 162.80, 160.71, 155.01, 149.43, 143.99, 135.30, 129.55, 127.84, 109.98, 100.22, 
80.39, 43.37, 38.59, 31.39, 28.22, 21.55. IR (neat, cm-1): 3106.87, 2966.96, 1692.92,
1442.19, 1365.94, 1163.80, 1116.32, 1046.30, 872.38, 663.57. HRMS (ESI) ([M+H]+)
Calcd. for C22H27F3N3O4S: 486.1669, found 486.1661.
tert-butyl (4-nitrilebenzyl)(3-(2-tosylhydrazono)
propyl) carbamate 1h. Following the general procedure with s2-h as starting material. 
Yield: 57%. Rf = 0.21 (ethyl acetate/hexanes: 1/2). 1H NMR (500 MHz, CDCl3): a mixture 
of amide rotamers and hydrazone E/Z isomers. δ 8.20 (s, 1H), 7.77 (d, J = 7.8 Hz, 2H), 
7.59 (m, 2H), 7.31 – 7.25 (m, 4H), 7.17 (s, 1H), 4.41 and 4.38 (s, 2H), 3.38 – 3.28 (br, 2H), 
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2.42 – 2.41 (m, 5H), 1.43 and 1.34 (s, 9H). 13C NMR (125 MHz, CDCl3): major isomer δ
155.43, 149.01, 144.15, 135.41, 132.37, 129.63, 127.98, 127.80, 127.51, 118.76, 111.02, 
80.63, 50.93, 44.11, 31.58, 28.28, 21.59. IR (neat, cm-1):  3145.62, 2973.85, 2227.90, 
1666.96, 1365.54, 1164.76, 1053.56, 812.85. HRMS (ESI) ([M+H]+) Calcd. for 
C23H29N4O4S: 457.1904, found 457.1920.
tert-butyl (4-nitrobenzyl)(3-(2-tosylhydrazono)
propyl) carbamate 1i. Following the general procedure with s2-i as starting material. 
Yield: 59%. Rf = 0.26 (ethyl acetate/hexanes: 1/2). 1H NMR (400 MHz, CDCl3): a mixture 
of amide rotamers and hydrazone E/Z isomers. δ 8.15 (br, 2H), 7.90 (s, 1H), 7.83 – 7.75
(m, 2H), 7.39 – 7.07 (m, 5H), 4.44 and 4.42 (s, 2H), 3.40 and 3.29 (m, br, 2H), 2.40 – 2.39
(m, 5H), 1.42 and 1.34 (s, 9H). 13C NMR (100 MHz, CDCl3): major isomer δ 155.32,
148.92, 147.26, 145.96, 144.26, 135.37, 129.62, 128.02, 127.60, 123.78, 80.70, 50.80, 
44.14, 31.64, 28.27, 21.56. IR (neat, cm-1): 3198.38, 2976.31, 1667.31, 1342.94, 1160.54, 
813.21, 664.41. HRMS (ESI) ([M+H]+) Calcd. for C22H29N4O6S: 477.1802, found
477.1812.
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tert-butyl (2-chloro-4-nitrobenzyl)(3-(2-
tosylhydrazono)propyl)carbamate 1j. Following the general procedure with s2-j as 
starting material. Yield: 63%. Rf = 0.36 (ethyl acetate/hexanes: 1/2). 1H NMR (600 MHz, 
CDCl3): a mixture of amide rotamers and hydrazone E/Z isomers. δ 8.06 – 7.96 (m, 3H), 
7.77 (d, J = 7.9 Hz, 2H), 7.52 (m, br, 1H), 7.31 – 7.28 (m, 2H), 7.20 (m, br, 1H), 4.50 and 
4.45 (s, 2H), 3.45 – 3.31 (m, 2H), 2.49 – 2.40 (m, 5H), 1.46 and 1.36 (s, 9H). 13C NMR 
(150 MHz, CDCl3): major isomer δ 157.86, 151.52, 149.50, 146.92, 142.35, 140.74, 
137.99, 133.16, 132.30, 130.46, 125.84, 125.61, 83.72, 51.35, 47.20, 34.07, 30.90, 24.24. 
IR (neat, cm-1): 3193.25, 2975.19, 1690.76, 1670.95, 1523.00, 1343.10, 1160.55, 1049.95,
812.31. HRMS (ESI) ([M+Na]+) Calcd. for C22H27ClN4NaO6S: 533.1232, found 533.1228.
tert-butyl (3-vinylbenzyl)(3-(2-tosylhydrazono)
propyl) carbamate 1k. Following the general procedure with s2-k as starting material. 
Yield: 79%. Rf = 0.42 (ethyl acetate/hexanes: 1/2). 1H NMR (500 MHz, CDCl3): a mixture 
of amide rotamers and hydrazone E/Z isomers. δ 8.11 (br, 1H), 7.80 (d, J = 7.8 Hz, 2H), 
7.26 – 7.25 (m, 5H), 7.20 (m, br, 2H), 6.72 – 6.66 (m, 1H), 5.73 (dd, J = 17.6, 3.4 Hz, 1H), 
5.25 (d, J = 10.8 Hz, 1H), 4.35 and 4.31 (s, 2H), 3.33 – 3.19 (m, 2H), 2.40 – 2.29 (m, 5H), 
1.48 – 1.39 (br, 9H). 13C NMR (125 MHz, CDCl3): major isomer δ 155.61, 149.57, 143.97, 
138.48, 137.83, 136.59, 135.43, 129.57, 128.74, 127.82, 126.64, 125.43, 125.13, 114.19, 
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80.15, 50.66, 43.54, 31.32, 28.38, 21.57. IR (neat, cm-1): 3192.54, 2976.69, 1688.26, 
1414.31, 1365.24, 1160.59, 904.80, 663.86. HRMS (ESI) ([M+H]+) Calcd. for 
C24H32N3O4S: 458.2108, found 458.2119.
tert-butyl ((E)-2-methyl-3-phenylallyl)(3-(2-
tosylhydrazono)propyl)carbamate 1l. Following the general procedure with s2-l as 
starting material. Yield: 61%. Rf = 0.30 (ethyl acetate/hexanes: 1/2). 1H NMR (600 MHz, 
CDCl3): a mixture of amide rotamers and hydrazone E/Z isomers. δ 8.20 (br, 1H), 7.78 (d, 
J = 7.8 Hz, 2H), 7.33 – 7.21 (m, 8H), 6.25 (s, 1H), 3.86 (s, 2H), 3.36 – 3.20 (m, 2H), 2.44 
– 2.37 (m, 5H), 1.76 (s, 3H), 1.48 – 1.41 (br, 9H). 13C NMR (150 MHz, CDCl3): major 
isomer δ 155.63, 149.72, 146.57, 143.87, 137.39, 134.46, 129.55, 128.82, 128.15, 127.82, 
126.65, 126.49, 79.94, 55.13, 43.20, 31.46, 28.36, 21.53, 15.56. IR (neat, cm-1): 2975.79, 
1687.33, 1660.61, 1415.37, 1364.83, 1160.16, 1051.97, 699.62. HRMS (ESI) ([M+Na]+)
Calcd. for C25H33N3NaO4S: 494.2084, found 494.2083.
tert-butyl (3-phenylprop-2-yn-1-yl)(3-(2-
tosylhydrazono)propyl)carbamate 1m. Following the general procedure with s2-m as 
starting material. Yield: 88%. Rf = 0.43 (ethyl acetate/hexanes: 1/2). 1H NMR (500 MHz, 
CDCl3): a mixture of amide rotamers and hydrazone E/Z isomers. δ 7.88 (br, 1H), 7.79 (d, 
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J = 8.0 Hz, 2H), 7.40 – 7.39 (m, 2H), 7.31 – 7.26 (m, 5H), 7.20 (t, J = 5.1 Hz, 1H), 4.20 
and 4.14 (br, 2H), 3.51 – 3.39 (m, 2H), 2.56 – 2.49 (m, 2H), 2.39 (s, 3H), 1.49 and 1.43 (s, 
9H). 13C NMR (125 MHz, CDCl3): major isomer δ 154.84, 149.61, 144.07, 135.37, 131.64, 
129.59, 128.36, 128.33, 127.86, 122.67, 84.82, 84.25, 80.50, 60.38, 43.43, 31.49, 28.35, 
21.55. IR (neat, cm-1): 3192.75, 2976.10, 1692.14, 1409.42, 1365.32, 1159.93, 1049.77, 
756.86, 691.46. HRMS (ESI) ([M+Na]+) Calcd. for C24H29N3NaO4S: 478.1771, found
478.1774.
tert-butyl phenethyl(3-(2-tosylhydrazono)
propyl)carbamate 1n. Following the general procedure with s2-n as starting material. 
Yield: 58%. Rf = 0.40 (ethyl acetate/hexanes: 1/2). 1H NMR (500 MHz, CDCl3): a mixture 
of amide rotamers and hydrazone E/Z isomers. δ 8.46 (br, 1H), 7.76 (d, J = 7.8 Hz, 2H), 
7.28 – 7.12 (m, 8H), 3.33 – 3.11 (m, 4H), 2.72 – 2.71 (m, 2H), 2.39 – 2.25 (m, 5H), 1.43 –
1.36 (s, 9H). 13C NMR (125 MHz, CDCl3): major isomer δ 155.43, 149.48, 143.84, 139.06, 
135.54, 129.55, 128.82, 128.49, 127.82, 126.30, 79.73, 49.43, 44.14, 35.26, 31.75, 28.34, 
21.55. IR (neat, cm-1): 3194.97, 2974.90, 1660.43, 1415.49, 1364.79, 1159.91, 813.28, 
748.04, 700.45. HRMS (ESI) ([M+H]+) Calcd. for C23H32N3O4S: 446.2108, found 
446.2101.
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tert-butyl (cyclohexylmethyl)(3-(2-tosylhydrazono)propyl) 
carbamate 1o. Following the general procedure with s2-o as starting material. Yield: 73%. 
Rf = 0.32 (ethyl acetate/hexanes: 1/2). 1H NMR (500 MHz, CDCl3): a mixture of amide 
rotamers and hydrazone E/Z isomers. δ 8.12 (br, 1H), 7.78 (d, J = 8.0 Hz, 2H), 7.29 (d, J
= 7.2 Hz, 2H), 7.17 (br, 1H), 3.29 – 3.11 (m, br, 2H), 2.96 – 2.90 (m, 2H), 2.41 – 2.38 (m, 
br, 5H), 1.69 – 1.59 (m, 5H), 1.46 – 1.38 (m, 10H), 1.22 – 1.12 (m, 3H), 0.88 – 0.84 (m, 
2H). 13C NMR (125 MHz, CDCl3): major isomer δ 155.84, 149.78, 146.13, 143.87, 129.55, 
127.84, 79.47, 53.38, 44.18, 37.22, 31.38, 30.84, 28.37, 26.45, 25.90, 21.56. IR (neat, cm-
1):  3196.28, 2923.97, 1659.99, 1417.60, 1365.18, 1163.60, 1050.74, 812.99, 736.06. 
HRMS (ESI) ([M+H]+) Calcd. for C22H36N3O4S: 438.2421, found 438.2427.
benzyl N-(tert-butoxycarbonyl)-N-(3-(2-
tosylhydrazono)propyl)glycinate 1p. Following the general procedure with s2-p as 
starting material. Yield: 72%. Rf = 0.5 (ethyl acetate/hexanes: 1/1). 1H NMR (500 MHz, 
CDCl3): a mixture of amide rotamers and hydrazone E/Z isomers. δ 7.94 (s, 1H), 7.85 –
7.75 (m, 2H), 7.38 – 7.25 (m, 7H), 7.14 – 7.13 and 6.80 - 6.76 (m, 1H), 5.21 and 5.12 (s, 
2H), 3.94 and 3.80 (s, 2H), 3.44 – 3.30 (m, 2H), 2.46 – 2.37 (m, 5H), 1.41 and 1.25 (s, 9H).
13C NMR (125 MHz, CDCl3): major isomer δ 169.92, 155.09, 149.57, 147.49, 144.03, 
135.43, 129.61, 128.61, 128.46, 128.33, 127.84, 80.54, 66.81, 50.06, 45.80, 31.47, 28.08, 
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21.54. IR (neat, cm-1): 3194.32, 2976.82, 1746.99, 1694.34, 1455.86, 1365.77, 1249.43, 
1159.51, 888.95, 750.98. HRMS (ESI) ([M+H]+) Calcd. for C24H32N3O6S: 490.2052,
found 490.2065.
tert-butyl (pyridin-3-ylmethyl)(3-(2-tosylhydrazono)
propyl) carbamate 1q. Following the general procedure with s2-q as starting material. 
Yield: 56%. Rf = 0.40 (ethyl acetate/hexanes: 3/1). 1H NMR (500 MHz, CDCl3): a mixture 
of amide rotamers and hydrazone E/Z isomers. δ 8.83 (br, 1H), 8.49 – 8.41 (m, 2H), 7.76
(d, J = 8.1 Hz, 2H), 7.54 (m, br, 1H), 7.34 – 7.12 (m, 4H), 4.36 and 4.32 (s, 2H), 3.36 –
3.27 (m, 2H), 2.43 – 2.39 (m, 5H), 1.45 – 1.36 (br, 9H). 13C NMR (125 MHz, CDCl3): 
major isomer δ 155.33, 148.91, 148.57, 143.95, 135.57, 135.04, 133.96, 129.91, 129.58, 
127.77, 123.61, 80.52, 48.65, 43.87, 31.54, 28.32, 21.56. IR (neat, cm-1): 2976.36, 1687.57, 
1410.54, 1159.16, 1054.28, 813.41, 706.76. HRMS (ESI) ([M+H]+) Calcd. for 
C21H29N4O4S: 433.1904, found 433.1917.
tert-butyl (pyridin-2-ylmethyl)(3-(2-tosylhydrazono)
propyl) carbamate 1r. Following the general procedure with s2-r as starting material. 
Yield: 61%. Rf = 0.43 (ethyl acetate/hexanes: 3/1). 1H NMR (600 MHz, CDCl3): a mixture 
of amide rotamers and hydrazone E/Z isomers. δ 8.86 – 8.50 (m, br, 1H), 8.04 and 8.10 (s, 
1H), 7.79 – 7.66 (m, 3H), 7.28 – 7.12 (m, 5H), 4.51 and 4.42 (s, 2H), 3.46 – 3.37 (m, 2H), 
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2.44 – 2.40 (m, 5H), 1.44 – 1.33 (br, 9H). 13C NMR (150 MHz, CDCl3): major isomer δ
160.99, 158.17, 152.21, 151.62, 146.23, 139.81, 138.77, 132.20, 130.50, 124.83, 123.67, 
82.91, 56.81, 47.29, 34.31, 30.91, 24.22. IR (neat, cm-1): 3128.02, 2973.70, 1656.61, 
1464.10, 1408.22, 1319.68, 1163.60, 1059.44, 872.65. HRMS (ESI) ([M+H]+) Calcd. for 
C21H29N4O4S: 433.1904, found 433.1910.
tert-butyl (pyridin-4-ylmethyl)(3-(2-tosylhydrazono)
propyl) carbamate 1s. Following the general procedure with s2-s as starting material. 
Yield: 49%. Rf = 0.23 (ethyl acetate/hexanes: 4/1). 1H NMR (400 MHz, CDCl3): a mixture 
of amide rotamers and hydrazone E/Z isomers. δ 8.51 – 8.50 (m, br, 3H), 7.76 (d, J = 8.0 
Hz, 2H), 7.34 – 7.04 (m, 5H), 4.34 and 4.32 (s, 2H), 3.38 – 3.28 (m, br, 2H), 2.42 – 2.33 
(m, 5H), 1.41 and 1.23 (s, 9H). 13C NMR (125 MHz, CDCl3): major isomer δ 155.39,
149.75, 148.78, 147.95, 144.02, 135.62, 129.60, 127.79, 121.83, 80.62, 50.31, 44.24,
31.63, 28.27, 21.59. IR (neat, cm-1): 2976.44, 1689.00, 1410.49, 1365.61, 1159.55, 885.60, 
813.39, 752.47. HRMS (ESI) ([M+H]+) Calcd. for C21H29N4O4S: 433.1904, found
433.1915.
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tert-butyl (quinolin-4-ylmethyl)(3-(2-tosylhydrazono)
propyl) carbamate 1t. Following the general procedure with s2-t as starting material. 
Yield: 79%. Rf = 0.30 (ethyl acetate/hexanes: 3/1). 1H NMR (500 MHz, CDCl3): a mixture 
of amide rotamers and hydrazone E/Z isomers. δ 8.85 (m, br, 1H), 8.44 (m, br, 1H), 8.14 
(m, br, 1H), 8.98 – 7.74 (m, 4H), 7.59 (m, br, 1H), 7.31 – 7.11 (m, 4H), 4.87 (br, 2H), 3.45 
– 3.32 (m, 2H), 2.49 – 2.31 (m, 5H), 1.48 and 1.27 (s, 9H). 13C NMR (125 MHz, CDCl3): 
major isomer δ 155.33, 150.06, 149.06, 147.86, 144.09, 143.67, 135.28, 130.08, 129.58, 
127.77, 126.91, 126.32, 122.61, 119.27, 118.00, 80.72, 48.05, 44.15, 31.60, 28.28, 21.54. 
IR (neat, cm-1): 2974.45, 1689.81, 1476.24, 1353.48, 1162.34, 1057.39, 894.38, 762.94, 
680.14. HRMS (ESI) ([M+Na]+) Calcd. for C25H30N4NaO4S: 505.1880, found 505.1875.
tert-butyl 3-(((tert-butoxycarbonyl)(3-(2-
tosylhydrazono)propyl)amino)methyl)-1H-indole-1-carboxylate 1u. Following the 
general procedure with s2-u as starting material. Yield: 88%. Rf = 0.35 (ethyl 
acetate/hexanes: 1/2). 1H NMR (500 MHz, CDCl3): a mixture of amide rotamers and 
hydrazone E/Z isomers. δ 8.13 (s, 1H), 7.81 and 7.76 (d, J = 8.0 Hz, 2H), 7.59 – 7.48 (m, 
2H), 7.35 – 7.22 (m, 5H), 7.05 – 6.66 (m, 1H), 4.50 and 4.47 (s, 2H), 3.33 – 3.13 (m, 2H), 
2.43 – 2.21 (m, 5H), 1.68 (s, 9H), 1.47 (s, 9H). 13C NMR (125 MHz, CDCl3): major isomer 
δ 151.67, 149.77, 144.00, 142.47, 135.72, 131.75, 129.55, 127.98, 124.86, 123.72, 122.54, 
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119.13, 117.11, 115.73, 115.18, 82.56, 80.31, 61.51, 47.05, 41.31, 28.37, 28.19, 21.57. IR 
(neat, cm-1):  2976.21, 1731.20, 1686.43, 1451.78, 1364.56, 1253.66, 1156.11, 1082.02, 
855.63, 766.62, 663.65. HRMS (ESI) ([M+Na]+) Calcd. for C29H38N4NaO6S: 593.2404, 
found 593.2430.
tert-butyl (thiophen-3-ylmethyl)(3-(2-tosylhydrazono)
propyl) carbamate 1v. Following the general procedure with s2-v as starting material. 
Yield: 87%. Rf = 0.34 (ethyl acetate/hexanes: 1/2). 1H NMR (500 MHz, CDCl3): a mixture 
of amide rotamers and hydrazone E/Z isomers. δ 8.01 – 7.96 (m, 1H), 7.78 (d, J = 8.2 Hz, 
2H), 7.29 – 7.26 (m, 3H), 7.09 – 6.93 (m, 3H), 4.34 and 4.29 (s, 2H), 3.32 – 3.19 (m, 2H), 
2.45 – 2.25 (m, 5H), 1.48 – 1.42 (s, 9H). 13C NMR (125 MHz, CDCl3): major isomer δ
155.34, 149.67, 144.03, 139.15, 138.70, 135.45, 129.59, 127.85, 126.13, 122.46, 80.12, 
46.29, 43.54, 31.41, 28.39, 21.59. IR (neat, cm-1):  3107.86, 2977.68, 1659.83, 1366.08, 
1250.89, 1162.09, 1053.71, 812.58, 734.14. HRMS (ESI) ([M+Na]+) Calcd. for 
C20H27N3NaO4S2: 460.1335, found 460.1356.
tert-butyl (benzo[b]thiophen-3-ylmethyl)(3-(2-
tosylhydrazono)propyl)carbamate 1w. Following the general procedure with s2-w (5 
mmol) as starting material. Yield: 80%. Rf = 0.29 (ethyl acetate/hexanes: 1/2). 1H NMR 
(500 MHz, CDCl3): a mixture of amide rotamers and hydrazone E/Z isomers. δ 7.87 – 7.76
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(m, 5H), 7.37 (m, 2H), 7.37 – 7.05 (m, 4H), 4.63 and 4.59 (s, 2H), 3.35 – 3.18 (m, 2H), 
2.40 – 2.17 (m, 5H), 1.54-1.45 (s, 9H). 13C NMR (125 MHz, CDCl3): major isomer δ
155.34, 149.65, 146.18, 144.12, 140.66, 137.95, 135.23, 132.87, 129.60, 127.85, 124.60, 
124.34, 122.84, 121.61, 80.25, 44.33, 42.97, 31.50, 28.41, 21.58. IR (neat, cm-1): 3191.11, 
2975.32, 1661.25, 1414.33, 1364.38, 1160.79, 876.54, 767.28, 664.08. HRMS (ESI) 
([M+Na]+) Calcd. for C24H29N3NaO4S2: 510.1492, found 510.1512.
tert-butyl (ferrocenyl)(3-(2-tosylhydrazono)propyl) 
carbamate 1x. Following the general procedure with s2-x as starting material. Yield: 50%. 
Rf = 0.17 (ethyl acetate/hexanes: 1/3). 1H NMR (600 MHz, CDCl3): a mixture of amide 
rotamers and hydrazone E/Z isomers. δ 7.81 – 7.68 (m, 3H), 7.30 (br, 2H), 6.67 – 6.65 (br, 
1H), 4.33 – 3.86 (m, 11H), 3.22 –3.09 (m, br, 2H), 2.43 – 2.19 (br, 5H), 1.52 – 1.40 (br, 
9H). 13C NMR (150 MHz, CDCl3): major isomer δ 157.77, 152.60, 146.59, 137.98, 132.21, 
130.48, 82.46, 71.62 (br), 49.32, 46.11, 34.39, 31.11, 24.26. IR (neat, cm-1):  3096.54, 
2973.63, 1660.36, 1417.00, 1365.18, 1250.72, 1037.85, 812.76. HRMS (ESI) ([M]+)
Calcd. for C26H33FeN3O4S: 539.1541, found 539.1539.
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N'-(3-(benzyloxy)propylidene)-4-methylbenzene
sulfonohydrazide 1y. Following the general procedure with s2-y as starting material. 
Yield: 78%. Rf = 0.24 (ethyl acetate/hexanes: 1/3). 1H NMR (400 MHz, CDCl3): a mixture 
of hydrazone E/Z isomers. δ 8.97 (s, 1H), 7.80 (d, J = 8.3 Hz, 1H), 7.58 (d, J = 8.1 Hz, 
1H), 7.34 – 7.19 (m, 8H), 4.45 (s, 2H), 3.61 – 3.55 (m, 2H), 2.54 – 2.46 (m, 2H), 2.39 (s, 
3H). 13C NMR (100 MHz, CDCl3): δ 148.51, 143.67, 136.72, 135.54, 129.44, 128.63, 
127.90, 127.80, 127.63, 73.59, 67.48, 28.86, 21.55. IR (neat, cm-1): 3209.79, 2851.50, 
1595.31, 1453.36, 1379.35, 1187.33, 1016.10, 892.07, 735.34, 666.22. HRMS (ESI) 
([M+H]+) Calcd. for  C17H21N2O3S: 333.1267, found 333.1259.
N'-(3-(benzylthio)propylidene)-4-methylbenzene 
sulfonohydrazide 1z. Following the general procedure with s2-z as starting material. 
Yield: 72%. Rf = 0.26 (ethyl acetate/hexanes: 1/3). 1H NMR (600 MHz, CDCl3): a mixture 
of hydrazone E/Z isomers. δ 7.84 – 7.79 (m, 3H), 7.32 – 7.24 (m, 7H), 7.10 (t, J = 5.0 Hz, 
1H), 3.66 and 3.63 (s, 2H), 2.52 (t, J = 7.2 Hz, 2H), 2.44 – 2.41 (m, 5H). 13C NMR (150 
MHz, CDCl3): δ 152.86, 146.82, 140.67, 137.84, 132.28, 131.46, 131.20, 130.58, 129.74, 
38.84, 34.62, 30.36, 24.26. IR (neat, cm-1): 3193.77, 2921.72, 1595.81, 1357.63, 1325.51, 
1155.62, 1041.82, 1003.59, 924.56, 814.73. HRMS (ESI) ([M+H]+) Calcd. for 
C17H21N2O2S2: 349.1039, found 349.1042.
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4-methyl-N'-(5-phenylpentylidene)benzenesulfono
hydrazide 1aa. Following the general procedure with 5-phenylpentanal as starting 
material. Yield: 71%. Rf = 0.40 (ethyl acetate/hexanes: 1/3). 1H NMR (600 MHz, CDCl3): 
a mixture of hydrazone E/Z isomers. δ 8.01 and 7.92 (s, 1H), 7.83 and 7.80 (d, J = 8.3 Hz, 
2H), 7.28 – 7.27 (m, 4H), 7.21 – 7.10 (m, 4H), 2.55 (t, J = 7.6 Hz, 2H), 2.42 and 2.39 (s, 
3H), 2.21 (td, J = 7.3, 5.7 Hz, 1.5 H), 2.10 (td, J = 7.4, 5.5 Hz, 0.5H), 1.61 – 1.43 (m, 4H). 
13C NMR (150 MHz, CDCl3): δ 155.33, 146.72, 144.73, 137.91, 132.25, 131.00, 130.95, 
130.54, 128.42, 38.16, 34.75, 33.21, 28.24, 24.24. IR (neat, cm-1): 3205.50, 2939.40, 
1437.91, 1354.08, 1317.49, 1160.42, 1039.46, 906.24, 815.23. HRMS (ESI) ([M+H]+)
Calcd. for  C18H23N2O2S: 331.1475, found 331.1481.
tert-butyl phenethyl(2-(2-tosylhydrazono)ethyl)carbamate 
1ab. Following the general procedure with s2-aa as starting material. Yield: 84%. Rf =
0.33 (ethyl acetate/hexanes: 1/2). 1H NMR (600 MHz, CDCl3): a mixture of amide 
rotamers and hydrazone E/Z isomers. δ 8.01 and 7.96 (s, 1H), 7.81 and 7.71 (d, J = 8.3 Hz, 
2H), 7.27 – 7.24 (m, 5H), 7.08 – 7.03 (m, 2H), 6.86 – 6.65 (br, 1H), 3.84 and 3.68 (d, J =
6.2 Hz, 2H), 3.41 – 3.22 (m, 2H), 2.76 – 2.67 (m, 2H), 2.41-2.33 (br, 3H), 1.39 and 1.38 
(s, 9H). 13C NMR (150 MHz, CDCl3): major isomer δ 158.08, 149.66, 146.83, 141.45, 
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137.91, 132.27, 131.60, 131.15, 130.49, 129.02, 83.00, 51.76, 50.97, 37.57, 30.95, 24.16. 
IR (neat, cm-1):  2975.01, 1662.62, 1454.17, 1365.19, 1339.53, 1157.90, 1094.23, 893.29, 
700.35. HRMS (ESI) ([M+Na]+) Calcd. for  C22H29N3NaO4S: 454.1771, found 454.1773.
tert-butyl (R)-(1-phenylethyl)(3-(2-tosylhydrazono)
propyl) carbamate 4a. Following the general procedure with s2-ab as starting material. 
Yield: 83%. Rf = 0.27 (ethyl acetate/hexanes: 1/3). We are unable to get a consistent value 
for optical rotation, presumably due to the interconversion of amide rotamers in this linear 
molecule. 1H NMR (600 MHz, CDCl3): a mixture of amide rotamers and hydrazone E/Z 
isomers. 7.93 (s, 1H), 7.83 – 7.75 (m, 2H), 7.27 – 7.26 (m, 7H), 6.56 and 6.54 (br, 1H), 
5.31 (br, 1H), 3.05 – 2.90 (m, br, 2H), 2.41 (br, 3H), 2.21 – 1.96 (br, 2H), 1.52 (s, 3H), 1.46 
– 1.42 (br, 9H). 13C NMR (150 MHz, CDCl3): major isomer δ 155.49, 150.00, 143.81, 
141.62, 135.69, 129.41, 128.31, 127.88, 127.19, 126.97, 79.92, 53.82, 32.84, 28.42, 28.39, 
21.40, 17.20. HPLC analysis: ee = 99%. ADH (90% hexanes: 10% isopropanol, 1.0 
mL/min) : tmajor = 21.01 min, tminor = 26.81 min. IR (neat, cm-1): 3200.18, 2976.53, 1682.86, 
1451.44, 1365.15, 1159.39, 1043.39, 813.42, 699.72. HRMS (ESI) ([M+Na]+) Calcd. for 
C23H31N3NaO4S: 468.1927, found 468.1921.
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4.4.6 General Procedure for [Co(P6)]-Catalyzed Enantioselective Radical 
Cyclization
  An oven-dried Schlenk tube was charged with sulfonyl hydrazone 1 (0.1 mmol), 
[Co(P6)] (3 mol %) and 1.5 equivalent of Cs2CO3 (0.15 mmol). The Schlenk tube was then 
evacuated and backfilled with nitrogen for 3 times. The Teflon screw cap was replaced 
with a rubber septum, dioxane (0.6 mL) was added via a gas-tight syringe. The tube was 
then purged with nitrogen for 30 s and the rubber septum was replaced with a Teflon screw 
cap. The mixture was then stirred at 60 oC. After 24 h, the reaction mixture was 
concentrated and purified by flash chromatography. The fractions containing product were 
collected and concentrated by rotary evaporation to afford the desired compound 2.
tert-butyl (S)-2-phenylpyrrolidine-1-carboxylate 2a, known compound.22
Following the general procedure with 1a as starting material. Yield: 93%. ee: 92%. 
Hexanes/ethyl acetate = 8/1, Rf = 0.45. [α]20 D = -55.6 (c = 0.5, CHCl3). 1H NMR (500 
MHz, CDCl3): a mixture of amide rotamers. δ 7.30 – 7.15 (m, 5H), 4.96 and 4.76 (m, br, 
1H), 3.62 and 3.52 (m, br, 2H), 2.31 (m, br, 1H), 1.90 – 1.83 (m, 3H), 1.45 (s, 3H), 1.17 (s, 
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6H). 13C NMR (125 MHz, CDCl3): major isomer δ 154.56, 145.13, 128.08, 126.44, 125.48, 
79.15, 61.33, 47.08, 36.01, 28.12, 23.18. HPLC analysis: ee = 92%. OJH (99% hexanes : 
1% isopropanol, 1.0 mL/min): tmajor = 8.73 min, tminor = 7.26 min. HRMS (ESI) ([M+H]+)
Calcd. for C15H22NO2: 248.1645, found 248.1654. 
tert-butyl (S)-2-(p-tolyl)pyrrolidine-1-carboxylate 2b, known 
compound.22 Following the general procedure with 1b as starting material. Yield: 84%. ee:
93%. Hexanes/ethyl acetate = 8/1, Rf = 0.45. [α]20 D = -166.0 (c = 0.5, CHCl3). 1H NMR 
(500 MHz, CDCl3): a mixture of amide rotamers. δ 7.10 – 7.05 (m, 4H), 4.92 and 4.74 (m, 
br, 1H), 3.61 (m, br, 2H), 2.32 (m, br, 4H), 1.89 – 1.82 (m, 3H), 1.45 (s, 3H), 1.20 (s, 6H). 
13C NMR (125 MHz, CDCl3): major isomer δ 154.64, 142.05, 135.90, 128.72, 125.40, 
79.09, 61.01, 46.99, 35.99, 28.18, 23.10, 21.02. HPLC analysis: ee = 93%. ADH (99.9% 
hexanes : 0.1% isopropanol, 1.0 mL/min): tmajor = 19.55 min, tminor = 18.40 min. HRMS 
(ESI) ([M+H]+) Calcd. for C16H24NO2: 262.1802, found 262.1804.
tert-butyl (S)-2-(3-methoxyphenyl)pyrrolidine-1-carboxylate 2c,
known compound.22 Following the general procedure with 1c as starting material. Yield: 
91%. ee: 93%. Hexanes/ethyl acetate = 6/1, Rf = 0.40. [α]20 D = -69.6 (c = 0.5, CHCl3). 1H
NMR (500 MHz, CDCl3): a mixture of amide rotamers. δ 7.20 (t, J = 7.9 Hz, 1H), 6.76 –
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6.71 (m, 3H), 4.94 and 4.74 (m, br, 1H), 3.79 (s, 3H), 3.61 and 3.45 (m, br, 2H), 2.30 (m, 
br, 1H), 1.90 – 1.84 (m, 3H), 1.46 (s, 3H), 1.20 (s, 6H). 13C NMR (125 MHz, CDCl3): 
major isomer δ 159.57, 154.57, 146.90, 129.11, 117.92, 111.66, 111.25, 79.18, 61.26, 
55.17, 47.04, 35.91, 28.17, 23.18. HPLC analysis: ee = 93%. ADH (99% hexanes : 1% 
isopropanol, 1.0 mL/min): tmajor = 16.75 min, tminor = 14.06 min. HRMS (ESI) ([M+H]+)
Calcd. for C16H24NO3: 278.1752, found 278.1756.
tert-butyl (S)-2-(2-methoxyphenyl)pyrrolidine-1-carboxylate 2d, known 
compound.22 Following the general procedure with 1d as starting material. Yield: 87%. ee:
91%. Hexanes/ethyl acetate = 6/1, Rf = 0.40. [α]20 D = -58.6 (c = 0.5, CHCl3). 1H NMR (500 
MHz, CDCl3): a mixture of amide rotamers. δ 7.19 (t, J = 7.1 Hz, 1H), 7.05 (d, J = 7.2 Hz, 
1H), 6.87 (t, J = 7.4 Hz, 1H), 6.84 (d, J = 7.8 Hz, 1H), 5.25 – 5.09 (m, br, 1H), 3.83 (s, 
3H), 3.62 – 3.46 (m, br, 2H), 2.29 – 2.21 (m, br, 1H), 1.82 (m, br, 3H), 1.46 and 1.18 (s, 
9H). 13C NMR (125 MHz, CDCl3): major isomer δ 156.11, 154.57, 132.93, 127.32, 125.92, 
120.12, 110.16, 78.84, 56.08, 55.34, 46.86, 33.88, 28.13, 23.09. HPLC analysis: ee = 91%. 
ADH (99% hexanes : 1% isopropanol, 1.0 mL/min): tmajor = 9.57 min, tminor = 11.71 min.
HRMS (ESI) ([M+H]+) Calcd. for C16H24NO3: 278.1752, found 278.1758.
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tert-butyl (S)-2-(3,5-bis(trifluoromethyl)phenyl)pyrrolidine-1-
carboxylate 2e, known compound.23 Following the general procedure with 1e as starting 
material. Yield: 91%. ee: 95%. Hexanes/ethyl acetate = 8/1, Rf = 0.43. [α]20 D = -173.2 (c
= 0.5, CHCl3). 1H NMR (600 MHz, CDCl3): a mixture of amide rotamers. δ 7.74 – 7.62 
(m, 3H), 4.83 (m, br, 1H), 3.69 – 3.57 (m, 2H), 2.43 (m, br, 1H), 1.93 – 1.85 (m, 3H), 1.45 
(s, 3H), 1.16 (s, 6H). 13C NMR (125 MHz, CDCl3): major isomer δ 154.16, 147.91, 131.60 
(q, J = 33.2 Hz), 125.83, 123.32 (q, J = 272.5 Hz), 120.55, 79.98, 60.92, 47.27, 36.07, 
27.98, 23.47. 19F NMR (376 MHz, CDCl3) δ -63.37 (s, 6F). HPLC analysis: ee = 95%. 
ADH (99.8% hexanes : 0.2% isopropanol, 0.8 mL/min): tmajor = 10.31 min, tminor = 8.99 
min. HRMS (ESI) ([M+Na]+) Calcd. for C17H19F6NO2Na: 406.1212, found 406.1214.
tert-butyl (S)-2-(4-bromophenyl)pyrrolidine-1-carboxylate 2f,
known compound.22 Following the general procedure with 1f as starting material. Yield: 
92%. ee: 92%. Hexanes/ethyl acetate = 8/1, Rf = 0.48. [α]20 D = -90.6 (c = 0.5, CHCl3). 1H
NMR (500 MHz, CDCl3): a mixture of amide rotamers. δ 7.41 (d, J = 6.7 Hz, 2H), 7.04 (d, 
J = 7.8 Hz, 2H), 4.88 and 4.71 (m, br, 1H), 3.60 (m, br, 2H), 2.30 (m, br, 1H), 1.88 – 1.85
(m, 2H), 1.84 – 1.82 (m, 1H), 1.44 (s, 3H), 1.20 (s, 6H). 13C NMR (125 MHz, CDCl3): 
major isomer δ 154.43, 144.23, 131.18, 127.22, 120.06, 79.43, 60.79, 47.05, 35.92, 28.17, 
23.12. HPLC analysis: ee = 92%. ADH (99% hexanes : 1% isopropanol, 1.0 mL/min): 
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tmajor = 10.23 min, tminor = 8.12 min. HRMS (ESI) ([M+H]+) Calcd. for C15H21BrNO2:
326.0750, found 326.0735. The absolute stereochemistry of the major enantiomer was 
assigned by X-ray crystallography. 
tert-butyl (S)-2-(2,4,6-trifluorophenyl)pyrrolidine-1-carboxylate 2g. 
Following the general procedure with 1g as starting material. Yield: 70%. ee: 87%. 
Hexanes/ethyl acetate = 8/1, Rf = 0.45. [α]20 D = -54.8 (c = 0.5, CHCl3). 1H NMR (600 
MHz, CDCl3): a mixture of amide rotamers. δ 6.61 (t, J = 8.6 Hz, 2H), 5.02 – 4.99 (m, br, 
1H), 3.72 – 3.46 (m, br, 2H), 2.35 – 2.32 (m, 1H), 2.01 – 1.83 (m, 3H), 1.41 (s, 3H), 1.21 
(s, 6H). 13C NMR (125 MHz, CDCl3): major isomer δ 161.26 (d, J = 248.2 Hz), 160.91 (d, 
J = 250.6 Hz), 153.82 (s), 116.45 (s), 100.06 (t, J = 27.5 Hz), 79.34, 51.24, 46.49, 33.44, 
28.08, 24.62. 19F NMR (376 MHz, CDCl3) δ -110.93 – -111.25 (m, 1F), -112.76 – -113.03
(m, 2F). HPLC analysis: ee = 87%. ODH (99% hexanes : 1% isopropanol, 1.0 mL/min):
tmajor = 6.22 min, tminor = 5.71 min. IR (neat, cm-1): 2974.52, 1693.79, 1634.23, 1603.07, 
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1393.47, 1365.54, 1115.97, 999.07. HRMS (ESI) ([M+H]+) Calcd. for C15H19F3NO2:
302.1362, found 302.1377.
tert-butyl (S)-2-(4-cyanophenyl)pyrrolidine-1-carboxylate 2h,
known compound.10c Following the general procedure with 1h as starting material. Yield: 
92%. ee: 93%. Hexanes/ethyl acetate = 3/1, Rf = 0.35. [α]20 D = -122.6 (c = 0.5, CHCl3). 1H
NMR (500 MHz, CDCl3): a mixture of amide rotamers. δ 7.57 (d, J = 8.1 Hz, 2H), 7.26 (d, 
J = 8.1 Hz, 2H), 4.92 and 4.76 (m, br, 1H), 3.61 (m, br, 2H), 2.33 (m, br, 1H), 1.86 (m, br, 
2H), 1.76 (m, br, 1H), 1.42 and 1.15 (s, 9H). 13C NMR (125 MHz, CDCl3): major isomer 
δ 154.18, 150.80, 132.12, 126.21, 118.90, 110.41, 79.70, 61.15, 47.16, 35.89, 28.10, 23.26. 
HPLC analysis: ee = 93%. ADH (95% hexanes : 5% isopropanol, 1.0 mL/min): tmajor =
12.38 min, tminor = 9.09 min. HRMS (ESI) ([M+H]+) Calcd. for C16H21N2O2: 273.1604,
found 273.1603.
tert-butyl (S)-2-(4-nitrophenyl)pyrrolidine-1-carboxylate 2i. 
Following the general procedure with 1i as starting material. Yield: 88%. ee: 92%. 
Hexanes/ethyl acetate = 3/1, Rf = 0.35. [α]20 D = -101.6 (c = 0.5, CHCl3). 1H NMR (600 
MHz, CDCl3): a mixture of amide rotamers. δ 8.17 (d, J = 8.4 Hz, 2H), 7.34 (d, J = 8.6 Hz, 
2H), 4.98 and 4.84 (m, br, 1H), 3.66 – 3.65 (m, br, 2H), 2.39 (m, br, 1H), 1.91 – 1.90 (m, 
2H), 1.80 (m, br, 1H), 1.45 and 1.18 (s, 9H). 13C NMR (125 MHz, CDCl3): major isomer 
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δ 154.22, 152.91, 146.83, 126.27, 123.65, 79.87, 61.03, 47.23, 35.98, 28.17, 23.34. HPLC 
analysis: ee = 92%. ADH (95% hexanes : 5% isopropanol, 1.0 mL/min): tmajor = 15.08 
min, tminor = 7.75 min. IR (neat, cm-1): 2974.37, 1690.31, 1517.18, 1388.56, 1156.40, 
1111.56, 853.30. HRMS (ESI) ([M+H]+) Calcd. for C15H21N2O4: 293.1496, found
293.1501.
tert-butyl (S)-2-(2-chloro-4-nitrophenyl)pyrrolidine-1-carboxylate 
2j. Following the general procedure with 1j as starting material. Yield: 81%. ee: 94%. 
Hexanes/ethyl acetate = 5/1, Rf = 0.41. [α]20 D = -191.6 (c = 0.5, CHCl3). 1H NMR (600 
MHz, CDCl3): a mixture of amide rotamers. δ 8.05 – 7.98 (m, 2H), 7.50 (t, J = 6.7 Hz, 1H), 
5.25 – 5.15 (m, 1H), 3.74 – 3.55 (m, 2H), 2.46 – 2.42 (m, 1H), 1.92 – 1.79 (m, 3H), 1.46 
and 1.17 (s, 9H). 13C NMR (150 MHz, CDCl3): major isomer δ 154.42, 146.79, 143.31, 
138.61, 130.37, 122.56, 121.53, 79.86, 58.66, 47.23, 33.82, 28.39, 23.23. HPLC analysis: 
ee = 94%. ODH (99.5% hexanes : 0.5% isopropanol, 1.0 mL/min): tmajor = 16.61 min, tminor
= 15.79 min. IR (neat, cm-1):  2974.26, 1693.57, 1523.64, 1390.46, 1347.37, 1251.32, 
1159.81, 909.68, 757.43. HRMS (ESI) ([M+H]+) Calcd. for C15H20ClN2O4: 327.1106, 
found 327.1103.
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tert-butyl (S)-2-(3-vinylphenyl)pyrrolidine-1-carboxylate 2k. 
Following the general procedure with 1k as starting material. Yield: 81%. ee: 93%. 
Hexanes/ethyl acetate = 8/1, Rf = 0.46. [α]20 D = -144.8 (c = 0.5, CHCl3). 1H NMR (500 
MHz, CDCl3): a mixture of amide rotamers. δ 7.25 – 7.19 (m, 3H), 7.06 – 7.05 (m, 1H), 
6.69 (dd, J = 17.6, 10.7 Hz, 1H), 5.73 (d, J = 17.6 Hz, 1H), 5.22 (d, J = 10.7 Hz, 1H), 4.95 
and 4.75 (m, br, 1H), 3.63 and 3.52 (m, br, 2H), 2.32 (m, br, 1H), 1.91 – 1.84 (m, 3H), 1.46 
(s, 3H), 1.18 (s, 6H). 13C NMR (125 MHz, CDCl3): major isomer δ 154.57, 145.39, 137.39, 
136.86, 128.32, 125.06, 124.35, 123.42, 113.71, 79.23, 61.26, 47.10, 35.97, 28.14, 23.25. 
HPLC analysis: ee = 93%. ADH (99.2% hexanes : 0.8% isopropanol, 1.0 mL/min): tmajor
= 9.25 min, tminor = 10.36 min. IR (neat, cm-1): 2976.26, 1684.19, 1478.10, 1392.01, 
1265.11, 1161.51, 990.47, 874.91. HRMS (ESI) ([M+H]+) Calcd. for C17H24NO2:
274.1802, found 274.1808.
tert-butyl (S,E)-2-(1-phenylprop-1-en-2-yl)pyrrolidine-1-carboxylate 
2l. Following the general procedure with 1l as starting material. Yield: 63%. ee: 94%. 
Hexanes/ethyl acetate = 8/1, Rf = 0.43. [α]20 D = -124.4 (c = 0.5, CHCl3). 1H NMR (600 
MHz, CDCl3): a mixture of amide rotamers. δ 7.24 – 7.12 (m, 5H), 6.19 (s, 1H), 4.18 (m, 
br, 1H), 3.50 and 3.39 (m, br, 2H), 2.03 (br, 1H), 1.85 – 1.70 (m, 6H), 1.34 (s, 9H). 13C
NMR (150 MHz, CDCl3): major isomer δ 154.72, 139.29, 138.03, 128.82, 128.05, 126.04, 
123.53, 79.07, 64.38, 47.00, 31.82, 28.47, 23.21, 14.63. HPLC analysis: ee = 94%. ADH 
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(99% hexanes : 1% isopropanol, 0.8 mL/min): tmajor = 11.19 min, tminor = 9.94 min. IR (neat, 
cm-1): 2972.67, 1679.83, 1394.69, 1362.69, 1246.31, 1157.14, 1115.51, 843.25, 752.51.
HRMS (ESI) ([M+H]+) Calcd. for C18H26NO2: 288.1964, found 288.1966.
tert-butyl (S)-2-(phenylethynyl)pyrrolidine-1-carboxylate 2m. Following 
the general procedure with 1m as starting material. Yield: 60%. ee: 59%. Hexanes/ethyl 
acetate = 10/1, Rf = 0.46. [α]20 D = -122.8 (c = 0.5, CHCl3). 1H NMR (600 MHz, CDCl3): a
mixture of amide rotamers. δ 7.39 – 7.26 (m, 5H), 4.77 and 4.63 (m, br, 1H), 3.52 (m, br, 
1H), 3.36 (m, br, 1H), 2.11 (m, br, 3H), 1.92 (m, br, 1H), 1.49 (s, 9H). 13C NMR (150 MHz, 
CDCl3): major isomer δ 154.14, 131.52, 128.19, 127.93, 123.25, 89.94, 81.49, 79.60, 
48.75, 45.59, 33.81, 28.52, 23.78. HPLC analysis: ee = 59%. ADH (95% hexanes : 5% 
isopropanol, 1.0 mL/min): tmajor = 5.42 min, tminor = 5.01 min. IR (neat, cm-1): 2976.02, 
2359.60, 1698.46, 1489.78, 1395.29, 1255.91, 1168.33, 1089.97, 758.74. HRMS (ESI) 
([M+Na]+) Calcd. for C17H21NNaO2: 294.1465, found 294.1464. 
tert-butyl (S)-2-benzylpyrrolidine-1-carboxylate 2n, known 
compound.24 Following the general procedure with 1n as starting material. Yield: 96%. ee:
23%. Hexanes/ethyl acetate = 6/1, Rf = 0.49. [α]20 D = -3.2 (c = 0.5, CHCl3). 1H NMR (500 
MHz, CDCl3): a mixture of amide rotamers. δ 7.29 – 7.18 (m, 5H), 4.05 and 3.96 (m, br, 
1H), 3.38 and 3.29 (m, br, 2H), 3.18 and 3.07 (m, br, 1H), 2.55 (m, br, 1H), 1.76 (m, br, 
4H), 1.51 (s, 9H). 13C NMR (125 MHz, CDCl3): major isomer δ 154.53, 139.21, 129.37, 
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128.38, 126.19, 79.26, 58.87, 46.29, 40.59, 29.65, 28.61, 22.65. HPLC analysis: ee = 23%. 
ODH (99% hexanes : 1% isopropanol, 1.0 mL/min): tmajor = 6.16 min, tminor = 6.61 min. 
tert-butyl (S)-2-cyclohexylpyrrolidine-1-carboxylate 2o, known 
compound.10b Following the general procedure with 1o as starting material. Yield: 57%. 
ee: 88%. Hexanes/ethyl acetate = 10/1, Rf = 0.45. [α]20 D = -61.6 (c = 0.5, CHCl3). 1H NMR 
(500 MHz, CDCl3): a mixture of amide rotamers. δ 3.70 and 3.61 (m, br, 1H), 3.50 and 
3.40 (m, br, 1H), 3.22 – 3.16 (m, 1H), 1.81 – 1.59 (m, 10H), 1.45 (s, 9H), 1.25 – 0.90 (m, 
5H). 13C NMR (125 MHz, CDCl3): major isomer δ 155.04, 78.74, 61.80, 46.87, 40.77, 
36.52, 30.12, 28.52, 27.93, 26.62, 24.32. HPLC analysis: ee = 88%. ADH (99.5% hexanes 
: 0.5% isopropanol, 1.0 mL/min): tmajor = 5.91 min, tminor = 6.35 min. HRMS (ESI) 
([M+H]+) Calcd. for C15H28NO2: 254.2120, found 254.2128.
2-benzyl 1-(tert-butyl) (S)-pyrrolidine-1,2-dicarboxylate 2p, known 
compound.25 Following the general procedure with 1p as starting material. Yield: 56%. ee:
82%. Hexanes/ethyl acetate = 5/1, Rf = 0.50. [α]20 D = -53.2 (c = 0.5, CHCl3). 1H NMR (500 
MHz, CDCl3): a mixture of amide rotamers. δ 7.37 – 7.30 (m, 5H), 5.26 – 5.07 (m, 2H), 
4.39 (dd, J = 8.6, 3.2 Hz, 0.4H) and 4.26 (dd, J = 8.6, 4.0 Hz, 0.6H), 3.58 – 3.34 (m, 2H), 
2.26 – 2.15 (m, 1H), 1.99 – 1.83 (m, 3H), 1.46 and 1.34 (s, 9H). 13C NMR (125 MHz, 
CDCl3): major isomer δ 173.02, 153.78, 135.65, 128.56, 128.27, 127.97, 79.87, 66.59, 
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59.17, 46.31, 30.87, 28.22, 23.59. HPLC analysis: ee = 82%. ADH (97% hexanes : 3% 
isopropanol, 0.8 mL/min): tmajor = 21.68 min, tminor = 14.26 min.
tert-butyl (S)-2-(pyridin-3-yl)pyrrolidine-1-carboxylate 2q, known 
compound.26 Following the general procedure with 1q as starting material. Yield: 73%. ee:
92%. Hexanes/ethyl acetate = 2/1, Rf = 0.27. [α]20 D = -48.2 (c = 0.5, CHCl3). 1H NMR (400 
MHz, CDCl3): a mixture of amide rotamers. δ 8.45 (br, 2H), 7.47 (d, J = 7.7 Hz, 1H), 7.26 
– 7.22 (m, 1H), 4.95 and 4.76 (br, 1H), 3.61 (br, 2H), 2.35 (br, 1H), 1.90 – 1.82 (m, 3H), 
1.44 (s, 3H), 1.18 (s, 6H). 13C NMR (125 MHz, CDCl3): major isomer δ 154.23, 148.07, 
147.94, 140.32, 133.08, 123.30, 79.60, 59.24, 47.19, 35.96, 28.22, 23.27. HPLC analysis: 
ee = 92%. ADH (95% hexanes : 5% isopropanol, 1.0 mL/min): tmajor = 19.47 min, tminor =
25.97 min. HRMS (ESI) ([M+H]+) Calcd. for C14H21N2O2: 249.1598, found 249.1610. 
tert-butyl (S)-2-(pyridin-2-yl)pyrrolidine-1-carboxylate 2r, known 
compound.26 Following the general procedure with 1r as starting material. Yield: 51%. ee:
85%. Hexanes/ethyl acetate = 2/1, Rf = 0.27. [α]20 D = -72.4 (c = 0.5, CHCl3). 1H NMR (500 
MHz, CDCl3): a mixture of amide rotamers. δ 8.53 (br, 1H), 7.62 (t, J = 7.1 Hz, 1H), 7.16 
– 7.11 (m, 2H), 4.99 – 4.85 (m, br, 1H), 3.67 – 3.51 (m, 2H), 2.36 – 1.99 (m, br, 1H), 2.00 
– 1.86 (m, 3H), 1.45 (s, 3H), 1.18 (s, 6H). 13C NMR (125 MHz, CDCl3): major isomer δ
163.76, 154.49, 148.94, 136.22, 121.52, 119.62, 79.28, 62.83, 47.06, 34.27, 28.15, 23.21. 
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HPLC analysis: ee = 85%. ADH (90% hexanes : 10% isopropanol, 1.0 mL/min): tmajor =
11.77 min, tminor = 7.83 min. HRMS (ESI) ([M+H]+) Calcd. for C14H21N2O2: 249.1598, 
found 249.1612.
tert-butyl (S)-2-(pyridin-4-yl)pyrrolidine-1-carboxylate 2s, known 
compound.27 Following the general procedure with 1s as starting material. Yield: 63%. ee:
95%. Hexanes/ethyl acetate = 2/1, Rf = 0.27. [α]20 D = -58.0 (c = 0.5, CHCl3). 1H NMR (500 
MHz, CDCl3): a mixture of amide rotamers. δ 8.52 (br, 2H), 7.10 – 7.10 (m, 2H), 4.90 and 
4.73 (m, br, 1H), 3.63 (m, br, 2H), 2.35 (m, br, 1H), 1.88 – 1.80 (m, 3H), 1.45 (s, 3H), 1.19 
(s, 6H). 13C NMR (125 MHz, CDCl3): major isomer δ 154.17, 153.16, 149.67, 120.71, 
79.77, 60.48, 47.10, 35.50, 28.11, 23.20. HPLC analysis: ee = 95%. OJH (98% hexanes : 
2% isopropanol, 1.0 mL/min): tmajor = 15.14 min, tminor = 13.85 min. HRMS (ESI) ([M+H]+)
Calcd. for C14H21N2O2: 249.1598, found 249.1605.
tert-butyl (S)-2-(quinolin-4-yl)pyrrolidine-1-carboxylate 2t. Following 
the general procedure with 1t as starting material. Yield: 91%. ee: 97%. Hexanes/ethyl 
acetate = 2/1, Rf = 0.26. [α]20 D = -172.4 (c = 0.5, CHCl3). 1H NMR (500 MHz, CDCl3): a
mixture of amide rotamers. δ 8.84 (d, J = 3.6 Hz, 1H), 8.15 – 8.11 (m, 1H), 7.99 (d, J = 8.4 
Hz, 1H), 7.73 – 7.68 (m, 1H), 7.58 – 7.26 (m, 1H), 7.20 – 7.14 (m, 1H), 5.71 – 5.55 (m, br, 
1H), 3.76 – 3.58 (m, 2H), 2.53 – 2.47 (m, br, 1H), 1.92 – 1.89 (m, 3H), 1.48 (s, 4H), 1.10 
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(s, 5H). 13C NMR (125 MHz, CDCl3): major isomer δ 154.24, 150.07, 148.87, 148.29, 
130.33, 129.02, 126.45, 125.65, 122.77, 116.66, 79.68, 57.69, 46.93, 34.23, 28.05, 23.16. 
HPLC analysis: ee = 97%. ODH (95% hexanes : 5% isopropanol, 1.0 mL/min): tmajor =
15.03 min, tminor = 11.22 min. IR (neat, cm-1): 2980.93, 1687.59, 1593.98, 1392.98, 
1264.44, 1158.78, 896.45. HRMS (ESI) ([M+H]+) Calcd. for C18H23N2O3: 315.1703, found
315.1715.
tert-butyl (S)-3-(1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-1H-indole-1-
carboxylate 2u. Following the general procedure with 1u as starting material. Yield: 88%. 
ee: 95%. Hexanes/ethyl acetate = 3/1, Rf = 0.35. [α]20 D = -244.1 (c = 0.5, CHCl3). 1H NMR 
(500 MHz, CDCl3): a mixture of amide rotamers. δ 8.15 (br, 1H), 7.50 (d, J = 7.8 Hz, 1H), 
7.31 – 7.21 (m, 3H), 5.20 and 5.06 (m, br, 1H), 3.62 and 3.50 (m, br, 2H), 2.25 (m, br, 1H), 
2.04 – 1.87 (m, 3H), 1.65 (s, 9H), 1.47 (s, 4H), 1.23 (s, 5H). 13C NMR (150 MHz, CDCl3): 
major isomer δ 154.63, 149.75, 135.91, 128.51, 124.22, 123.62, 122.32, 121.96, 119.11, 
115.35, 83.50, 79.31, 54.17, 46.38, 33.29, 28.52, 28.21, 23.30. HPLC analysis: ee = 95%. 
ADH (99% hexanes : 1% isopropanol, 1.0 mL/min): tmajor = 12.64 min, tminor = 9.34 min.
IR (neat, cm-1): 2975.37, 1730.74, 1691.92, 1451.53, 1365.68, 1153.88, 1068.04, 855.98. 
HRMS (ESI) ([M+H]+) Calcd. for C22H31N2O4: 387.2278, found 387.2287.
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tert-butyl (S)-2-(thiophen-3-yl)pyrrolidine-1-carboxylate 2v, known 
compound.28 Following the general procedure with 1v as starting material. Yield: 71%. ee:
91%. Hexanes/ethyl acetate = 6/1, Rf = 0.42. [α]20 D = -78.4 (c = 0.5, CHCl3). 1H NMR (500 
MHz, CDCl3): a mixture of amide rotamers. δ 7.27 – 7.23 (m, 1H), 6.97 and 6.93 (br, 2H), 
5.05 and 4.89 (m, br, 1H), 3.54 and 3.49 (m, br, 2H), 2.22 (m, br, 1H), 2.18 – 1.87 (m, 3H), 
1.46 (s, 3H), 1.27 (s, 6H). 13C NMR (125 MHz, CDCl3): major isomer δ 154.57, 145.96, 
125.84, 125.44, 119.56, 79.22, 57.20, 46.41, 34.72, 28.26, 23.22. HPLC analysis: ee =
91%. ADH (95% hexanes : 5% isopropanol, 0.8 mL/min): tmajor = 6.50 min, tminor = 6.07 
min. HRMS (ESI) ([M+H]+) Calcd. for C13H20NO2S: 254.1209, found 254.1228. 
tert-butyl (S)-2-(benzo[b]thiophen-3-yl)pyrrolidine-1-carboxylate 2w,
known compound.29 Following the general procedure with 1w as starting material. Yield: 
86%. ee: 96%. (For reaction with 2.0 mmol scale: yield: 82%. ee: 96%). Hexanes/ethyl 
acetate = 6/1, Rf = 0.38. [α]20 D = -144.8 (c = 0.5, CHCl3). 1H NMR (600 MHz, CDCl3): a
mixture of amide rotamers. δ 7.85 (br, 1H), 7.72 (d, J = 6.7 Hz, 1H), 7.35 (br, 2H), 7.06 
(br, 1H), 5.37 – 5.20 (m, br, 1H), 3.71 – 3.50 (m, br, 2H), 2.31 (br, 1H), 1.98 and 1.92 (m, 
br, 3H), 1.48 (s, 3.5H), 1.16 (s, 5.5H). 13C NMR (150 MHz, CDCl3): major isomer δ 154.55,
140.98, 139.07, 137.07, 124.15, 123.84, 122.96, 121.55, 120.55, 79.28, 56.70, 46.52, 
33.23, 28.16, 23.17. HPLC analysis: ee = 96%. ADH (99% hexanes : 1% isopropanol, 1.0 
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mL/min): tmajor = 14.66 min, tminor = 11.01 min. HRMS (ESI) ([M+H]+) Calcd. for 
C17H22NO2S: 304.1366, found 304.1371.
tert-butyl (S)-2-ferrocenylpyrrolidine-1-carboxylate 2x. Following the 
general procedure with 1x as starting material. Yield: 53%. ee: 92%. Hexanes/ethyl acetate 
= 5/1, Rf = 0.43. [α]20 D = -26.0 (c = 0.5, CHCl3). 1H NMR (600 MHz, CDCl3): a mixture 
of amide rotamers. δ 4.88 and 4.72 (m, br, 1H), 4.52 and 4.36 (m, br, 1H), 4.15 and 4.10 
(m, br, 8H), 3.50 and 3.31 (br, 2H), 2.24 – 2.14 (br, 2H), 2.04 – 1.91 (m, 2H), 1.45 (s, 9H). 
13C NMR (150 MHz, CDCl3): major isomer δ 154.61, 90.37, 79.41, 69.75, 68.55, 65.75, 
55.72, 46.39, 32.72, 28.59, 24.71. HPLC analysis: ee = 92%. ODH (99% hexanes : 1% 
isopropanol, 1.0 mL/min): tmajor = 9.85 min, tminor = 13.10 min. IR (neat, cm-1): 3092.07, 
2972.86, 1690.94, 1390.64, 1248.38, 1165.54, 1106.86, 1000.94, 875.23, 819.20. HRMS 
(ESI) ([M]+) Calcd. For C19H25FeNO2: 355.1235, found 355.1244. 
(S)-2-phenyltetrahydrofuran 2y, known compound.30 Following the general 
procedure with 1y as starting material. Yield: 54%. ee: 85%. Hexanes/ethyl acetate = 10/1; 
Rf = 0.35. [α]20 D = -8.1 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.32 – 7.23 (m, 
5H), 4.87 (t, J = 7.2 Hz, 1H), 4.08 (dd, J = 14.8, 7.0 Hz, 1H), 3.92 (dd, J = 14.8, 7.6 Hz, 
1H), 2.30 (td, J = 12.5, 7.0 Hz, 1H), 2.03 – 1.95 (m, 2H), 1.79 (ddd, J = 16.0, 12.2, 7.6 Hz, 
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1H). 13C NMR (100 MHz, CDCl3): δ 143.41, 128.23, 127.06, 125.58, 80.63, 68.62, 34.57, 
25.99. HPLC analysis: ee = 85%. ADH (100% hexanes, 0.8 mL/min): tmajor = 19.89 min, 
tminor = 24.78 min.
(S)-2-phenyltetrahydrothiophene 2z. Following the general procedure with 
1z as starting material. Yield: 85%. ee: 91%. Hexanes/ethyl acetate = 10/1; Rf = 0.70. [α]20
D = -9.6 (c = 0.5, CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.42 (d, J = 7.4 Hz, 2H), 7.31 (t, 
J = 7.6 Hz, 2H), 7.23 (t, J = 7.3 Hz, 1H), 4.54 – 4.51 (m, 1H), 3.18 – 3.14 (m, 1H), 3.04 –
3.00 (m, 1H), 2.41 – 2.38 (m, 1H), 2.28 – 2.26 (m, 1H), 2.04 – 1.92 (m, 2H). 13C NMR 
(150 MHz, CDCl3): δ 142.96, 128.35, 127.60, 126.95, 52.73, 40.50, 33.48, 31.04. HPLC 
analysis: ee = 91%. ODH (100% hexanes, 1.0 mL/min): tmajor = 14.43 min, tminor = 13.55 
min. IR (neat, cm-1): 2943.69, 1598.42, 1490.46, 1260.22, 1098.22, 1018.64, 758.87, 
698.96. HRMS (ESI) ([M+H]+) Calcd. For C10H13S: 165.0732, found 165.0741. 
cyclopentylbenzene 2aa, known compound.31 Following the general 
procedure with 1aa as starting material and [Co(P1)] (3 mol %) as the catalyst. Yield: 76%. 
Pentane; Rf = 0.80. 1H NMR (500 MHz, CDCl3) δ 7.30 – 7.24 (m, 4H), 7.1 – 7.15 (m, 1H), 
3.03 – 2.96 (m, 1H), 2.11 – 2.04 (m, 2H), 1.83 – 1.77 (m, 2H), 1.73 – 1.65 (m, 2H), 1.64 –
1.56 (m, 2H). 13C NMR (125 MHz, CDCl3): δ 146.51, 128.19, 127.08, 125.63, 45.93, 
34.59, 25.52.
Chapter 4. Enantioselective C–H Alkylation with In Situ-Generated Alkyldiazomethanes   
tert-butyl (S)-3-phenylpyrrolidine-1-carboxylate 2ab. Following the 
general procedure with 1ab as starting material. Yield: 50%. ee: 67%. Hexanes/ethyl 
acetate = 10/1; Rf = 0.50. [α]20 D = -5.3 (c = 0.5, CHCl3). 1H NMR (600 MHz, CDCl3): a
mixture of amide rotamers. δ 7.34 – 7.23 (m, 5H), 3.88 – 3.76 (m, 1H), 3.55 (t, J = 8.7 Hz, 
1H), 3.44 – 3.27 (m, 3H), 2.26 – 2.25 (m, 1H), 2.02 – 1.97 (m, 1H), 1.47 (s, 9H). 13C NMR 
(150 MHz, CDCl3): major isomer δ 154.50, 141.46, 128.56, 127.04, 126.75, 79.18, 52.60, 
45.62, 44.27, 32.44, 28.54. HPLC analysis: ee = 67%. OJH (99% hexanes : 1% 
isopropanol, 1.0 mL/min): tmajor = 9.48 min, tminor = 8.42 min. IR (neat, cm-1): 2973.27, 
1697.99, 1454.43, 1406.93, 1365.73, 1169.52, 1124.12, 880.73, 700.43. HRMS (ESI) 
([M+Na]+) Calcd. For C15H21NNaO2: 270.1465, found 270.1466. 
tert-butyl (quinolin-4-yl((2,2,6,6-tetramethylpiperidin-1-
yl)oxy) methyl) (3-((2,2,6,6-tetramethylpiperidin-1-yl)oxy)propyl)carbamate 3t.
Reaction procedure: An oven-dried Schlenk tube was charged with 1.0 equivalent of 
sulfonyl hydrazone 1t (0.1 mmol), [Co(P1)] (5 mol %) and 1.5 equivalent of Cs2CO3 (0.15 
mmol). The Schlenk tube was then evacuated and backfilled with nitrogen for 3 times.
Then TEMPO (2.0 equiv.) was added under nitrogen, followed by the injection of dioxane 
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(0.6 mL) via a gas-tight syringe. The Schlenk tube was then purged with nitrogen for 10 s 
and sealed with a Teflon screw cap. The mixture was then stirred at 60 oC. After 24 h, the 
reaction mixture was concentrated and purified by flash chromatography. The fractions 
containing 3t were collected and concentrated by rotary evaporation to afford the pure 
compound. Yield: 20%. Hexanes/ethyl acetate = 6/1, Rf = 0.50. 1H NMR (600 MHz, 
CDCl3): a mixture of amide rotamers. δ 8.96 and 8.94 (d, J = 4.3 Hz, 1H), 8.24 and 8.15 
(d, J = 8.4 Hz, 1H), 8.11 (d, J = 8.4 Hz, 1H), 7.81 (br, 1H), 7.73 – 7.68 (m, 1H), 7.55 (t, J
= 7.6 Hz, 1H), 7.40 and 7.30 (s, 1H), 3.34 – 3.17 (m, 4H), 1.67 (s, 3H), 1.58 – 1.43 (m, 
12H), 1.40 – 1.36 (m, 6H), 1.29 – 1.11 (m, 10H), 1.03 – 0.98 (m, 9H), 0.89 (br, 3H), 0.83 
(br, 3H), 0.17 – 0.07 (m, br, 1H). 13C NMR (150 MHz, CDCl3): δ 155.00, 154.02(minor), 
150.15(minor), 149.89, 148.12(minor), 148.14, 145.87, 144.81(minor), 130.32(minor), 
129.91, 129.18, 129.07(minor), 126.94, 126.62(minor), 125.97, 125.81(minor), 124.16, 
123.29(minor), 119.10, 119.32(minor), 86.79, 86.44(minor), 80.61(minor), 80.04, 74.18, 
74.11(minor), 60.95(minor), 60.88, 59.48, 59.39(minor), 40.53(minor), 40.45, 
40.39(minor), 40.19, 39.82, 39.49, 33.30(minor), 33.00, 32.89(minor), 32.83(minor), 32.43, 
28.69(minor), 28.31, 28.12, 27.17(minor), 20.48(minor), 20.46, 20.25(minor), 
20.15(minor), 19.94, 17.14(minor), 17.07, 17.05. IR (neat, cm-1): 2973.56, 2930.79, 
1693.40, 1592.91, 1465.13, 1402.57, 1365.90, 1259.53, 1170.61, 1043.10, 910.39. HRMS 
(ESI) ([M+H]+) Calcd. For C36H59N4O4: 611.4531, found 611.4530. The structure was 
further characterized and confirmed with H-H COSY, DEPT and HSQC.
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tert-butyl (S)-2-methyl-2-phenylpyrrolidine-1-carboxylate 5a. Following 
the general procedure with 4a as starting material and with [Co(P1)] (3 mol %) as the 
catalyst. Yield: 55%. ee: 81%. Hexanes/ethyl acetate = 10/1, Rf = 0.40. [α]20 D = -43.6 (c =
0.5, CHCl3). 1H NMR (500 MHz, CDCl3): a mixture of amide rotamers δ 7.29 – 7.17 (m, 
5H), 3.71 – 3.59 (m, 2H), 2.08 – 2.00 (m, 2H), 1.87 – 1.79 (m, 2H), 1.74 (s, 3H), 1.44 and 
1.11 (s, 9H). 13C NMR (125 MHz, CDCl3): major isomer δ 154.28, 148.45, 127.84, 125.92, 
125.01, 79.05, 64.87, 48.59, 45.80, 28.10, 25.43, 22.05. HPLC analysis: ee = 81%. ODH 
(99% hexanes : 1% isopropanol, 1.0 mL/min): tmajor = 6.28 min, tminor = 6.94 min. IR (neat, 
cm-1): 2972.63, 1687.81, 1446.93, 1392.64, 1367.02, 1165.68, 1029.22, 761.48. HRMS 
(ESI) ([M+Na]+) Calcd. for C16H23NNaO2: 284.1621, found 284.1620. The absolute 
stereochemistry of the major enantiomer was assigned by X-ray crystallography.
4.4.7 Procedure for HRMS Experiment
To an over-dried Schlenk tube, tosylhydrazone 1a (0.05 mmol) and Cs2CO3 (1.5 
equiv.) were added. The Schlenk tube was then evacuated and backfilled with nitrogen for 
3 times. The Teflon screw cap was replaced with a rubber septum, CH3CN (0.5 mL) was 
added via a gas-tight syringe. The mixture was then stirred at 60 oC for 1 h. The resulting 
light yellow solution was then passed through a short pad of Celite (to get rid of base and 
salt) under the flow of nitrogen and the filtrate was collected in a HPLC vial (vial A, 
degassed and backfilled with argon). During the time, [Co(P1)] (3 mol %) was charged 
into another HPLC vial (vial B, degassed and backfilled with argon) and dissolved in 
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CH3CN (0.5 mL). After mixing equal amount of solutions from vial A (0.1 mL) and vial B 
(0.1 mL), the sample was further diluted with CH3CN and immediately injected into HRMS 
instrument. The HRMS experiment was carried out in the absence of any additives such as 
formic acid, commonly act as electron carriers for ionization, allowing the detection of the 
molecular ion signals corresponding to Co(III)-alkyl radical (C91H109CoN9O6·) by the loss 
of one electron.
4.4.8 Procedure for EPR Experiment
To an oven-dried Schlenk tube A, tosylhydrazone 1a (0.05 mmol), and Cs2CO3 (1.5
equiv.) were added. The Schlenk tube was then evacuated and backfilled with nitrogen for 
3 times. The Teflon screw cap was replaced with a rubber septum, benzene (0.5 mL) was 
added via a gas-tight syringe. The mixture was then stirred at 60 oC for 1 h. During the 
time, [Co(P1)] (3 mol %) was charged into another oven-dried Schlenk tube B. The 
Schlenk tube B was then evacuated and backfilled with nitrogen for 3 times. After 1 h, the 
resulting light yellow solution from tube A was passed through a short pad of Celite (to get 
rid of base and salt) under the flow of nitrogen and transferred to Schlenk tube B. The 
mixture was stirred for 1 min, followed by the addition of phenyl N-tert-butylnitrone (PBN, 
0.05 mmol). The reaction mixture was stirred for 2 min and transferred into a degassed 
EPR tube (filled with argon) through a gas tight syringe. The sample was then carried out 
for EPR experiment at room temperature (EPR settings: T = 298 K; microwave frequency: 
9.37762 GHz; power: 20 mW; modulation amplitude: 1.0 G)
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Enantioselective Radical Cis-Cyclopropanation of Alkenes 


































































































































Enantioselective Radical Cyclization for Construction of 5-
Membered Ring Structures by Metalloradical 
C–H Alkylation
Free Base of 2,4,6-trimethyl-Zhuphyrin [H2(P6)] 
































Note: The spectrum contains a mixture of amide rotamers.
benzyl N-(tert-butoxycarbonyl)-N-(3-hydroxypropyl)glycinate s1-p
























Note: The spectrum contains a mixture of amide rotamers.
tert-butyl benzyl(3-oxopropyl)carbamate s2-a
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (4-methylbenzyl)(3-oxopropyl)carbamate s2-b
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (4-methylbenzyl)(3-oxopropyl)carbamate s2-b
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (3-methoxybenzyl)(3-oxopropyl)carbamate s2-c
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (3-methoxybenzyl)(3-oxopropyl)carbamate s2-c
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (2-methoxybenzyl)(3-oxopropyl)carbamate s2-d
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (2-methoxybenzyl)(3-oxopropyl)carbamate s2-d
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (3,5-bis(trifluoromethyl)benzyl)(3-oxopropyl)carbamate s2-e
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (3,5-bis(trifluoromethyl)benzyl)(3-oxopropyl)carbamate s2-e
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (4-bromobenzyl)(3-oxopropyl)carbamate s2-f
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (4-bromobenzyl)(3-oxopropyl)carbamate s2-f
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (2,4,6-trifluorobenzyl)(3-oxopropyl)carbamate s2-g
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (2,4,6-trifluorobenzyl)(3-oxopropyl)carbamate s2-g
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (4-nitrilebenzyl)(3-oxopropyl)carbamate s2-h
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (4-nitrilebenzyl)(3-oxopropyl)carbamate s2-h
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (4-nitrobenzyl)(3-oxopropyl)carbamate s2-i
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (4-nitrobenzyl)(3-oxopropyl)carbamate s2-i
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (2-chloro-4-nitrobenzyl)(3-oxopropyl)carbamate s2-j
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (2-chloro-4-nitrobenzyl)(3-oxopropyl)carbamate s2-j
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (3-vinylbenzyl)(3-oxopropyl)carbamate s2-k
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (3-vinylbenzyl)(3-oxopropyl)carbamate s2-k
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (E)-(2-methyl-3-phenylallyl)(3-oxopropyl)carbamate s2-l
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (E)-(2-methyl-3-phenylallyl)(3-oxopropyl)carbamate s2-l
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (3-oxopropyl)(3-phenylprop-2-yn-1-yl)carbamate s2-m
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (3-oxopropyl)(3-phenylprop-2-yn-1-yl)carbamate s2-m
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (3-oxopropyl)(phenethyl)carbamate s2-n
Note: The spectrum contains a mixture of amide rotamers.
DCM
tert-butyl (3-oxopropyl)(phenethyl)carbamate s2-n
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (cyclohexylmethyl)(3-oxopropyl)carbamate s2-o
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (cyclohexylmethyl)(3-oxopropyl)carbamate s2-o
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
Note: The spectrum contains a mixture of amide rotamers.
benzyl N-(tert-butoxycarbonyl)-N-(3-oxopropyl)glycinate s2-p 
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
benzyl N-(tert-butoxycarbonyl)-N-(3-oxopropyl)glycinate s2-p 
tert-butyl (3-oxopropyl)(pyridin-3-ylmethyl)carbamate s2-q
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (3-oxopropyl)(pyridin-3-ylmethyl)carbamate s2-q
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (3-oxopropyl)(pyridin-2-ylmethyl)carbamate s2-r
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (3-oxopropyl)(pyridin-2-ylmethyl)carbamate s2-r
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (3-oxopropyl)(pyridin-4-ylmethyl)carbamate s2-s
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (3-oxopropyl)(pyridin-4-ylmethyl)carbamate s2-s
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (3-oxopropyl)(quinolin-4-ylmethyl)carbamate s2-t
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (3-oxopropyl)(quinolin-4-ylmethyl)carbamate s2-t
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl 3-(((tert-butoxycarbonyl)(3-oxopropyl)amino)methyl)-1H-indole-1-carboxylate s2-u
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl 3-(((tert-butoxycarbonyl)(3-oxopropyl)amino)methyl)-1H-indole-1-carboxylate s2-u
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (3-oxopropyl)(thiophen-3-ylmethyl)carbamate s2-v
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (3-oxopropyl)(thiophen-3-ylmethyl)carbamate s2-v
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (benzo[b]thiophen-3-ylmethyl)(3-oxopropyl)carbamate s2-w
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (benzo[b]thiophen-3-ylmethyl)(3-oxopropyl)carbamate s2-w
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (ferrocenyl)(3-oxopropyl)carbamate s2-x
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (ferrocenyl)(3-oxopropyl)carbamate s2-x







Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (2-oxoethyl)(phenethyl)carbamate s2-aa
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl (R)-(3-oxopropyl)(1-phenylethyl)carbamate s2-ab
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (R)-(3-oxopropyl)(1-phenylethyl)carbamate s2-ab
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major rotamer was labelled.
tert-butyl benzyl(3-(2-tosylhydrazono)propyl)carbamate 1a
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl benzyl(3-(2-tosylhydrazono)propyl)carbamate 1a
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (4-methylbenzyl)(3-(2-tosylhydrazono)propyl) carbamate 1b
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (4-methylbenzyl)(3-(2-tosylhydrazono)propyl) carbamate 1b
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (3-methoxybenzyl)(3-(2-tosylhydrazono)propyl) carbamate 1c
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (3-methoxybenzyl)(3-(2-tosylhydrazono)propyl) carbamate 1c
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (2-methoxybenzyl)(3-(2-tosylhydrazono)propyl) carbamate 1d
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (2-methoxybenzyl)(3-(2-tosylhydrazono)propyl) carbamate 1d
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (3,5-bis(trifluoromethyl)benzyl)(3-(2-tosylhydrazono)propyl)carbamate 1e
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (3,5-bis(trifluoromethyl)benzyl)(3-(2-tosylhydrazono)propyl)carbamate 1e
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (4-bromobenzyl)(3-(2-tosylhydrazono)propyl) carbamate 1f
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (4-bromobenzyl)(3-(2-tosylhydrazono)propyl) carbamate 1f
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (2,4,6-trifluorobenzyl)(3-(2-tosylhydrazono)propyl) carbamate 1g
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
dioxane
tert-butyl (2,4,6-trifluorobenzyl)(3-(2-tosylhydrazono)propyl) carbamate 1g
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (4-nitrilebenzyl)(3-(2-tosylhydrazono)propyl) carbamate 1h
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (4-nitrilebenzyl)(3-(2-tosylhydrazono)propyl) carbamate 1h
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (4-nitrobenzyl)(3-(2-tosylhydrazono)propyl) carbamate 1i
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (4-nitrobenzyl)(3-(2-tosylhydrazono)propyl) carbamate 1i
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (2-chloro-4-nitrobenzyl)(3-(2-tosylhydrazono) propyl)carbamate 1j
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (2-chloro-4-nitrobenzyl)(3-(2-tosylhydrazono) propyl)carbamate 1j
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (3-vinylbenzyl)(3-(2-tosylhydrazono)propyl) carbamate 1k
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (3-vinylbenzyl)(3-(2-tosylhydrazono)propyl) carbamate 1k
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl ((E)-2-methyl-3-phenylallyl)(3-(2-tosylhydrazono) propyl)carbamate 1l
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl ((E)-2-methyl-3-phenylallyl)(3-(2-tosylhydrazono) propyl)carbamate 1l
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (3-phenylprop-2-yn-1-yl)(3-(2-tosylhydrazono) propyl)carbamate 1m
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (3-phenylprop-2-yn-1-yl)(3-(2-tosylhydrazono) propyl)carbamate 1m
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl phenethyl(3-(2-tosylhydrazono)propyl)carbamate 1n
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl phenethyl(3-(2-tosylhydrazono)propyl)carbamate 1n
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (cyclohexylmethyl)(3-(2-tosylhydrazono)propyl) carbamate 1o
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (cyclohexylmethyl)(3-(2-tosylhydrazono)propyl) carbamate 1o
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
benzyl N-(tert-butoxycarbonyl)-N-(3-(2-tosylhydrazono) propyl)glycinate 1p
benzyl N-(tert-butoxycarbonyl)-N-(3-(2-tosylhydrazono) propyl)glycinate 1p
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (pyridin-3-ylmethyl)(3-(2-tosylhydrazono)propyl) carbamate 1q
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (pyridin-3-ylmethyl)(3-(2-tosylhydrazono)propyl) carbamate 1q
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (pyridin-2-ylmethyl)(3-(2-tosylhydrazono)propyl) carbamate 1r
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (pyridin-2-ylmethyl)(3-(2-tosylhydrazono)propyl) carbamate 1r
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (pyridin-4-ylmethyl)(3-(2-tosylhydrazono)propyl) carbamate 1s
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (pyridin-4-ylmethyl)(3-(2-tosylhydrazono)propyl) carbamate 1s
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (quinolin-4-ylmethyl)(3-(2-tosylhydrazono)propyl) carbamate 1t
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (quinolin-4-ylmethyl)(3-(2-tosylhydrazono)propyl) carbamate 1t
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl 3-(((tert-butoxycarbonyl)(3-(2-tosylhydrazono) propyl)amino)methyl)-1H-indole-1-
carboxylate 1u
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl 3-(((tert-butoxycarbonyl)(3-(2-tosylhydrazono) propyl)amino)methyl)-1H-indole-1-
carboxylate 1u
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (thiophen-3-ylmethyl)(3-(2-tosylhydrazono)propyl) carbamate 1v
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (thiophen-3-ylmethyl)(3-(2-tosylhydrazono)propyl) carbamate 1v
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (benzo[b]thiophen-3-ylmethyl)(3-(2-tosylhydrazono) propyl)carbamate 1w
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (benzo[b]thiophen-3-ylmethyl)(3-(2-tosylhydrazono) propyl)carbamate 1w
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl (ferrocenyl)(3-(2-tosylhydrazono)propyl) carbamate 1x
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl (ferrocenyl)(3-(2-tosylhydrazono)propyl) carbamate 1x
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
N'-(3-(benzyloxy)propylidene)-4-methylbenzenesulfonohydrazide 1y
Note: The spectrum contains a mixture of E/Z isomers of hydrazone C=N bond.
N'-(3-(benzyloxy)propylidene)-4-methylbenzenesulfonohydrazide 1y
Note: The spectrum contains E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
N'-(3-(benzylthio)propylidene)-4-methylbenzene sulfonohydrazide 1z
Note: The spectrum contains a mixture of E/Z isomers of hydrazone C=N bond.
N'-(3-(benzylthio)propylidene)-4-methylbenzene sulfonohydrazide 1z
Note: The spectrum contains E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
4-methyl-N'-(5-phenylpentylidene)benzenesulfonohydrazide 1aa
Note: The spectrum contains a mixture of E/Z isomers of hydrazone C=N bond.
4-methyl-N'-(5-phenylpentylidene)benzenesulfonohydrazide 1aa
Note: The spectrum contains E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
4-methyl-N'-(5-phenylpentylidene)benzenesulfonohydrazide 1ab
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
4-methyl-N'-(5-phenylpentylidene)benzenesulfonohydrazide 1ab
Note: The spectrum contains  amide rotamers and E/Z isomers of hydrazone C=N bond. The major isomer was labelled.
tert-butyl phenethyl(2-(2-tosylhydrazono)ethyl)carbamate 4a
Note: The spectrum contains a mixture of amide rotamers and E/Z isomers of hydrazone C=N bond.
tert-butyl phenethyl(2-(2-tosylhydrazono)ethyl)carbamate 4a




Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-phenylpyrrolidine-1-carboxylate 2a




Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-(4-methylphenyl)pyrrolidine-1-carboxylate 2b




Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-(3-methoxyphenyl)pyrrolidine-1-carboxylate 2c




Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-(2-methoxyphenyl)pyrrolidine-1-carboxylate 2d




Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-(3,5-bis(trifluoromethyl)phenyl)pyrrolidine-1-carboxylate 2e





Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-(4-bromophenyl)pyrrolidine-1-carboxylate 2f




Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-(2,4,6-trifluorophenyl)pyrrolidine-1-carboxylate 2g





Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-(4-cyanophenyl)pyrrolidine-1-carboxylate 2h




Note: The spectrum contains a mixture of amide rotamers.
DCM
tert-butyl (S)-2-(4-nitrophenyl)pyrrolidine-1-carboxylate 2i




Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-(2-chloro-4-nitrophenyl)pyrrolidine-1-carboxylate 2j
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major isomer was labelled .
tert-butyl (S)-2-(2-chloro-4-nitrophenyl)pyrrolidine-1-carboxylate 2j
tert-butyl (S)-2-(2-chloro-4-nitrophenyl)pyrrolidine-1-carboxylate 2j
tert-butyl (S)-2-(3-vinylphenyl)pyrrolidine-1-carboxylate 2k 
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-(3-vinylphenyl)pyrrolidine-1-carboxylate 2k 
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major isomer was labelled .
tert-butyl (S)-2-(3-vinylphenyl)pyrrolidine-1-carboxylate 2k 
tert-butyl (S)-2-(3-vinylphenyl)pyrrolidine-1-carboxylate 2k 
tert-butyl (S,E)-2-(1-phenylprop-1-en-2-yl)pyrrolidine-1-carboxylate 2l
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S,E)-2-(1-phenylprop-1-en-2-yl)pyrrolidine-1-carboxylate 2l
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major isomer was labelled .
tert-butyl (S,E)-2-(1-phenylprop-1-en-2-yl)pyrrolidine-1-carboxylate 2l
tert-butyl (S,E)-2-(1-phenylprop-1-en-2-yl)pyrrolidine-1-carboxylate 2l
tert-butyl (S)-2-phenethylpyrrolidine-1-carboxylate 2m 
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-phenethylpyrrolidine-1-carboxylate 2m 
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major isomer was labelled .
tert-butyl (S)-2-phenethylpyrrolidine-1-carboxylate 2m 
tert-butyl (S)-2-phenethylpyrrolidine-1-carboxylate 2m 
tert-butyl (S)-2-phenethylpyrrolidine-1-carboxylate 2n
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-phenethylpyrrolidine-1-carboxylate 2n




Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-cyclohexylpyrrolidine-1-carboxylate 2o
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major isomer was labelled .
tert-butyl (S)-2-cyclohexylpyrrolidine-1-carboxylate 2o
tert-butyl (S)-2-cyclohexylpyrrolidine-1-carboxylate 2o
2-benzyl 1-(tert-butyl) (S)-pyrrolidine-1,2-dicarboxylate 2p
Note: The spectrum contains a mixture of amide rotamers.
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major isomer was labelled .
2-benzyl 1-(tert-butyl) (S)-pyrrolidine-1,2-dicarboxylate 2p
2-benzyl 1-(tert-butyl) (S)-pyrrolidine-1,2-dicarboxylate 2p
2-benzyl 1-(tert-butyl) (S)-pyrrolidine-1,2-dicarboxylate 2p
tert-butyl (S)-2-(pyridin-3-yl)pyrrolidine-1-carboxylate 2q
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-(pyridin-3-yl)pyrrolidine-1-carboxylate 2q




Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-(pyridin-2-yl)pyrrolidine-1-carboxylate 2r




Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-(pyridin-4-yl)pyrrolidine-1-carboxylate 2s




Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-(quinolin-4-yl)pyrrolidine-1-carboxylate 2t




Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-3-(1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-1H-indole-1-carboxylate 2u




Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-(thiophen-3-yl)pyrrolidine-1-carboxylate 2v




Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-(benzo[b]thiophen-3-yl)pyrrolidine-1-carboxylate 2w




Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-(2-ferrocenyl)pyrrolidine-1-carboxylate 2x














Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-3-phenylpyrrolidine-1-carboxylate 2ab




Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (S)-2-methyl-2-phenylpyrrolidine-1-carboxylate 5a





Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (quinolin-4-yl((2,2,6,6-tetramethylpiperidin-1-yl)oxy)methyl)(3-((2,2,6,6-
tetramethylpiperidin-1-yl)oxy)propyl)carbamate 3t
Note: The spectrum contains a mixture of amide rotamers and the chemical shift of the major isomer was labelled .
tert-butyl (quinolin-4-yl((2,2,6,6-tetramethylpiperidin-1-yl)oxy)methyl)(3-((2,2,6,6-
tetramethylpiperidin-1-yl)oxy)propyl)carbamate 3t
Upfield of H-H COSY Spectrum 
Note: The hydrogens in pink are correlated with the ones in red, indicating either Ha or Hb has a 




Note: From HSQC, it is confirmed that the protons with chemical shift around 3.17 – 3.35 ppm are 
attached to two different carbons, as highlighted in green and pink balls. Moreover, the proton with 
chemical shift around 7.40 ppm is highly deshielded by two heteroatom and sp2 carbon, and it is 
confirmed from HSQC that the proton is from the benzylic methine group. 
tert-butyl (quinolin-4-yl((2,2,6,6-tetramethylpiperidin-1-yl)oxy)methyl)(3-((2,2,6,6-
tetramethylpiperidin-1-yl)oxy)propyl)carbamate 3t
DEPT Experiment of Quaternary Carbons
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (quinolin-4-yl((2,2,6,6-tetramethylpiperidin-1-yl)oxy)methyl)(3-((2,2,6,6-
tetramethylpiperidin-1-yl)oxy)propyl)carbamate 3t
Note: The spectrum contains a mixture of amide rotamers.





DEPT: CH/CH3 up & CH2 down
Note: The spectrum contains a mixture of amide rotamers.
tert-butyl (quinolin-4-yl((2,2,6,6-tetramethylpiperidin-1-yl)oxy)methyl)(3-((2,2,6,6-
tetramethylpiperidin-1-yl)oxy)propyl)carbamate 3t
Note: The spectrum contains a mixture of amide rotamers.
DEPT: CH/CH3 up & CH2 down
Diastereotopic Diastereotopic
Diastereotopic Diastereotopic
